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PREFACE 
No one wants to live forever. However, everyone prizes their vitality. Sadly, the aging process 
decreases physical wellbeing and is a major risk factor for the onset of chronic illnesses like 
metabolic syndrome, atheroschlerosis, cancer, and dementia. Scientific investigations over the 
last several decades have revealed that the phenomenon of aging is not a stochastic decay but is 
in fact regulated by signaling pathways activated both systemically and within tissues. These 
genetic programs are under the control of transcription factors that either activate or inhibit genes 
associated with longevity. FoxO transcription factor activity is strongly associated with increased 
wellness and longevity. Insulin-like signaling (IIS) inhibits FoxO activity, and decreasing 
insulin-like signaling extends lifespan. Importantly, IIS is subject to regulation by environmental 
stimuli, including diet. As such, understanding how environmental interventions activate 
conserved FoxO longevity pathways may lead to new knowledge that slows or prevents aging. 
FoxO transcription factors operate in nuclei that contain DNA arranged in a complex chromatin 
architecture. Whether DNA binding sites are accessible depends on chemical modifications to 
chromatin. This extra layer of transcriptional regulation is known as epigenetics. Although 
changes in epigenetic modifications have been described in aging and epigenetic patterns are 
disordered in diseases of aging, remarkably little mechanistic work has shown how these marks 
contribute to FoxO regulation. It is unknown whether FoxO transcription factors require certain 
epigenetic partner enzymes to activate longevity genes. This gap in knowledge led to us 
undertaking investigations to increase our understanding how epigenetic factors promote 
conserved mechanisms of aging. Like IIS, epigenetic programs are sensitive to environmental 
perturbations, and intervening in an individual may have multigenerational effects. This work is 
only one step in a path that may yet lead to a fuller understanding how epigenetic modifications 
contribute to vitality and to therapies that may show exponential benefits across generational 
time.  
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ABSTRACT 
 
FoxO transcription factors promote longevity across diverse organisms through upregulation of 
parallel stress responses. Therefore, understanding how FoxO activity is regulated may provide 
insights for improving overall vitality in an aging population. Insulin and insulin-like growth 
factor signaling (IIS) is highly conserved across metazoans and antagonizes FoxO function. 
Decreasing IIS pathway activity increases lifespan in model organisms and may be conserve in 
humans. This association between FoxO transcription factors and longevity was first discovered 
in studies using the free living nematode Caenorhabditis elegans. In C. elegans, the DAF-2/IIS 
pathway also influences dauer diapause. Dauer is a state of larval developmental diapause that 
occurs in response to stressful environmental conditions including population stress perceived 
through elaboration of a complex pheromone mixture. Mutations that reduce DAF-2/IIS pathway 
activity arrest as dauers in a manner requiring the FoxO transcription factor DAF-16. When AKT 
activity is reduced, DAF-16/FoxO translocates to the nucleus, where it is inhibited by EAK-
7/TLDC1, a conserved protein of unknown function. eak-7;akt-1 double mutants always arrest as 
dauers. We designed a forward genetic screen to discover novel regulators of DAF-16/FOXO by 
mutagenizing eak-7;akt-1 worms and looking for suppressors of eak-7;akt-1 dauer arrest (seak 
mutants). Whole genome sequencing revealed one seak mutant strain harbored a mutation in set-
4, which encodes a conserved histone H4 lysine 20 (H4K20) methyltransferase. SET-4 is 
required for dauer arrest in both reduced IIS mutant backgrounds and in response to dauer 
inducing pheromone. SET-4 promotes dauer arrest only in XX hermaphrodites, not XO males, 
consistent with existing data that SET-4 participates in dosage compensation of X chromosomes. 
We found that neuron-specific overexpression of set-4 rescued dauer arrest in set-4 mutants to a 
similar extent as the native promoter. SET-4 acts together with DAF-16/FoxO in specific sensory 
neurons to silence expression of the X-linked insulin-like peptide ins-9.  Loss of ins-9 rescues the 
xvii 
 
dauer-defective phenotype observed in set-4 mutants in response to pheromone. ins-9 itself is 
also sensitive to dauer pheromone. Taken together, these data implicate chromatin remodeling as 
a novel mechanism that regulates FoxO transcription factor activity. Since epigenetic marks like 
histone methylation are sensitive to environmental interventions, these findings may lead to new 
therapies for chronic diseases associated with aging. 
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Chapter 1 
Introduction 
 
Conserved metabolic pathways influence development and longevity 
Aging is associated with increased risks of disease, including cardiovascular disease, diabetes, 
dementia, autoimmunity, frailty, and cancer (Niccoli and Partridge, 2012). Previously, aging was 
considered a slow stochastic process in which cellular function declines because of accumulation 
of damaged DNA and proteins. While such molecular phenotypes are some of the hallmarks of 
aging and attributable to errors in DNA and/or protein synthesis	(Lopez-Otin et al., 2013), the 
accumulation of these defects may also be under the control  conserved metabolic pathways. 
These pathways participate in nutrient-sensing, cellular energy balance, stress responses, and 
growth factor signaling. Extensive crosstalk exists between these signaling programs that 
regulate gene expression changes at the level of transcription. In general, signals that indicate 
low nutrient availability or moderate stress levels combine to promote enhanced stress resistance 
and longevity. Increased lifespan is also associated with delayed incidence of disease, increasing 
the quality of life in addition to overall length (Selman and Withers, 2011)  
 
FoxO transcription factors promote longevity and stress resistance 
Conserved pathways associated with aging converge on FoxO transcription factors and modulate 
their activity. FoxO transcription factors are members of the Forkhead superfamily, possessing a 
Forkhead box DNA binding domain (Kaestner et al., 2000). Forkhead transcription factors have 
been found in animals, yeast, and fungi. Mammals express four FoxO proteins: FoxO1, FoxO3, 
FoxO4, and FoxO6 (Greer and Brunet, 2005). The invertebrate model organisms Drosophila 
melanogaster and Caenorhabditis elegans express FoxO orthologs from a single locus. All 
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orthologs bind the same consensus sequence (Liu et al., 2004); however, distinct expression 
patterns or differentially spliced isoforms may underlie specific effects attributed to FoxO 
variants (Eijkelenboom and Burgering, 2013). 
Animals exhibiting enhanced FoxO transcription factor activity demonstrate increased lifespan. 
(Bluher et al., 2003; Giannakou et al., 2004; Hwangbo et al., 2004; Kenyon et al., 1993; 
Yamamoto and Tatar, 2011). This phenomenon may be conserved in humans. Certain FoxO1 
and FoxO3A polymorphisms are enriched in centenarians, further supporting the important role 
of FoxO in longevity (Anselmi et al., 2009; Flachsbart et al., 2009; Li et al., 2009; Willcox et al., 
2008). 
How do FoxO transcription factors promote longevity? FoxO activity can promote either cell 
survival or apoptosis depending on upstream environmental cues (Accili and Arden, 2004) and 
may interact with p53 (Pinkston et al., 2006; Renault et al., 2011). Recent work has linked loss of 
FoxO with diseases associated with aging. FoxO proteins decrease oxidative stress in osteoblast 
lineages, promoting the maintenance of skeletal bone integrity, which may reduce age-related 
frailty and osteoporosis (Ambrogini et al., 2010; Li et al., 2010; Rached et al., 2010). FoxO’s 
role in responding to oxidative stress has also been implicated in Alzheimer’s Disease and 
diabetes (Manolopoulos et al., 2010). The C. elegans ortholog DAF-16/FoxO has been shown to 
prevent cell death due to poly-glutamine aggregations in models of muscular dystrophy and 
Alzheimer’s (Hsu et al., 2003; Oh and Kim, 2013). Ablation of FoxO1, FoxO3, and FoxO4 in 
mice leads to lymphoma and hemangioma, demonstrating that these transcription factors act as 
tumor suppressors (Paik et al., 2007). 
 
Insulin and Insulin-like growth factor signaling (IIS) control FoxO activity 
Insulin and insulin-like growth factor signaling (IIS) is highly conserved across metazoans and 
acts to inhibit FoxO activity (Fig. 1.1) (Woods and Rena, 2002). Insulin or insulin-like peptides 
bind to receptor tyrosine kinases, leading to autophosphorylation of their intracellular kinase 
domains. This activation recruits the insulin receptor substrate and PI3 kinase, which catalyzes 
the conversion of phosphatidylinositol (4,5)-bisphosphate (PIP2) into phosphatidylinositol 
(3,4,5)=triphosphate (PIP3) (Vanhaesebroeck and Alessi, 2000). Signaling proteins possessing 
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pleckstrin homology domains including PDK and Akt/PKB are then recruited to the plasma 
membrane. PDK then phosphorylates and activates Akt (Paradis et al., 1999). Activated Akt acts 
on many substrates containing an RXRXXS/T phosphorylation motif 	(Obata et al., 2000). After 
translocating to the nucleus, Akt phosphorylates FoxO transcription factors at multiple conserved 
consensus sites. Phosphorylation of FoxOs leads to their nuclear export and sequestration in the 
cytosol (Brunet et al., 1999). Binding of 14-3-3 proteins to phosphorylated FoxO blocks the 
ability of FoxO to bind DNA and masks the nuclear localization sequence, re-enforcing nuclear 
exclusion (Brunet et al., 2002; Cahill et al., 2001; Obsilova et al., 2005). Phosphorylation of 
FoxO by Akt triggers ubiquitination and subsequent degradation (Hu et al., 2004; Huang et al., 
2004). Therefore, increased insulin-like signaling suppresses FoxO mediated stress responses 
and associated longevity. 
 
C. elegans is a model for developmental pathways linked to longevity 
Much of the logic of the insulin-like signaling pathway came from epistasis experiments in C. 
elegans using mutant strains that exhibited abnormal rates of entry into an alternative 
developmental larval state known as dauer (discussed below)	(Klass and Hirsh, 1976). Mutations 
in the daf-2 gene cause increased rates of dauer arrest and also doubled adult lifespans relative to 
wild type animals (Kenyon et al., 1993). This greatly enhanced longevity was entirely dependent 
on the presence of daf-16; both daf-16 and daf-16;daf-2 mutant strains were found to be short-
lived. DAF-2 was later identified as the sole insulin-like growth factor receptor homolog in 
worms (Kimura et al., 1997), while DAF-16 is the single FoxO transcription factor (Lin et al., 
1997; Ogg et al., 1997). Further pathway analysis revealed that the entire IIS pathway is 
conserved in C. elegans (Fig. 1.1)	(Engelman et al., 2006). 
The simplicity of C. elegans is useful for dissecting conserved mechanisms of aging. First, these 
animals are small but easily manipulated, and can be grown at large numbers. Second, these 
animals typically live for only two to three weeks. Third, they are highly genetically tractable 
with mutants available for most genes, including viable daf-16 null mutants. Many of these 
mutations produce visible phenotypes that can aid in pathway dissection or forward genetic 
mutagenesis screens. Importantly, they also exhibit developmental plasticity in conditions of 
high or low environmental stress that is DAF-16/FoxO dependent. 
	 4	
 
 
Figure 1.1. Insulin and insulin-like growth factor signaling (IIS) is conserved. The IIS pathways and 
downstream consequences for mammals and C. elegans are shown. Adapted (Engelman et al., 2006). 
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Under replete conditions where food is plentiful, C. elegans develops from an embryo through 
four larval stages (L1-L4) to become reproductively mature in two to four days depending on 
temperature. However, animals that face adverse environmental conditions like high heat, lack of 
food, or overcrowding will enter a morphologically distinct larval diapause known as dauer (Fig. 
1.2) (Cassada and Russell, 1975). Compared to animals continuing reproductive development, 
dauers have enhanced resistance to stresses. They have a thickened, specialized cuticle to survive 
harsh environments (Blaxter, 1993) and are protected against endogenous oxidative stress 
(Honda et al., 2008). During diapause, animals cease feeding, and a buccal plug occludes their 
constricted pharynx. Dauers develop distinct anatomical features that facilitate dispersal from the 
undesirable environment. Cuticular ridges called alae allow fast movement (Popham and 
Webster, 1978) while increased dendritic branching and neuromuscular connections permit 
dauer-specific behaviors like nictation (Dixon et al., 2008; Schroeder et al., 2013). Dauers 
generate energy via the glyoxylate pathway, converting stored fat to glucose (Wadsworth and 
Riddle, 1989). The dauer state can persist for months, far longer than typical adult lifespans 
(Klass and Hirsh, 1976). Once they sense improved conditions, animals will resume reproductive 
development at L4 and have a typical adult lifespan. 
The decision whether to proceed with reproductive development or arrest as dauers is mediated 
through multiple sensory inputs. Animals detect an unknown bacterial food signal as well as a 
mixture of modified ascarosides collectively known as dauer pheromone (Golden and Riddle, 
1984; Ludewig and Schroeder, 2013). This pheromone is produced constitutively and may be 
how animals sense population density. Several different ascaroside derivatives have been found 
to be active in the pheromone mixture at different potencies (Butcher et al., 2007). In 
combination with temperature sensing AFD neurons (Mori and Ohshima, 1995), these signals are 
integrated into a binary choice of developmental fates. 
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Figure 1.2. C. elegans larval development. Animals develop through four larval stages between embryo 
and adult stages. Under conditions of high temperature, high population density measured by 
pheromone, and low food, L1s will develop in to L2D larvae and then arrest as dauer larvae. Once 
conditions improve, dauer larvae will molt into the L4 stage and proceed with reproductive development. 
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Multiple neuroendocrine signaling pathways transduce environmental cues into developmental 
strategy (Birnby et al., 2000; Ren et al., 1996; Schackwitz et al., 1996; Thomas et al., 1993; 
Vowels and Thomas, 1992). The characterization of abnormal dauer formation mutants (daf) has 
identified two classes of genes that make up components of conserved pathways that control the 
dauer decision (Fig. 1.3). Mutants that exhibited highly penetrant dauer arrest under permissive 
conditions were designated dauer-constitutive, or daf-c, while animals that bypassed dauer when 
animals typically would arrest were dauer defective, or daf-d. The guanylyl cyclase DAF-11 may 
function most upstream in regulation of dauer arrest via regulation of cGMP gated ion channels 
TAX-2 and TAX-4 (Birnby et al., 2000; Vowels and Thomas, 1994). DAF-11 also promotes 
expression of a TGFβ-like signaling pathway ligand daf-7 that binds to type 1 and type 2 TGFβ 
receptors DAF-1 and DAF-4, respectively (Estevez et al., 1993; Georgi et al., 1990; Ren et al., 
1996). These receptors activate SMAD transcription factors DAF-8, DAF-14, but inhibit the 
SMAD/SNO-SKI complex of DAF-3 and DAF-5 (da Graca et al., 2004; Park et al., 2010; 
Tewari et al., 2004). TGFβ and cGMP act in parallel to the IIS pathway but also interact through 
upregulation of the insulin-like peptide daf-28 (Li et al., 2003; Ogg et al., 1997). DAF-28 
activates DAF-2/IGFR, leading to an AGE-1/PI3Kinase phosphorylation cascade and subsequent 
phosphorylation cascade of PDK-1, AKT-1 and AKT-2 (Fig. 1.1) (Kimura et al., 1997; Morris et 
al., 1996; Paradis et al., 1999; Paradis and Ruvkun, 1998). The PTEN tumor suppressor ortholog 
DAF-18 antagonizes this phosphorylation cascade by dephosphorylating, preventing AKT 
activation 	(Gil	et	al.,	1999;	Mihaylova	et	al.,	1999;	Ogg	and	Ruvkun,	1998). AKT phosphorylates 
DAF-16/FoxO, leading to its exclusion from the nucleus and sequestration in the cytosol in a 
manner dependent on 14-3-3 proteins FTT-2 and PAR-5 (Berdichevsky et al., 2006; Lee et al., 
2001; Lin et al., 1997; Lin et al., 2001; Ogg et al., 1997). Importantly, daf-11/guanylyl cyclase, 
daf-7/TGFβ, and insulin-like peptide ligands for DAF-2/IGFR are expressed in subsets of 
sensory neurons that have been shown to be important for dauer arrest (Birnby et al., 2000; Ren 
et al., 1996; Ritter et al., 2013). 
Signals from these conserved genetic pathways converge onto a sterol hormone biosynthesis 
pathway. The Rieske oxygenase DAF-36 functions upstream of a cytochrome P450 steroid 
monooxygenase DAF-9 in the synthesis of bile-acid like hormones known as dafachronic acids 
(DAs) (Gerisch and Antebi, 2004; Gerisch et al., 2001; Jia et al., 2002; Mak and Ruvkun, 2004; 
Motola et al., 2006; Rottiers et al., 2006). daf-9 is constitutively expressed in XXX 
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neuroendocrine cells; however, daf-9 expression in the hypodermis is reported to dramatically 
rise in late L2, driving forward the commitment to reproductive development (Schaedel et al., 
2012). DAF-12, a nuclear hormone receptor transcription factor distantly related to the vitamin D 
and thyroid hormone receptors, acts furthest downstream in the dauer decision (Antebi et al., 
2000). DAs ligand DAF-12 to promote dauer bypass; unliganded DAF-12 promotes dauer arrest 
through association with DIN-1	(Ludewig	et	al.,	2004). Animals harboring a daf-9 null allele are 
non-conditional dauer unless daf-12 is also disrupted or if exogenous DA is added to the media 	
(Gerisch et al., 2001; Sharma et al., 2009). 
The dauer phenotype can be used as a proxy for IIS regulation of lifespan. Mutations in IIS cause 
enhanced dauer arrest in a temperature dependent manner. Strong alleles of daf-2/igfR are daf-c 
at 25°C while akt-1 null alleles develop reproductively at 25°C but arrest at 27°C (Ailion and 
Thomas, 2000). Disruption of either daf-2 or akt-1 enhances longevity (Kenyon et al., 1993; 
Paradis and Ruvkun, 1998). Loss of daf-16/foxo is daf-d, and suppresses either daf-2 or akt-1 
mediated dauer arrest. Similarly, daf-16/foxo mutants fully suppress the lifespan extension of 
daf-2 and akt-1. Therefore, although dauer arrest is not specific to the IIS pathway, dauer is an 
easily observed readout of DAF-16/FoxO activity during development. Therefore, genetically 
manipulating the dauer phenotype is useful for finding novel conserved regulatory inputs on 
DAF-16/FoxO that may be associated with enhanced stress resistance and longevity. 
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Figure 1.3. Multiple genetic pathways regulate dauer formation. Conserved signal transduction 
pathways acting in parallel converge on dafachronic acid (DA) hormone biosynthesis (boxed) In the 
presence of DA, DAF-12 drives reproductive development. In the absence of DA, DAF-12 promotes 
dauer arrest. 
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Insulin-like peptides regulate DAF-16/FoxO activity 
In contrast to the genetic simplicity of the insulin-like signaling pathway, C. elegans expresses 
40 insulin-like peptides (ILPs), many times more than either mammals or flies (Lau and 
Chalasani, 2014). These 40 ILPs are divergent in their structures and functions, and are grouped 
into subtypes based on their predicted disulfide bonding patterns (Pierce et al., 2001). Type γ 
ILPs are believed to have the canonical disulfide bonds found in most insulins. Type β ILPs may 
have one additional disulfide bond, while Type α ILPs may lack the conserved A6-A11 cysteine 
bridge. The type β INS-1 and type γ INS-18 are most like mammalian insulin, containing a C-
peptide between the B- and A-peptides that is cleaved off during maturation. It is believed both 
INS-1 and INS-18 antagonize DAF-2/IGFR and therefore promote dauer arrest (Hung et al., 
2014; Pierce et al., 2001). Type β INS-2 through INS-9 along with DAF-28 have an upstream F-
peptide that is cleaved off and lack a C-peptide. Many Type β ILPs have been shown to be DAF-
2/IGFR agonists and therefore inhibitors of DAF-16/FoxO (Fig. 1.3) (Hung et al., 2014; Li et al., 
2003; Pierce et al., 2001). 
ILPs are synthesized in many tissues, and their site of expression may change throughout 
development (Fernandes de Abreu et al., 2014; Ritter et al., 2013). Because of their number, 
overlapping expression patterns, and functional redundancy, genetic analysis of the effects of 
ILPs on DAF-16/FoxO activity has proven difficult to interpret. For example, a daf-28 loss of 
function allele causes a weak dauer phenotype, but dauer penetrance can be greatly enhanced in 
combination with a deletion allele that eliminated three other type β ILPs, ins-4, ins-5, and ins-6 
(Hung et al., 2014). A systemic investigation recently clarified the roles of some ILPs in 
development, dauer arrest, longevity, as well as ILP crosstalk	(Fernandes de Abreu et al., 2014). 
What emerges is complex ins-to-ins signaling across tissues. Both DAF-2/IGFR agonists and 
antagonists are synthesized in the same amphid sensory neurons, suggesting regulation of IIS is 
subject to tight control. Downstream of the amphids, ins-7 expression in the intestine has been 
hypothesized to coordinate DAF-16/FoxO activity across tissues (Hung et al., 2014; Murphy et 
al., 2007). There is evidence supporting feedback regulation on agonist daf-28 and antagonist 
ins-18 (Hahm et al., 2009).  
ILP expression is also dependent on other developmental signals, including those associated with 
the dauer decision. daf-28 expression requires both DAF-11 and DAF-7 (	(Li et al., 2003). 
	 11	
Similarly, exposure to dauer pheromone down-regulates daf-28 and changes the spatial 
expression of ins-6 from ASI to ASJ neurons, associated with dauer entry and exit, respectively 
(Cornils et al., 2011).	Both pheromone exposure and disruption of cGMP synthesis has been 
shown to extend lifespan in C. elegans through activation of DAF-16/FoxO (Hahm et al., 2009; 
Lans and Jansen, 2007; Ludewig et al., 2013). Although the role of pheromone in C. elegans 
longevity has been questioned (Alcedo and Kenyon, 2004), one component of pheromone also 
extends lifespan in mice	(Park et al., 2014). Unexpectedly, ILPs may also be regulated post-
translationally. During dauer both INS-7 and INS-35 produced in the intestine are no longer 
secreted into the body cavity; rather, they are trafficked into the intestinal lumen and degraded 
(Matsunaga et al., 2016). Taken together, these data demonstrate ILPs participate in the 
integration of diverse environmental cues and through the canonical insulin-like signaling 
pathway regulate DAF-16/FoxO mediated dauer arrest. 
  
Evidence for regulation of DAF-16/FoxO in parallel with DAF-2/IIS 
While the upstream signals feeding into insulin-like signaling have proven complex, the 
mechanism by which the canonical IIS pathway inhibits DAF-16/FoxO is clear. Akt 
phosphorylates FoxO on conserved motifs, leading to nuclear export of FoxO. Mutation of all 
four canonical Akt phosphorylation sites leads to DAF-16/FoxO constitutive nuclear localization 
(Lee et al., 2001; Lin et al., 2001). Surprisingly, however, this nuclear accumulation of DAF-
16/FoxO did not lead to a constitutive dauer phenotype nor to enhanced longevity (Lin et al., 
2001). Also, knockdown of the 14-3-3 protein ftt-2 increases DAF-16/FoxO nuclear localization 
but does not lead to dauer arrest (Li et al., 2007). The suggestion that parallel regulatory 
mechanisms act on DAF-16/FoxO independently of its subcellular localization was recently 
substantiated. Physical association between DAF-16/FoxO and the conserved nuclear protein 
HCF-1 has been shown to decrease transcription of genes associated with the stress response (Li 
et al., 2008). This association does not alter nuclear localization, consistent with HCF-1 acting in 
parallel with IIS. 
FoxO proteins are extensively modified post-translationally with functional consequences. In 
addition to phosphorylation by Akt, cytokines can trigger the poly-ubiquitination and subsequent 
degradation of FoxOs (Hu et al., 2004). Mono-ubiquitination, on the other hand, promotes 
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FoxO4 nuclear localization and activity (Brenkman et al., 2008; van der Horst et al., 2006). 
Acetylation has been observed at multiple FoxO lysine residues. Acetylation within the DNA 
binding domain is associated with decreased activity but not with altered localization (Matsuzaki 
et al., 2005; Tsai et al., 2007). Acetylation can be reversed by the NAD-dependent lysine 
deacetylase Sir2, a protein that may promote longevity in model organisms (Ha and Huh, 2011; 
Viswanathan and Guarente, 2011). The lysine methyltransferase Set9 also methylates 
mammalian FOXO3 at lysine 271 (Calnan et al., 2012). This modification does not alter FOXO 
localization but may increase transcriptional activity at the expense of overall stability. Similarly, 
arginine methylation of DAF-16/FoxO promotes longevity by blocking phosphorylation by AKT 
(Takahashi et al., 2011). 
Epigenetic mechanisms may also be important for DAF-16/FoxO activity. For example, DAF-
16/FoxO interacts with the C. elegans SWI-SNF chromatin remodeling complex to promote 
transcription of its target genes (Riedel et al., 2013). Heterochromatin protein 1 (HP1) isoforms 
can both positively and negatively affect transcription across species (Font-Burgada et al., 2008; 
Lin et al., 2008; Ogawa et al., 2002; Piacentini et al., 2009). Deleting the HP1 ortholog hpl-2 
enhances dauer arrest in a daf-2 mutant background under permissive conditions (Meister et al., 
2011). Consistent with using dauer as a proxy for DAF-16-mediated longevity, hpl-2 mutants 
were modestly long-lived. However, a full understanding of how DAF-16/FoxO interacts with 
epigenetic modifications is lacking. 
 
EAK pathway proteins act in parallel to IIS mutants to inhibit DAF-16/FoxO 
Because of the findings implicating that one or more pathways act in parallel with IIS, we 
performed a forward genetic screen to identify these novel regulators of nuclear-localized DAF-
16/FoxO. akt-1 mutants arrest as dauers at 27°C but not at 25°C. Therefore, these animals were 
mutagenized to find enhancers of akt-1 dauer arrest (eak screen) (Hu et al., 2006). Specifically, 
recovered mutant strains arrested spontaneously at 25°C in combination with an akt-1 null 
background. eak mutants increase dauer arrest. Six of seven eak mutants have been identified. 
No combination of eak double mutants enhances dauer arrest, suggesting they belong to a single 
pathway. All identified eak genes are expressed in the paired endocrine XXX cells (Alam et al., 
2010; Dumas et al., 2010; Hu et al., 2006; Zhang et al., 2008). XXX cells are a site of DAF-9-
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mediated dafachronic acid synthesis and are critical to bypassing dauer (Motola et al., 2006). 
However, XXX cells do not express DAF-16/FoxO (Hu et al., 2006). These data support that the 
eak pathway acts cell-non-autonomously to inhibit DAF-16/FoxO via endocrine signaling. 
eak-2 encodes a conserved 3β-hydroxysteroid dehydrogenase known as HSD-1 (Dumas et al., 
2010; Patel et al., 2008). Importantly, loss of hsd-1 does not enhance DAF-16/FoxO localization, 
linking the eak pathway specifically with inhibition of nuclear-localized DAF-16/FoxO. As 
expected from the design of the eak screen, HSD-1 synergizes with reduced insulin signaling in 
activation of DAF-16/FoxO target genes. This enhancement requires the nuclear hormone 
receptor/transcription factor DAF-12 in addition to DAF-16. Therefore, the eak pathway may act 
through hormonal signaling.  
EAK-7 is unique among EAK pathway members in that it is expressed in multiple tissues, 
including XXX cells, neurons, and the intestine (Alam et al., 2010). EAK-7 is conserved and 
possesses an N-terminal myristoylation domain that facilitates membrane association as well as a 
C-terminal TBC- and LysM-domain-containing (TLDc) domain. The function of TLDc domains 
remains obscure. Similar to HSD-1, EAK-7 inhibits nuclear DAF-16. eak-7 null animals have a 
weak dauer phenotype at 27ºC that is enhanced by cholesterol deprivation (Alam et al., 2010), 
consistent with the eak pathway interacting with dafachronic acid steroid hormone synthesis 
pathway in XXX cells. However, when combined with akt-1 null alleles, the eak-7;akt-1 double 
mutant dauer phenotype is fully penetrant at 25°C. Loss of eak-7 also enhances longevity in a 
DAF-16/FoxO dependent manner. eak-7;akt-1 animals live longer than either single mutant, 
confirming that the eak and IIS pathways act in parallel to inhibit DAF-16/FoxO activity not 
only in dauer but also in longevity. 
EAK-7 is expressed in multiple tissues that co-express DAF-16, suggesting EAK-7 may be the 
most downstream member of the eak pathway identified so far (Alam et al., 2010). Over-
expression of an eak-7::gfp translational fusion revealed that EAK-7 is localized to the plasma 
membrane (Alam et al., 2010). Mutation of the myristoylation motif abrogated this localization. 
However, whether this myristoylation dead mutant was still capable of inhibiting DAF-16/FoxO 
was ambiguous. Nevertheless, the plasma membrane association of wild type EAK-7 suggests 
that it cannot act directly on nuclear DAF-16. Therefore, it is plausible that there exist 
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components of the eak pathway further downstream of EAK-7 that are required for inhibition of 
nuclear-localized DAF-16/FoxO.  
Understanding how EAK-7 inhibits DAF-16/FoxO activity may lead to fundamental insights into 
endocrine control of longevity. The mammalian homolog of EAK-7, TLDc1, is expressed in 
liver, osteoblasts, and retinal pigment epithelium (Ambrogini et al., 2010; Rached et al., 2010; Su 
et al., 2004). FoxO transcription factors are expressed in these tissues with potential roles in 
glucose metabolism and tissue homeostasis. To gain greater insight into parallel regulation of 
FoxO transcription factors, we once again turned to C. elegans genetics to develop our 
understanding of parallel inputs on DAF-16/FoxO activity. 
 
A genetic screen reveals X-linked gene regulation of DAF-16/FoxO  
In order to enhance our understanding of parallel inputs on DAF-16/FoxO activity, we conducted 
a new forward genetic screen, again using the dauer arrest phenotype as our readout (Dumas et 
al., 2013). We used eak-7;akt-1 animals that always arrest as dauers at 25°C because we could 
target both the eak and IIS parallel pathways simultaneously. It is unknown how the eak pathway 
influences DAF-16/FoxO activity in the nucleus, so we reasoned such a screen may provide 
missing links between EAK-7, situated at the plasma membrane, and nuclear-localized DAF-
16/FoxO (Alam et al., 2010). We also may expect to find genes that interact with the IIS pathway 
that controls DAF-16/FoxO subcellular nuclear localization, as well as genes that act on DAF-
16/FoxO in parallel with both IIS and eak pathways. We endeavored to discover mutant alleles 
that suppressed the dauer-constitutive phenotype of eak-7;akt-1, (SEAK alleles). We treated P0 
animals with the mutagen N-ethyl-N-nitrosourea (ENU) at the L4 stage and allowed these 
animals to lay eggs. F1 animals were grown to adulthood, allowed to lay eggs, and their eggs 
were transferred to 25°C. F2s found to bypass dauer were propagated and the dauer defective 
(daf-d) phenotypes of these strains were verified in subsequent generations. We sequenced the 
genomes of the resulting 16 strains as well as performed linkage mapping to find candidate 
alleles.  
Three of sixteen strains had distinct mutations in the conserved protein DPY-21 (Dumas et al., 
2013). An independently derived nonsense allele, e428, also completely suppressed dauer in both 
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eak-7;akt-1 compound mutants and daf-2/igfR hypomorphs. Intriguingly, dpy-21 RNAi 
suppressed eak-7;akt-1 dauer arrest but not daf-2 animals. Because certain tissues including 
neurons and hypodermis are resistant to RNAi (Kamath et al., 2003; Timmons et al., 2001), these 
data suggest that the eak pathway and IIS may promote reproductive development in different 
tissue types. Loss of dpy-21 led to robust down-regulation of known DAF-16/FoxO target genes, 
including sod-3, mtl-1, and dod-3, and knockdown of dpy-21 decreased DAF-16/FoxO nuclear 
localization. Taken together, these data suggest that DPY-21 promotes DAF-16/FoxO activity 
downstream of both the eak and IIS pathway in multiple tissue types. 
DPY-21 is part of the worm dosage compensation complex (DCC) that equalizes X chromosome 
gene expression between XO males and XX hermaphrodites (Meyer, 2010). We found evidence 
that DPY-21 promotes dauer arrest through dosage compensation per se because knockdown of 
other DCC components in eak-7;akt-1 animals phenocopied loss of dpy-21 (Dumas et al., 2013). 
Further, the daf-d phenotype was only observed in hermaphrodites; the male X chromosome is 
not dosage compensated, and male eak-7;akt-1 animals continued to arrest normally. We also 
observed X-linked genes associated with dauer bypass were upregulated 2-fold in a dpy-21 
mutant background while autosomal genes were unchanged. From these data, we concluded that 
dosage compensation promotes dauer arrest by repressing inhibitors of DAF-16/FoxO activity. 
In addition to DPY-21-mediated dauer arrest, two other published SEAK strains contain 
causative defects on X chromosomes,	including a complex rearrangement and duplication that 
increases gene dosage of akt-2 (Itani et al., 2016a; Itani et al., 2016b). Such findings implicate X 
chromosome dosage compensation in the regulation of DAF-16/FoxO during development. 
Although the genetic programs that establish sex-specific assembly of the DCC and the identity 
of its components are well-defined, how this complex achieves dosage compensation remains 
unclear and may involve partner epigenetic effectors (Wells et al., 2012). Further, the specific X-
linked genes that cause to the daf-d phenotype associated with DCC disruption have not been 
rigorously defined. These unanswered questions underlie the rationale for the investigations 
presented herein. 
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Summary 
Understanding how FoxO transcription factors contribute to stress resistance and increase 
longevity may contribute to interventions that increase individual vitality and decrease incidence 
of chronic illness in the population. FoxO transcription factors are controlled by extensive post-
translational modification and acted upon by multiple conserved signal transduction pathways to 
control transcriptional output. In C. elegans, insulin-like signaling receives inputs from multiple 
upstream pathways through the insulin-like peptide milieu that controls the nuclear localization 
of DAF-16/FoxO. The eak pathway acts in parallel with IIS to inhibit nuclear DAF-16/FoxO 
activity, but the mechanism by which this pathway does this remains unclear. 
Others and we have shown that conserved epigenetic proteins can either promote or inhibit DAF-
16/FoxO activity (Dumas et al., 2013; Meister et al., 2011). To that end, this dissertation seeks to 
expand our knowledge of how conserved epigenetic programs influence DAF-16/FoxO activity. 
We previously showed dosage compensation promotes DAF-16/FoxO activity. However, 
disrupting the DCC leads to thousands of genes being dysregulated either directly or indirectly 	
(Kramer et al., 2015). In order to clarify the mechanism how dosage compensation promotes 
dauer arrest, we must interrogate genes believed to partner with the DCC to achieve appropriate 
gene expression. Intriguingly, one SEAK strain harbored a mutation in the conserved histone 
methyltransferase set-4, which has been implicated in dosage compensation (Wells et al., 2012). 
Chapter 2 briefly reviews the principles of dosage compensation across metazoans, focusing on 
the C. elegans DCC, then expands on the dynamics of dosage compensation-associated 
methylation of histone H4 lysine 20 (H4K20me). Chapter 3 provides clear evidence that the 
conserved H4K20 methyltransferase SET-4 acts like DCC protein DPY-21 in promoting DAF-
16/FoxO activity during development by repressing insulin like peptide production in sensory 
neurons. Chapter 4 refines our understanding of how SET-4 acts in concert with both upstream 
stress signals and downstream DAF-16/FoxO feedback to control ILP expression. Finally, 
chapter 5 explores roles for SET-4 in longevity, implicating H4K20 methylation in multiple 
conserved mechanisms of aging. 
 
  
	 17	
References 
Accili, D. and Arden, K. C. (2004). FoxOs at the crossroads of cellular metabolism, 
differentiation, and transformation. Cell 117, 421-426. 
Ailion, M. and Thomas, J. H. (2000). Dauer formation induced by high temperatures in 
Caenorhabditis elegans. Genetics 156, 1047-1067. 
Alam, H., Williams, T. W., Dumas, K. J., Guo, C., Yoshina, S., Mitani, S. and Hu, P. J. (2010). 
EAK-7 controls development and life span by regulating nuclear DAF-16/FoxO activity. 
Cell Metab 12, 30-41. 
Alcedo, J. and Kenyon, C. (2004). Regulation of C. elegans longevity by specific gustatory and 
olfactory neurons. Neuron 41, 45-55. 
Ambrogini, E., Almeida, M., Martin-Millan, M., Paik, J. H., Depinho, R. A., Han, L., Goellner, 
J., Weinstein, R. S., Jilka, R. L., O'Brien, C. A., et al. (2010). FoxO-mediated defense 
against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. 
Cell Metab 11, 136-146. 
Anselmi, C. V., Malovini, A., Roncarati, R., Novelli, V., Villa, F., Condorelli, G., Bellazzi, R. 
and Puca, A. A. (2009). Association of the FOXO3A locus with extreme longevity in a 
southern Italian centenarian study. Rejuvenation Res 12, 95-104. 
Antebi, A., Yeh, W. H., Tait, D., Hedgecock, E. M. and Riddle, D. L. (2000). daf-12 encodes a 
nuclear receptor that regulates the dauer diapause and developmental age in C. elegans. 
Genes Dev 14, 1512-1527. 
Berdichevsky, A., Viswanathan, M., Horvitz, H. R. and Guarente, L. (2006). C. elegans SIR-2.1 
interacts with 14-3-3 proteins to activate DAF-16 and extend life span. Cell 125, 1165-
1177. 
Birnby, D. A., Link, E. M., Vowels, J. J., Tian, H., Colacurcio, P. L. and Thomas, J. H. (2000). A 
transmembrane guanylyl cyclase (DAF-11) and Hsp90 (DAF-21) regulate a common set 
of chemosensory behaviors in caenorhabditis elegans. Genetics 155, 85-104. 
Blaxter, M. L. (1993). Cuticle surface proteins of wild type and mutant Caenorhabditis elegans. J 
Biol Chem 268, 6600-6609. 
Bluher, M., Kahn, B. B. and Kahn, C. R. (2003). Extended longevity in mice lacking the insulin 
receptor in adipose tissue. Science 299, 572-574. 
Brenkman, A. B., de Keizer, P. L., van den Broek, N. J., Jochemsen, A. G. and Burgering, B. M. 
(2008). Mdm2 induces mono-ubiquitination of FOXO4. PLoS One 3, e2819. 
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. 
C., Blenis, J. and Greenberg, M. E. (1999). Akt promotes cell survival by 
phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868. 
Brunet, A., Kanai, F., Stehn, J., Xu, J., Sarbassova, D., Frangioni, J. V., Dalal, S. N., DeCaprio, 
J. A., Greenberg, M. E. and Yaffe, M. B. (2002). 14-3-3 transits to the nucleus and 
participates in dynamic nucleocytoplasmic transport. J Cell Biol 156, 817-828. 
Butcher, R. A., Fujita, M., Schroeder, F. C. and Clardy, J. (2007). Small-molecule pheromones 
that control dauer development in Caenorhabditis elegans. Nat Chem Biol 3, 420-422. 
Cahill, C. M., Tzivion, G., Nasrin, N., Ogg, S., Dore, J., Ruvkun, G. and Alexander-Bridges, M. 
(2001). Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and 
function via 14-3-3-dependent and 14-3-3-independent pathways. J Biol Chem 276, 
13402-13410. 
	 18	
Calnan, D. R., Webb, A. E., White, J. L., Stowe, T. R., Goswami, T., Shi, X., Espejo, A., 
Bedford, M. T., Gozani, O., Gygi, S. P., et al. (2012). Methylation by Set9 modulates 
FoxO3 stability and transcriptional activity. Aging (Albany NY) 4, 462-479. 
Cassada, R. C. and Russell, R. L. (1975). The dauerlarva, a post-embryonic developmental 
variant of the nematode Caenorhabditis elegans. Dev Biol 46, 326-342. 
Cornils, A., Gloeck, M., Chen, Z., Zhang, Y. and Alcedo, J. (2011). Specific insulin-like peptides 
encode sensory information to regulate distinct developmental processes. Development 
138, 1183-1193. 
da Graca, L. S., Zimmerman, K. K., Mitchell, M. C., Kozhan-Gorodetska, M., Sekiewicz, K., 
Morales, Y. and Patterson, G. I. (2004). DAF-5 is a Ski oncoprotein homolog that 
functions in a neuronal TGF beta pathway to regulate C. elegans dauer development. 
Development 131, 435-446. 
Dixon, S. J., Alexander, M., Chan, K. K. and Roy, P. J. (2008). Insulin-like signaling negatively 
regulates muscle arm extension through DAF-12 in Caenorhabditis elegans. Dev Biol 
318, 153-161. 
Dumas, K. J., Delaney, C. E., Flibotte, S., Moerman, D. G., Csankovszki, G. and Hu, P. J. 
(2013). Unexpected role for dosage compensation in the control of dauer arrest, insulin-
like signaling, and FoxO transcription factor activity in Caenorhabditis elegans. Genetics 
194, 619-629. 
Dumas, K. J., Guo, C., Wang, X., Burkhart, K. B., Adams, E. J., Alam, H. and Hu, P. J. (2010). 
Functional divergence of dafachronic acid pathways in the control of C. elegans 
development and lifespan. Dev Biol 340, 605-612. 
Eijkelenboom, A. and Burgering, B. M. (2013). FOXOs: signalling integrators for homeostasis 
maintenance. Nat Rev Mol Cell Biol 14, 83-97. 
Engelman, J. A., Luo, J. and Cantley, L. C. (2006). The evolution of phosphatidylinositol 3-
kinases as regulators of growth and metabolism. Nat Rev Genet 7, 606-619. 
Estevez, M., Attisano, L., Wrana, J. L., Albert, P. S., Massague, J. and Riddle, D. L. (1993). The 
daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer 
larva development. Nature 365, 644-649. 
Fernandes de Abreu, D. A., Caballero, A., Fardel, P., Stroustrup, N., Chen, Z., Lee, K., Keyes, 
W. D., Nash, Z. M., Lopez-Moyado, I. F., Vaggi, F., et al. (2014). An insulin-to-insulin 
regulatory network orchestrates phenotypic specificity in development and physiology. 
PLoS Genet 10, e1004225. 
Flachsbart, F., Caliebe, A., Kleindorp, R., Blanche, H., von Eller-Eberstein, H., Nikolaus, S., 
Schreiber, S. and Nebel, A. (2009). Association of FOXO3A variation with human 
longevity confirmed in German centenarians. Proc Natl Acad Sci U S A 106, 2700-2705. 
Font-Burgada, J., Rossell, D., Auer, H. and Azorin, F. (2008). Drosophila HP1c isoform interacts 
with the zinc-finger proteins WOC and Relative-of-WOC to regulate gene expression. 
Genes Dev 22, 3007-3023. 
Georgi, L. L., Albert, P. S. and Riddle, D. L. (1990). daf-1, a C. elegans gene controlling dauer 
larva development, encodes a novel receptor protein kinase. Cell 61, 635-645. 
Gerisch, B. and Antebi, A. (2004). Hormonal signals produced by DAF-9/cytochrome P450 
regulate C. elegans dauer diapause in response to environmental cues. Development 131, 
1765-1776. 
	 19	
Gerisch, B., Weitzel, C., Kober-Eisermann, C., Rottiers, V. and Antebi, A. (2001). A hormonal 
signaling pathway influencing C. elegans metabolism, reproductive development, and life 
span. Dev Cell 1, 841-851. 
Giannakou, M. E., Goss, M., Junger, M. A., Hafen, E., Leevers, S. J. and Partridge, L. (2004). 
Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science 305, 361. 
Gil, E. B., Malone Link, E., Liu, L. X., Johnson, C. D. and Lees, J. A. (1999). Regulation of the 
insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the 
PTEN tumor suppressor gene. Proc Natl Acad Sci U S A 96, 2925-2930. 
Golden, J. W. and Riddle, D. L. (1984). ACaenorhabditis elegans dauer-inducing pheromone and 
an antagonistic component of the food supply. J Chem Ecol 10, 1265-1280. 
Greer, E. L. and Brunet, A. (2005). FOXO transcription factors at the interface between 
longevity and tumor suppression. Oncogene 24, 7410-7425. 
Ha, C. W. and Huh, W. K. (2011). The implication of Sir2 in replicative aging and senescence in 
Saccharomyces cerevisiae. Aging (Albany NY) 3, 319-324. 
Hahm, J. H., Kim, S. and Paik, Y. K. (2009). Endogenous cGMP regulates adult longevity via 
the insulin signaling pathway in Caenorhabditis elegans. Aging Cell 8, 473-483. 
Honda, Y., Tanaka, M. and Honda, S. (2008). Modulation of longevity and diapause by redox 
regulation mechanisms under the insulin-like signaling control in Caenorhabditis elegans. 
Exp Gerontol 43, 520-529. 
Hsu, A. L., Murphy, C. T. and Kenyon, C. (2003). Regulation of aging and age-related disease 
by DAF-16 and heat-shock factor. Science 300, 1142-1145. 
Hu, M. C., Lee, D. F., Xia, W., Golfman, L. S., Ou-Yang, F., Yang, J. Y., Zou, Y., Bao, S., 
Hanada, N., Saso, H., et al. (2004). IkappaB kinase promotes tumorigenesis through 
inhibition of forkhead FOXO3a. Cell 117, 225-237. 
Hu, P. J., Xu, J. and Ruvkun, G. (2006). Two membrane-associated tyrosine phosphatase 
homologs potentiate C. elegans AKT-1/PKB signaling. PLoS Genet 2, e99. 
Huang, H., Muddiman, D. C. and Tindall, D. J. (2004). Androgens negatively regulate forkhead 
transcription factor FKHR (FOXO1) through a proteolytic mechanism in prostate cancer 
cells. J Biol Chem 279, 13866-13877. 
Hung, W. L., Wang, Y., Chitturi, J. and Zhen, M. (2014). A Caenorhabditis elegans 
developmental decision requires insulin signaling-mediated neuron-intestine 
communication. Development 141, 1767-1779. 
Hwangbo, D. S., Gershman, B., Tu, M. P., Palmer, M. and Tatar, M. (2004). Drosophila dFOXO 
controls lifespan and regulates insulin signalling in brain and fat body. Nature 429, 562-
566. 
Itani, O. A., Flibotte, S., Dumas, K. J., Guo, C., Blumenthal, T. and Hu, P. J. (2016a). N-Ethyl-
N-Nitrosourea (ENU) Mutagenesis Reveals an Intronic Residue Critical for 
Caenorhabditis elegans 3' Splice Site Function in Vivo. G3 (Bethesda) 6, 1751-1756. 
Itani, O. A., Flibotte, S., Dumas, K. J., Moerman, D. G. and Hu, P. J. (2016b). 
Chromoanasynthetic Genomic Rearrangement Identified in a N-Ethyl-N-Nitrosourea 
(ENU) Mutagenesis Screen in Caenorhabditis elegans. G3 (Bethesda) 6, 351-356. 
Jia, K., Albert, P. S. and Riddle, D. L. (2002). DAF-9, a cytochrome P450 regulating C. elegans 
larval development and adult longevity. Development 129, 221-231. 
Kaestner, K. H., Knochel, W. and Martinez, D. E. (2000). Unified nomenclature for the winged 
helix/forkhead transcription factors. Genes Dev 14, 142-146. 
	 20	
Kamath, R. S., Fraser, A. G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A., Le Bot, 
N., Moreno, S., Sohrmann, M., et al. (2003). Systematic functional analysis of the 
Caenorhabditis elegans genome using RNAi. Nature 421, 231-237. 
Kenyon, C., Chang, J., Gensch, E., Rudner, A. and Tabtiang, R. (1993). A C. elegans mutant that 
lives twice as long as wild type. Nature 366, 461-464. 
Kimura, K. D., Tissenbaum, H. A., Liu, Y. and Ruvkun, G. (1997). daf-2, an insulin receptor-
like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277, 
942-946. 
Klass, M. and Hirsh, D. (1976). Non-ageing developmental variant of Caenorhabditis elegans. 
Nature 260, 523-525. 
Kramer, M., Kranz, A. L., Su, A., Winterkorn, L. H., Albritton, S. E. and Ercan, S. (2015). 
Developmental Dynamics of X-Chromosome Dosage Compensation by the DCC and 
H4K20me1 in C. elegans. PLoS Genet 11, e1005698. 
Lans, H. and Jansen, G. (2007). Multiple sensory G proteins in the olfactory, gustatory and 
nociceptive neurons modulate longevity in Caenorhabditis elegans. Dev Biol 303, 474-
482. 
Lau, H. E. and Chalasani, S. H. (2014). Divergent and convergent roles for insulin-like peptides 
in the worm, fly and mammalian nervous systems. Invert Neurosci 14, 71-78. 
Lee, R. Y., Hench, J. and Ruvkun, G. (2001). Regulation of C. elegans DAF-16 and its human 
ortholog FKHRL1 by the daf-2 insulin-like signaling pathway. Curr Biol 11, 1950-1957. 
Li, C. J., Chang, J. K., Chou, C. H., Wang, G. J. and Ho, M. L. (2010). The 
PI3K/Akt/FOXO3a/p27Kip1 signaling contributes to anti-inflammatory drug-suppressed 
proliferation of human osteoblasts. Biochem Pharmacol 79, 926-937. 
Li, J., Ebata, A., Dong, Y., Rizki, G., Iwata, T. and Lee, S. S. (2008). Caenorhabditis elegans 
HCF-1 functions in longevity maintenance as a DAF-16 regulator. PLoS Biol 6, e233. 
Li, J., Tewari, M., Vidal, M. and Lee, S. S. (2007). The 14-3-3 protein FTT-2 regulates DAF-16 
in Caenorhabditis elegans. Dev Biol 301, 82-91. 
Li, W., Kennedy, S. G. and Ruvkun, G. (2003). daf-28 encodes a C. elegans insulin superfamily 
member that is regulated by environmental cues and acts in the DAF-2 signaling 
pathway. Genes Dev 17, 844-858. 
Li, Y., Wang, W. J., Cao, H., Lu, J., Wu, C., Hu, F. Y., Guo, J., Zhao, L., Yang, F., Zhang, Y. 
X., et al. (2009). Genetic association of FOXO1A and FOXO3A with longevity trait in 
Han Chinese populations. Hum Mol Genet 18, 4897-4904. 
Lin, C. H., Li, B., Swanson, S., Zhang, Y., Florens, L., Washburn, M. P., Abmayr, S. M. and 
Workman, J. L. (2008). Heterochromatin protein 1a stimulates histone H3 lysine 36 
demethylation by the Drosophila KDM4A demethylase. Mol Cell 32, 696-706. 
Lin, K., Dorman, J. B., Rodan, A. and Kenyon, C. (1997). daf-16: An HNF-3/forkhead family 
member that can function to double the life-span of Caenorhabditis elegans. Science 278, 
1319-1322. 
Lin, K., Hsin, H., Libina, N. and Kenyon, C. (2001). Regulation of the Caenorhabditis elegans 
longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat Genet 28, 139-
145. 
Liu, T., Zimmerman, K. K. and Patterson, G. I. (2004). Regulation of signaling genes by 
TGFbeta during entry into dauer diapause in C. elegans. BMC Dev Biol 4, 11. 
Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. and Kroemer, G. (2013). The 
hallmarks of aging. Cell 153, 1194-1217. 
	 21	
Ludewig, A. H., Izrayelit, Y., Park, D., Malik, R. U., Zimmermann, A., Mahanti, P., Fox, B. W., 
Bethke, A., Doering, F., Riddle, D. L., et al. (2013). Pheromone sensing regulates 
Caenorhabditis elegans lifespan and stress resistance via the deacetylase SIR-2.1. Proc 
Natl Acad Sci U S A 110, 5522-5527. 
Ludewig, A. H., Kober-Eisermann, C., Weitzel, C., Bethke, A., Neubert, K., Gerisch, B., Hutter, 
H. and Antebi, A. (2004). A novel nuclear receptor/coregulator complex controls C. 
elegans lipid metabolism, larval development, and aging. Genes Dev 18, 2120-2133. 
Ludewig, A. H. and Schroeder, F. C. (2013). Ascaroside signaling in C. elegans. WormBook, 1-
22. 
Mak, H. Y. and Ruvkun, G. (2004). Intercellular signaling of reproductive development by the 
C. elegans DAF-9 cytochrome P450. Development 131, 1777-1786. 
Manolopoulos, K. N., Klotz, L. O., Korsten, P., Bornstein, S. R. and Barthel, A. (2010). Linking 
Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress. Mol 
Psychiatry 15, 1046-1052. 
Matsunaga, Y., Honda, Y., Honda, S., Iwasaki, T., Qadota, H., Benian, G. M. and Kawano, T. 
(2016). Diapause is associated with a change in the polarity of secretion of insulin-like 
peptides. Nat Commun 7, 10573. 
Matsuzaki, H., Daitoku, H., Hatta, M., Aoyama, H., Yoshimochi, K. and Fukamizu, A. (2005). 
Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. 
Proc Natl Acad Sci U S A 102, 11278-11283. 
Meister, P., Schott, S., Bedet, C., Xiao, Y., Rohner, S., Bodennec, S., Hudry, B., Molin, L., 
Solari, F., Gasser, S. M., et al. (2011). Caenorhabditis elegans Heterochromatin protein 1 
(HPL-2) links developmental plasticity, longevity and lipid metabolism. Genome Biol 12, 
R123. 
Meyer, B. J. (2010). Targeting X chromosomes for repression. Curr Opin Genet Dev 20, 179-
189. 
Mihaylova, V. T., Borland, C. Z., Manjarrez, L., Stern, M. J. and Sun, H. (1999). The PTEN 
tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer 
formation in an insulin receptor-like signaling pathway. Proc Natl Acad Sci U S A 96, 
7427-7432. 
Mori, I. and Ohshima, Y. (1995). Neural regulation of thermotaxis in Caenorhabditis elegans. 
Nature 376, 344-348. 
Morris, J. Z., Tissenbaum, H. A. and Ruvkun, G. (1996). A phosphatidylinositol-3-OH kinase 
family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382, 
536-539. 
Motola, D. L., Cummins, C. L., Rottiers, V., Sharma, K. K., Li, T., Li, Y., Suino-Powell, K., Xu, 
H. E., Auchus, R. J., Antebi, A., et al. (2006). Identification of ligands for DAF-12 that 
govern dauer formation and reproduction in C. elegans. Cell 124, 1209-1223. 
Murphy, C. T., Lee, S. J. and Kenyon, C. (2007). Tissue entrainment by feedback regulation of 
insulin gene expression in the endoderm of Caenorhabditis elegans. Proc Natl Acad Sci U 
S A 104, 19046-19050. 
Niccoli, T. and Partridge, L. (2012). Ageing as a risk factor for disease. Curr Biol 22, R741-752. 
Obata, T., Yaffe, M. B., Leparc, G. G., Piro, E. T., Maegawa, H., Kashiwagi, A., Kikkawa, R. 
and Cantley, L. C. (2000). Peptide and protein library screening defines optimal substrate 
motifs for AKT/PKB. J Biol Chem 275, 36108-36115. 
	 22	
Obsilova, V., Vecer, J., Herman, P., Pabianova, A., Sulc, M., Teisinger, J., Boura, E. and Obsil, 
T. (2005). 14-3-3 Protein interacts with nuclear localization sequence of forkhead 
transcription factor FoxO4. Biochemistry 44, 11608-11617. 
Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D. M. and Nakatani, Y. (2002). A complex 
with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. 
Science 296, 1132-1136. 
Ogg, S., Paradis, S., Gottlieb, S., Patterson, G. I., Lee, L., Tissenbaum, H. A. and Ruvkun, G. 
(1997). The Fork head transcription factor DAF-16 transduces insulin-like metabolic and 
longevity signals in C. elegans. Nature 389, 994-999. 
Ogg, S. and Ruvkun, G. (1998). The C. elegans PTEN homolog, DAF-18, acts in the insulin 
receptor-like metabolic signaling pathway. Mol Cell 2, 887-893. 
Oh, K. H. and Kim, H. (2013). Reduced IGF signaling prevents muscle cell death in a 
Caenorhabditis elegans model of muscular dystrophy. Proc Natl Acad Sci U S A 110, 
19024-19029. 
Paik, J. H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., Horner, J. 
W., Carrasco, D. R., et al. (2007). FoxOs are lineage-restricted redundant tumor 
suppressors and regulate endothelial cell homeostasis. Cell 128, 309-323. 
Paradis, S., Ailion, M., Toker, A., Thomas, J. H. and Ruvkun, G. (1999). A PDK1 homolog is 
necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in 
Caenorhabditis elegans. Genes Dev 13, 1438-1452. 
Paradis, S. and Ruvkun, G. (1998). Caenorhabditis elegans Akt/PKB transduces insulin receptor-
like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev 12, 
2488-2498. 
Park, D., Estevez, A. and Riddle, D. L. (2010). Antagonistic Smad transcription factors control 
the dauer/non-dauer switch in C. elegans. Development 137, 477-485. 
Park, J. H., Chung, H. Y., Kim, M., Lee, J. H., Jung, M. and Ha, H. (2014). Daumone fed late in 
life improves survival and reduces hepatic inflammation and fibrosis in mice. Aging Cell 
13, 709-718. 
Patel, D. S., Fang, L. L., Svy, D. K., Ruvkun, G. and Li, W. (2008). Genetic identification of 
HSD-1, a conserved steroidogenic enzyme that directs larval development in 
Caenorhabditis elegans. Development 135, 2239-2249. 
Piacentini, L., Fanti, L., Negri, R., Del Vescovo, V., Fatica, A., Altieri, F. and Pimpinelli, S. 
(2009). Heterochromatin protein 1 (HP1a) positively regulates euchromatic gene 
expression through RNA transcript association and interaction with hnRNPs in 
Drosophila. PLoS Genet 5, e1000670. 
Pierce, S. B., Costa, M., Wisotzkey, R., Devadhar, S., Homburger, S. A., Buchman, A. R., 
Ferguson, K. C., Heller, J., Platt, D. M., Pasquinelli, A. A., et al. (2001). Regulation of 
DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large 
and diverse C. elegans insulin gene family. Genes Dev 15, 672-686. 
Pinkston, J. M., Garigan, D., Hansen, M. and Kenyon, C. (2006). Mutations that increase the life 
span of C. elegans inhibit tumor growth. Science 313, 971-975. 
Popham, J. D. and Webster, J. M. (1978). An alternative interpretation of the fine structure of the 
basal zone of the cuticle of the dauerlarva of the nematode Caenorhabditis elegans 
(Nematoda). Can J Zool 56, 1556-1563. 
	 23	
Rached, M. T., Kode, A., Xu, L., Yoshikawa, Y., Paik, J. H., Depinho, R. A. and Kousteni, S. 
(2010). FoxO1 is a positive regulator of bone formation by favoring protein synthesis and 
resistance to oxidative stress in osteoblasts. Cell Metab 11, 147-160. 
Ren, P., Lim, C. S., Johnsen, R., Albert, P. S., Pilgrim, D. and Riddle, D. L. (1996). Control of 
C. elegans larval development by neuronal expression of a TGF-beta homolog. Science 
274, 1389-1391. 
Renault, V. M., Thekkat, P. U., Hoang, K. L., White, J. L., Brady, C. A., Kenzelmann Broz, D., 
Venturelli, O. S., Johnson, T. M., Oskoui, P. R., Xuan, Z., et al. (2011). The pro-
longevity gene FoxO3 is a direct target of the p53 tumor suppressor. Oncogene 30, 3207-
3221. 
Riedel, C. G., Dowen, R. H., Lourenco, G. F., Kirienko, N. V., Heimbucher, T., West, J. A., 
Bowman, S. K., Kingston, R. E., Dillin, A., Asara, J. M., et al. (2013). DAF-16 employs 
the chromatin remodeller SWI/SNF to promote stress resistance and longevity. Nature 
cell biology 15, 491-501. 
Ritter, A. D., Shen, Y., Fuxman Bass, J., Jeyaraj, S., Deplancke, B., Mukhopadhyay, A., Xu, J., 
Driscoll, M., Tissenbaum, H. A. and Walhout, A. J. (2013). Complex expression 
dynamics and robustness in C. elegans insulin networks. Genome Res 23, 954-965. 
Rottiers, V., Motola, D. L., Gerisch, B., Cummins, C. L., Nishiwaki, K., Mangelsdorf, D. J. and 
Antebi, A. (2006). Hormonal control of C. elegans dauer formation and life span by a 
Rieske-like oxygenase. Dev Cell 10, 473-482. 
Schackwitz, W. S., Inoue, T. and Thomas, J. H. (1996). Chemosensory neurons function in 
parallel to mediate a pheromone response in C. elegans. Neuron 17, 719-728. 
Schaedel, O. N., Gerisch, B., Antebi, A. and Sternberg, P. W. (2012). Hormonal signal 
amplification mediates environmental conditions during development and controls an 
irreversible commitment to adulthood. PLoS Biol 10, e1001306. 
Schroeder, N. E., Androwski, R. J., Rashid, A., Lee, H., Lee, J. and Barr, M. M. (2013). Dauer-
specific dendrite arborization in C. elegans is regulated by KPC-1/Furin. Curr Biol 23, 
1527-1535. 
Selman, C. and Withers, D. J. (2011). Mammalian models of extended healthy lifespan. Philos 
Trans R Soc Lond B Biol Sci 366, 99-107. 
Sharma, K. K., Wang, Z., Motola, D. L., Cummins, C. L., Mangelsdorf, D. J. and Auchus, R. J. 
(2009). Synthesis and activity of dafachronic acid ligands for the C. elegans DAF-12 
nuclear hormone receptor. Mol Endocrinol 23, 640-648. 
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., 
Hayakawa, M., Kreiman, G., et al. (2004). A gene atlas of the mouse and human protein-
encoding transcriptomes. Proc Natl Acad Sci U S A 101, 6062-6067. 
Takahashi, Y., Daitoku, H., Hirota, K., Tamiya, H., Yokoyama, A., Kako, K., Nagashima, Y., 
Nakamura, A., Shimada, T., Watanabe, S., et al. (2011). Asymmetric arginine 
dimethylation determines life span in C. elegans by regulating forkhead transcription 
factor DAF-16. Cell Metab 13, 505-516. 
Tewari, M., Hu, P. J., Ahn, J. S., Ayivi-Guedehoussou, N., Vidalain, P. O., Li, S., Milstein, S., 
Armstrong, C. M., Boxem, M., Butler, M. D., et al. (2004). Systematic interactome 
mapping and genetic perturbation analysis of a C. elegans TGF-beta signaling network. 
Mol Cell 13, 469-482. 
	 24	
Thomas, J. H., Birnby, D. A. and Vowels, J. J. (1993). Evidence for parallel processing of 
sensory information controlling dauer formation in Caenorhabditis elegans. Genetics 134, 
1105-1117. 
Timmons, L., Court, D. L. and Fire, A. (2001). Ingestion of bacterially expressed dsRNAs can 
produce specific and potent genetic interference in Caenorhabditis elegans. Gene 263, 
103-112. 
Tsai, K. L., Sun, Y. J., Huang, C. Y., Yang, J. Y., Hung, M. C. and Hsiao, C. D. (2007). Crystal 
structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-
translational modification. Nucleic Acids Res 35, 6984-6994. 
van der Horst, A., de Vries-Smits, A. M., Brenkman, A. B., van Triest, M. H., van den Broek, N., 
Colland, F., Maurice, M. M. and Burgering, B. M. (2006). FOXO4 transcriptional 
activity is regulated by monoubiquitination and USP7/HAUSP. Nat Cell Biol 8, 1064-
1073. 
Vanhaesebroeck, B. and Alessi, D. R. (2000). The PI3K-PDK1 connection: more than just a road 
to PKB. Biochem J 346 Pt 3, 561-576. 
Viswanathan, M. and Guarente, L. (2011). Regulation of Caenorhabditis elegans lifespan by sir-
2.1 transgenes. Nature 477, E1-2. 
Vowels, J. J. and Thomas, J. H. (1992). Genetic analysis of chemosensory control of dauer 
formation in Caenorhabditis elegans. Genetics 130, 105-123. 
---- (1994). Multiple chemosensory defects in daf-11 and daf-21 mutants of Caenorhabditis 
elegans. Genetics 138, 303-316. 
Wadsworth, W. G. and Riddle, D. L. (1989). Developmental regulation of energy metabolism in 
Caenorhabditis elegans. Dev Biol 132, 167-173. 
Wells, M. B., Snyder, M. J., Custer, L. M. and Csankovszki, G. (2012). Caenorhabditis elegans 
dosage compensation regulates histone H4 chromatin state on X chromosomes. 
Molecular and cellular biology 32, 1710-1719. 
Willcox, B. J., Donlon, T. A., He, Q., Chen, R., Grove, J. S., Yano, K., Masaki, K. H., Willcox, 
D. C., Rodriguez, B. and Curb, J. D. (2008). FOXO3A genotype is strongly associated 
with human longevity. Proc Natl Acad Sci U S A 105, 13987-13992. 
Woods, Y. L. and Rena, G. (2002). Effect of multiple phosphorylation events on the transcription 
factors FKHR, FKHRL1 and AFX. Biochem Soc Trans 30, 391-397. 
Yamamoto, R. and Tatar, M. (2011). Insulin receptor substrate chico acts with the transcription 
factor FOXO to extend Drosophila lifespan. Aging Cell 10, 729-732. 
Zhang, Y., Xu, J., Puscau, C., Kim, Y., Wang, X., Alam, H. and Hu, P. J. (2008). Caenorhabditis 
elegans EAK-3 inhibits dauer arrest via nonautonomous regulation of nuclear DAF-
16/FoxO activity. Dev Biol 315, 290-302. 
 
		 25	
	
	
	
	
Chapter 2 
Links between dosage compensation and 
histone H4 lysine 20 methylation 
 
Abstract 
Eukaryotes employ many epigenetic programs that act synergistically and in parallel to 
coordinate gene expression. Chromatin may be modified at the level of DNA, the nucleosome, 
higher order chromosomal loops, and local or chromosome-wide levels of compaction. A special 
case of chromosome level regulation of gene expression is dosage compensation, a phenomenon 
observed in many metazoans that equalizes gene expression between biological sexes. Skewed 
dosage compensation is associated with degenerative diseases and loss of embryonic viability. 
Different classes of metazoans achieve dosage compensation through distinct mechanisms. 
Caenorhabditis elegans employs a specialized condensin-like dosage compensation complex 
(DCC) that is only active in hermaphrodites and decreases by half the gene expression from each 
of two hermaphrodite X chromosomes to match transcription output with XO males. While the 
composition of the complex is well understood, how the DCC achieves dosage compensation is 
not fully understood. There is growing evidence that dosage compensation in metazoans requires 
epigenetic modifiers, especially those associated with histone H4 lysine 20 methylation 
(H4K20me). In this chapter, we examine the principles underlying dosage compensation and 
H4K20 methylation states, the gaps in knowledge regarding these epigenetic programs, and the 
emerging direct and indirect links between H4K20 dynamics and dosage compensation. 
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Introduction 
To preserve cellular identity and genomic integrity, eukaryotes employ chemical and structural 
modifications to chromatin that do not alter DNA sequences. These epigenetic programs form an 
important layer of control over cell proliferation, differentiation, and transcriptional activity. 
Multiple epigenetic mechanisms exist, including microRNA mediated heterochromatin 
formation (Emmerth et al., 2010), DNA methylation, histone tail modifications, and nuclear 
organization of chromatin.  Aging leads to skewed epigenetic patterns that may underlie changes 
in cellular transcriptomes and differentiation states (Feser and Tyler, 2011; Tsurumi and Li, 
2012; Zhan et al., 2007). Total histone protein may also decrease with aging (Dang et al., 2009). 
Therefore, organismal aging may be regulated at the level of the nucleosome. 
Nucleosomes consist of approximately 146 base pairs of DNA wrapped twice around a core 
octamer of two copies each of histones H2A, H2B, H3, and H4 (Fig. 2.1) (Luger et al., 1997). 
Histone proteins are highly basic, facilitating interaction with negatively charged DNA. Each of 
these histones possesses N-terminal tails projecting away from the nucleosome core. These tails 
can be extensively modified by methylation, phosphorylation, acetylation, sumoylation, 
crotonylation, and ubiquitination (Margueron et al., 2005; Tan et al., 2011). Acetylation 
promotes transcription by decreasing the net positive charge of nucleosomes, leading to less tight 
binding of DNA to the histone core (Berger, 2007). Aging is associated with increased histone 
tail acetylation (Dang et al., 2009; Kawahara et al., 2009). In contrast, the role of histone 
methylation in aging is less clear. Histone methylation can either promote or inhibit gene 
activation depending on the location of the mark. Methylation of H3 lysine 4 (H3K4me), 
H3K36, and H3K79 are considered gene activating, while H3K9, H3K27, and H4K20 mark 
heterochromatin (Barski et al., 2007; Lan and Shi, 2009). Repressive marks facilitate 
heterochromatin formation through distinct mechanisms. For example, heterochromatin protein 1 
(HP1) binds to adjacent sites of H3K9 trimethylation (H3K9me3), compacting the chromatin 
(Nishibuchi and Dejardin, 2017). H4K20 methylation increases chromatin compaction through 
stronger interaction between the modified H4 tail and the neighboring histone (Davey et al., 
2002; Dorigo et al., 2004; Luger et al., 1997). Lysine methyltransferases contain the Su(var), 
Enhancer of zeste, and Trithorax-domain (SET domain) and modify histone tails (Xiao et al., 
2003). 
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Figure 2.1. Schematic representation of the nucleosome. The nucleosome consists of a core octamer 
made up of two copies of H2A, H2B, H3, and H4 histones. DNA (black lines) wraps around the histone 
core twice. N- terminal histone tails project out from the core and can be extensively modified. Histone 
modifications control the strength of DNA-histone interactions as well as interactions between 
nucleosomes. 
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In addition to local nucleosome modifications, chromosome-level regulation of gene expression 
is critical for maintenance of gene expression. Three-dimensional chromatin architecture controls 
gene expression. Many heterochromatic regions are directed toward the nuclear periphery 
through interactions with the nuclear lamina (Towbin et al., 2012), and stereotypical 
chromosome loops are formed that bring cis-acting regulatory sequences into close proximity to 
their target genes (Kadauke and Blobel, 2009). CTCF proteins interacting with cohesins define 
the boundaries of these loops to define regulatory ‘neighborhoods’ that activate tissue-specific 
gene programs and reinforce silencing of inappropriate genes (Dowen et al., 2014). Finally, the 
special case of sex chromosome gene dosage is striking. Most autosomal aneuploidies are 
deleterious. Humans with trisomy 21 are viable but have Down’s Syndrome, characterized not 
only by impaired cognitive development but also early onset of diseases associated with aging, 
including cardiovascular disease and dementia (Hayes et al., 2017; Lautarescu et al., 2017). 
However, sex chromosomes tolerate imbalance between homogametic (XX) and heterogametic 
sexes (XY or XO) through the equalization of X chromosome expression between the sexes, a 
phenomenon known as dosage compensation. Although mechanistically distinct across 
metazoans, dosage compensation is required for embryonic viability (Belote and Lucchesi, 1980; 
Hodgkin, 1987; Plenefisch et al., 1989). In parallel to dosage compensation, X-linked gene 
expression is also upregulated globally to match hemizygous transcriptional output that of 2N 
autosomes (Deng et al., 2011; Ka et al., 2016). 
Disruption of dosage compensation is linked to many pathologies associated with aging. For 
example, women suffering from Alzheimer’s Disease demonstrate skewed X chromosome 
inactivation (SXCI) (Bajic et al., 2015), and X chromosome aneuploidy was detected in brain 
tissue from Alzheimer’s patients than in unaffected controls (Yurov et al., 2014). Similarly, 
SXCI was significantly enriched in somatic tissue of young patients presenting with high-grade 
glioma, indicating that maintenance of dosage compensation may protect against certain cancers 
(Li et al., 2013). Given that maintenance of dosage compensation is also associated with long life 
(Gentilini et al., 2012), it is important to understand how this phenomenon promotes conserved 
longevity pathways. This chapter seeks to briefly establish the principles underlying dosage 
compensation, focusing on the free-living nematode Caenorhabditis elegans, then elaborate 
more fully on the dynamics of dosage compensation-associated H4 lysine 20 methylation, and 
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finally discuss the evidence linking these two epigenetic mechanisms in the regulation of gene 
expression. 
 
Dosage compensation  
The evolution of sex chromosomes created the risk of deleterious gene expression imbalances 
between homo- and heterogametic sexes. Dosage compensation addresses this risk by equalizing 
gene expression of sex chromosomes between genders in many types of metazoans. In principle 
this phenomenon is conserved in worms, flies, and mammals--but perhaps not in birds (Julien et 
al., 2012; Wolf and Bryk, 2011)--yet the mechanism of achieving correct X chromosome gene 
dosage in different species is distinct, suggesting dosage compensation evolved independently in 
multiple animal lineages (Fig. 2.2). 
In placental mammals, random X inactivation completely silences one of the sex chromosomes 
stochastically using noncoding Xist RNA that binds in cis to the X to be silenced and recruits the 
Polycomb Repressive Complex 2 to deposit H3K27me3. This leads the increase of other 
heterochromatic marks including DNA hypermethylation, H3K9me3, and H4K20me3 (Robert 
Finestra and Gribnau, 2017; Wutz, 2011). 
In Drosophila melanogaster, a multi-subunit complex known as the male-specific lethal complex 
(MSL) assembles only on male X chromosomes. The MSL promotes two-fold upregulation of 
the male X to match female gene dosage through recruitment of MOF acetyltransferase that 
hyperacetylates histone H4K16 (Birchler, 2016). 
As compared to Drosophila, C. elegans achieves dosage compensation through a mechanism at 
once similar, in that a multi-subunit complex assembles on sex chromosomes, and opposite, both 
in terms of affected gender and consequences for gene expression.  A specialized 10 member 
condensin-like dosage compensation complex (DCC) assembles only in XX hermaphrodites and 
reduces gene expression on both X chromosomes by approximately half	(Meyer, 2010). Gender 
specificity is achieved through hermaphrodite-specific expression of DCC gene sdc-2 (Dawes et 
al., 1999), the expression of which is repressed by the X-linked male specifying xol-1 gene 
(Miller et al., 1988). SDC-2, in turn, represses male development and is required for DCC 
assembly on the two hermaphrodite X chromosomes (Dawes et al., 1999). Dosage compensation 
		 30	
promotes X chromosome compaction; impairment of dosage compensation increases the volume 
the X chromosome occupies in the nucleus without affecting autosomes (Lau et al., 2014). 
The DCC binds to the X chromosome at recruitment sites on the X (rex) sites that contain a 12 
BP consensus sequence known as motif enriched on X (mex) (Jans et al., 2009). These sites are 
sufficient for DCC binding, as fusion of X sequence containing rex sites and autosomal 
chromosomes on recruits the DCC to autosomal regions (Ercan et al., 2009). Despite there being 
only ~100 rex sites on X, DCC binding then spreads across the X to dox sites (dependent on X) 
to achieve repression across the entire X chromosome. The result is a depletion of RNA 
Polymerase II binding to X-linked promoters (Kruesi et al., 2013). 
Recent work has suggested that nuclear organization may play a role in DCC-mediated 
repression. X chromosomes are only weakly associated with the nuclear lamina in C. elegans, in 
contrast to autosomes, which show strong anchoring on both chromosome ends (Ikegami et al., 
2010). While hermaphrodite X chromosomes are randomly organized, the male X associates 
with nuclear pores in a manner dependent on rex sites (Sharma and Meister, 2015). Nuclear pore 
proximity is associated with active gene transcription, so preventing this nuclear positioning may 
be important for DCC inhibition of hermaphrodite X chromosomes. 
Remarkably, whether a gene is dosage compensated or escapes DCC regulation may be 
independent of local DCC binding. Therefore, the DCC may not be sufficient for dosage 
compensation; rather, it may require other epigenetic modifiers to achieve X chromosome 
compaction and reduced gene expression (Meyer, 2010). For example, recently it was shown that 
H3K9 methyltransferases are required for X chromosome compaction and stereotypical 
localization away from the transcriptionally active nuclear center (Snyder et al., 2016). 
Knockdown of these methyltransferases impaired dosage compensation, providing evidence that 
the DCC partners with enzymes that promote heterochromatin formation. 
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Figure 2.2. X chromosome regulation balances output with autosomes and between sexes. 
Divergent animals show distinct X chromosome dosage compensation. Drosophila upregulates the single 
male X chromosome to match females via the MSL complex. In C. elegans and mammals, global 
upregulation of the X chromosome balances hemizygous X chromosome gene expression with diploid 
autosome. In XX animals, this upregulation is followed by repression of X chromosome gene expression 
to match male X gene dosage. The dosage compensation complex (DCC) mediates dosage 
compensation in C. elegans. Random X chromosome inactivation (XCI) silences one X chromosome in 
mammals. 
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Histone H4 Lysine 20 methylation 
Lysine 20 is typically the only lysine on histone H4 that is methylated in eukaryotes (van Nuland 
and Gozani, 2016). Despite being described first in 1969 (DeLange et al., 1969), understanding 
how these marks participate in epigenetic regulation of development and longevity remains 
incomplete. Below I discuss the roles attributed to each methylation state of H4K20, the enzymes 
believed to establish or remove these marks, and current gaps in knowledge regarding this highly 
conserved epigenetic regulator of genomic integrity. Data is summarized in Table 1.1. 
Monomethylation of H4K20 plays a key role in cell cycle regulation (Wu and Rice, 2011). 
H4K20me1 is enriched on mitotic nucleosomes and is bound by condensin II subunits N-CAPG2 
and N-CAPD3 in M-phase (Liu et al., 2010). This modification is reported to recruit 53BP1 to 
sites of double-strand breaks (Dulev et al., 2014; Hartlerode et al., 2012) and protects against 
DNA damage in replicating cells (Li et al., 2016). PHF8 is believed to demethylate H4K20me1 
(Liu et al., 2010; Qi et al., 2010), while PR-SET7(SETD8) catalyzes K20 monomethylation in 
mammals and is required for embryonic viability past the 8-cell stage (Nishioka et al., 2002; Oda 
et al., 2009). In C. elegans, animals deficient in the PR-SET7 ortholog SET-1 grow in to sterile 
adults (Terranova et al., 2002). Similarly, Drosophila animals deficient in PR-SET7 die at the 
second instar larval stage, although whether loss of H4K20me1 is responsible for this lethal 
phenotype associated with loss of the methyltransferase has become controversial (McKay et al., 
2015; Shi et al., 2007). 
H4K20me1 is associated with actively transcribed genes (Barski et al., 2007), yet also may 
contribute to transcriptional repression due to recruitment of both euchromatic and 
heterochromatin-inducing proteins and modifications. For example, H4K20me1 is bound by the 
polycomb protein L3MBTL1, promoting compaction and is necessary for higher methylation 
states of H4K20, which are associated with gene repression (Kalakonda et al., 2008). Similarly, 
H4K20me1 was recently identified in budding yeast, and it is enriched in heterochromatic 
regions (Edwards et al., 2011). Mutants deficient in H4K20me1 experienced de-repression of 
subtelomeric genes as well as reporters located near telomeres and the silent mating type locus. 
In contrast, H4K20me1 also recruits the MSL complex in flies that promotes H4K16 acetylation 
and the release of transcriptional pausing of RNA polymerase II	(Kapoor-Vazirani and Vertino, 
2014). In addition to decreased global H4K20me1 levels, loss of PR-Set7 is also associated with 
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increased markers of senescence including increased p16/Ink4A expression, increased ribosome 
biogenesis and nucleolar activity in addition to (Tanaka et al., 2017). Brains of mice that 
experience accelerated senescence also show decreased K20 monomethylation (Wang et al., 
2010). 
Like monomethylated H4K20, dimethylated H4K20 is attributed a role in the DNA damage 
response, and its presence is cell cycle dependent. H4K20me2 is enriched in interphase/G1 cells 
during which time it constitutes 80% or more of total H4 (Schotta et al., 2008; Yang et al., 2008) 
and does not display focal enrichment in the genome (Schotta et al., 2004). Also like 
H4K20me1, dimethylated H4K20 is reported to recruit 53BP1 to sites of DNA damage (Botuyan 
et al., 2006). Similarly, fission yeast checkpoint protein Crb2 localizes to sites of DNA damage 
in a H4K20me2 dependent fashion (Greeson et al., 2008).  Local increase of H4K20 
dimethylation at double stranded DNA breaks in mammalian cells is dependent on the 
methyltransferase MMSET (Pei et al., 2011) and this interaction is stymied by the lysine 
demethylase JMJD2A (Mallette et al., 2012). Although loss of dimethylated H4K20 is tolerated 
in flies and worms, mice deficient in the dimethylase SUV420H1 die perinatally and demonstrate 
genome instability (Schotta et al., 2008). The loss of both H4K20me2 and H4K20me3 leads to 
genome-wide DNA damage in these mice. This phenotype may be due to a loss of chromatin 
compaction; both recombinant nucleosomes marked with either me2 or me3 condense chromatin 
fibers to a greater degree than unmodified nucleosomes (Lu et al., 2008). 
In mammals H4K20 trimethylation is enriched in regions of constitutive heterochromatin, 
including pericentromeric and telomeric regions, while in the fission yeast Schizosaccharomyces 
pombe, it is broadly distributed (Sanders et al., 2004). Observations in mammalian cells suggest 
that H3K9me3 may be necessary for subsequent H4K20me3 (Schotta et al., 2004). Consistent 
with these data, the putative H4K20 trimethylase SUV420H2 contains a chromoshadow motif 
that facilitates its recruitment to constitutive heterochromatin marked by H3K9me3 through 
interactions with HP1 (Souza et al., 2009; Wang et al., 2017). H4K20me3 may antagonize H4 
acetylation, and vice versa, consistent with H4K20 methylation being associated with chromatin 
compaction and transcriptional repression (Sarg et al., 2004; Serrano et al., 2013). H4K20me3 
promotes RNA polymerase II pausing, perhaps through depletion of H4K16 acetylation (Kapoor-
Vazirani et al., 2011). A functional and physical relationship between PR-SET7 and histone 
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deacetylase (HDAC) SirT2 was recently described, demonstrating that de-acetylation of H4K16 
promotes H4K20 methylation to maintain genomic integrity (Serrano et al., 2013). Intriguingly, 
in contrast to mice deficient in the dimethylase SUV420H1, mice lacking SUV420H2 and 
associated H4K20me3 lack obvious developmental defects (Schotta et al., 2008), suggesting that 
H4K20me3 is not essential for maintenance of genomic integrity during normal development. 
Trimethylation of H4K20 has not been ascribed a major role in cell cycle regulation, but 
increased H4K20me2 may be associated with replication errors in S-phase (Beck et al., 2012).  
H4K20 trimethylation is disordered in cancer progression. Greater trimethylation levels in 
tumors correlated with good prognosis in colon cancer (Benard et al., 2014). Loss of RB tumor 
suppressor proteins causes a dramatic loss of genomic stability perhaps due to decreased 
trimethylated H4K20me3 at constitutive heterochromatic regions (Gonzalo et al., 2005). Further, 
lung carcinoma tissues showed depleted H4K20me3 that was associated with either disease 
progression or reduced survival (Van Den Broeck et al., 2008). Similar depletion of H4K20me3 
is found in breast cancer cell lines and increased cell invasion in breast cancer tissues (Shinchi et 
al., 2015; Tryndyak et al., 2006). H4K20me3 loss at repetitive DNA was also observed in liver 
tumorogenesis (Pogribny et al., 2006). In contrast, greater tumor trimethylation was positively 
correlated with bladder cancer mortality (Schneider et al., 2011) and may be associated with 
aggressive prostate cancer (Vieira et al., 2015). 
H4K20me3 is enriched in aged mammalian tissues while other H4K20 methylation states do not 
change with age (Sarg et al., 2002). This enrichment was also observed in fibroblasts derived 
from Hutchinson-Gilford Progeria Syndrome patients, whose cells manifest defects in nuclear 
lamin leading to loss of heterochromatin and appear to experience accelerated aging and early 
death (Shumaker et al., 2006). This increase in trimethylation may occur as cells exit the cell 
cycle. Conversely, H4K20me3 is inversely related to pluripotency. During embryonic 
development H4K20me3 selectively represses the pluripotency marker homologs Oct-25 in 
Xenopus and Oct-4 in mice (Nicetto et al., 2013). H4K20me3 is not maintained in 
preimplantation murine embryos, recovering only in mid-gestation (Eid et al., 2016; Wongtawan 
et al., 2011). Deposition of H4K20me3 prevents telomere elongation and recombination (Benetti 
et al., 2007), and induced pluripotent stem cells from both young and old donors demonstrate 
decreased trimethylation as they acquire increased “stem-ness” (Marion et al., 2009). Taken 
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together, these findings suggest H4K20me3 is associated with both aged and differentiated 
tissues. 
Recent work suggests that another interpretation of increased H4K20me3 during aging is a mark 
of cellular quiescence. Consistent with this alternative interpretation, oocytes derived from 
middle-aged mice show depleted dimethylation in compared to young sexually mature mice, 
potentially through conversion to H4K20me3	(Manosalva and Gonzalez, 2010). Quiescent 
macrophages must undergo selective demethylation of H4K20me3 to fully activate the 
proinflammatory immune response, mediated by the demethylase PHF2 (Stender et al., 2012). 
Further, in primary human fibroblasts induced into quiescence via contact inhibition, both 
H4K20me2 and H4K20me3 levels increased, promoting chromatin compaction, while other 
histone modifications remained unchanged	(Evertts et al., 2013). Loss of the Suv4-20 enzymes 
increased the proportion of fibroblasts in S-phase, suggesting these proteins are required to 
maintain quiescence. In a separate study, senescent cells resistant to oxidative stress-induced 
apoptosis also demonstrated increased Suv420H2 protein coupled to increased global 
H4K20me3 and decreased MOF acetyltransferase and associated H4K16 acetylation (Sanders et 
al., 2013). The crustacean Artemia undergoes developmental diapause in unfavorable 
environments that can persist for years, and this extreme quiescent phenomenon requires the 
H4K20 trimethylase SETD4 (Dai et al., 2017). Demethylation of H4K20me3 in mouse neurons 
is required for the acquisition of new memories and spatial learning, consistent with its role in 
transcriptional inhibition (Wang et al., 2015). H4K20 trimethylation patterns are among the 
heterochromatic marks regulating proliferative potential of neural stem progenitor cells in the 
subventricular zone and are altered in the common glial cell cancer glioblastoma multiforme 
(Rhodes et al., 2016). Taken together, these reports link H4K20 trimethylation with the 
repression of both cellular proliferation and plasticity. 
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H4K20 Modification Bound by Functional roles 
H4K20me1 Condensins 
L3MBTL1 
53BP1 
MBTD1(TIP60) 
Cell cycle regulation (M phase) 
Cell proliferation 
DNA damage response 
Chromosome condensation 
Embryonic viability 
Transcription activation 
Dosage compensation 
H4K20me2 53BP1 
MBTD1(TIP60) 
JMJD2A 
Crb2 
Postnatal viability 
DNA damage response 
Chromatin condensation 
Cell cycle regulation (G1 phase) 
H4K20me3 ? Constitutive heterochromatin 
Cell cycle exit 
Quiescence/senescence 
Aging 
Chromatin compaction 
Diapause 
 
Table 2.1. Binding partners and functions attributed to distinct H4K20 methylation states. 
 
Enzymes responsible for higher order methylation of H4K20 
In mammals, dimethylation and trimethylation are believed to be performed by the structurally 
similar SUV420H1 and SUV420H2, respectively, both of which potentially recognize both 
histone and non-histone substrates (Jorgensen et al., 2013; Weirich et al., 2016). In contrast, flies 
and worms possess a single ortholog homologous to both enzymes (SUV4-20 and SET-4, 
respectively) that are required for both di- and tri-methylation (Vielle et al., 2012; Yang et al., 
2008), while Set9 is required for all H4K20 methylation states in S. pombe (Sanders et al., 2004). 
This conservation suggests either that these Drosophila and C. elegans homologs enzymes 
perform both methylation reactions or that they are dimethylases that provide a required 
substrate for subsequent trimethylation performed by one or more trimethylases. Although both 
conversion to di- and/or tri-methylation requires a monomethylated substrate, evidence in mouse 
embryonic fibroblasts suggests SUV420H2 does not require a dimethylated intermediate to 
trimethylate H4K20, nor does SUV420H2 rescue H4K20me2 in cells lacking SUV420H1 
(Schotta et al., 2008). However, independent reports using in vitro functional assays suggest that 
the SET domain of both SUV420H enzymes is limited to dimethylation (Southall et al., 2014; 
Weirich et al., 2016; Wu et al., 2013). These findings may indicate that trimethylation kinetics do 
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not allow for in vitro detection, that undescribed domains outside the SET domain may provide 
additional regulation of enzymatic specificity, and/or enzymes other than the SUV4-20 
methyltransferases perform trimethylation. Recent studies have implicated several conserved 
non-suv4-20 enzymes in H4K20 trimethylation, including SETD4, SMYD5, and SMYD3 (Dai et 
al., 2017; Foreman et al., 2011; Kidder et al., 2017; Stender et al., 2012). Although these findings 
have not been independently validated, such data suggest that multiple enzymes may be 
responsible for deposition of H4K20me3 depending on tissue type and/or developmental time. 
Remarkably, little progress has been made in identifying H4K20 demethylases that target di- and 
tri-methylated residues. PHF8 is established as a H4K20me1 demethylase (Liu et al., 2010; Qi et 
al., 2010). Only one report suggests that the histone demethylase JMJD2A binds H4K20me2, but 
this association may not lead to dimethylation (Mallette et al., 2012). Similarly, only a single 
publication suggests PHF2 demethylates H4K20me3 in macrophages (Stender et al., 2012); 
however, many reports identify PHF2 as a H3K9me2 demethylase associated with increased 
adipogenesis (Kim et al., 2014; Lee et al., 2014; Okuno et al., 2013). A recently described 
neuron-specific splice variant of LSD1 (LSD1n) involved in brain development can demethylate 
both H4K20me1 and H4K20me2 in vitro while changes in H4K20me3 methylation were not 
reported (Wang et al., 2015; Zibetti et al., 2010).  
 
Organism H4K20 Modification Methyltransferase(s) Demethylase 
  me1 
 
  
S. pombe me2 Set9 ? 
  me3     
  me1 SET-1 ? 
C. elegans me2 SET-4 
  
? 
  me3   
  me1 PR-SET7 ? 
Drosophila me2 SUV4-20 
  
? 
  me3   
  me1 PR-SET7/SETD8 PHF8 
mammals me2 SUV420H1 (SUV420H2?) ? 
  me3 SUV420H2, SMYD3, SMYD5, MMSET PHF2? 
 
Table 2.2. Enzymes associated with distinct H4K20 methylation states in model organisms.  
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Crosstalk between dosage compensation and H4K20 methylation 
Emerging evidence has linked the establishment of dosage compensation on X chromosomes 
with X-specific patterns of H4K20 methylation in C. elegans. Independent groups have shown 
H4K20me1 is deposited on the X in embryos after establishment of dosage compensation 
(Custer et al., 2014; Kramer et al., 2015). Although a direct physical interaction between DCC 
components and H4K20 methyltransferases were not observed in C. elegans (Csankovszki et al., 
2009), condensin II proteins have been shown to bind H4K20me1 in a different system	(Liu et 
al., 2010). Further, intact dosage compensation is associated with an enrichment of H4K20me1 
in both mammals and C. elegans (Kelsey et al., 2015; Vielle et al., 2012). In worms this 
enrichment occurs at the expense of H4K20me3 levels, which are depleted on X relative to 
autosomes. Disruption of the DCC eliminates the imbalance of monomethylation between sex 
chromosomes and autosomes. 
Despite the observed depletion of H4K20me3 on X, both SET-1 and SET-4 activity may be 
required for dosage compensation (Webster et al., 2013; Wells et al., 2012). Loss of either SET-1 
or SET-4 led to X-specific decondensation similar to that observed in DCC disruption (Lau et al., 
2014). Recently, Webster et al. demonstrated that both dosage compensation and histone H4 
lysine 20 methylation have important metabolic consequences during development (Webster et 
al., 2013). Animals deficient in TOR complex 2 (TORC2) have delayed development, decreased 
brood size and increased fat content (Soukas et al., 2009). Knockdown of DCC components 
including dpy-21 rescued these phenotypes, as did RNAi against both known H4K20 
methyltransferases set-1 and set-4 (Webster et al., 2013). Importantly, a role for H4K20 
dimethylation in dosage compensation and X chromosome compaction remains undescribed 
(Fig. 2.3). 
In addition to direct regulation of H4K20 methylation states, dosage compensation may interact 
with H4K20 indirectly through distinct chromatin modifications. Like SET-4, the HDAC SIR-
2.1 may participate in dosage compensation, and H4K16 deacetylation promotes the 
establishment of H4K20 methylation (Lau et al., 2014; Serrano et al., 2013; Wells et al., 2012). 
H3K9 methylation promotes dosage compensation (Snyder et al., 2016), and previous evidence 
in mammals suggests that H3K9me3 promotes H4K20me3 deposition (Schotta et al., 2004; 
Souza et al., 2009). 
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Figure 2.3. The C. elegans dosage compensation complex (DCC) interacts with H4K20 
modifications to achieve dosage compensation. Binding of the DCC promotes H4K20me1 enrichment 
on the X chromosome and depletes H4K20me3, but both SET-1 and SET-4 may promote dosage 
compensation. SET-1 activity promotes H4K16 deacetylation by SIR-2.1. Proteins are represented as 
shapes while histone modifications are text. Plausible relationships for which direct evidence is lacking 
are indicated with dashed lines and question marks. 
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Summary 
The epigenetic code permits highly complex regulation over gene expression in cells and tissues 
across differentiation states. These chemical modifications occur at multiple levels, ranging from 
the DNA itself, the nucleosome, higher order chromatin structure, to chromosome-wide 
compaction and nuclear positioning. At the level of chromatin, activating and repressive marks, 
including H4K16 acetylation and H4K20 methylation, respectively, compete for occupancy 
among many other post-translational histone modifications, while at the level of the 
chromosome, dosage compensation employs multiple epigenetic mechanisms to equalize gene 
expression between the sexes within a species. While this phenomenon is conserved, the 
mechanisms employed to achieve dosage compensation are remarkably distinct, suggesting 
dosage compensation evolved independently in distantly related metazoans.  
In C. elegans the components of the dosage compensation complex are known and how dosage 
compensation is achieved has been extensively studied. Yet, the interplay between the DCC and 
partner epigenetic effectors and its consequences for development is only now becoming 
apparent. In Chapter 3, we expand the link between DPY-21 and SET-4 activity in controlling 
distinct developmental fates in C. elegans larvae in response to environmental stress. 
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Chapter 3 
A histone H4 lysine 20 methyltransferase couples environmental 
cues to sensory neuron control of developmental plasticity1 
 
Abstract 
Animals change developmental fates in response to external cues. In the nematode 
Caenorhabditis elegans, unfavorable environmental conditions induce a state of diapause known 
as dauer by inhibiting the conserved DAF-2 insulin-like signaling (ILS) pathway through 
incompletely understood mechanisms. We previously established a role for the C. elegans 
dosage compensation protein DPY-21 in the control of dauer arrest and DAF-2 ILS. Here we 
show that the histone H4 lysine 20 methyltransferase SET-4, which also influences dosage 
compensation, promotes dauer arrest in part by repressing the X-linked ins-9 gene, which 
encodes a new agonist insulin-like peptide (ILP) expressed specifically in the paired ASI sensory 
neurons that are required for dauer bypass. ins-9 repression in dauer-constitutive mutants 
requires DPY-21, SET-4, and the FoxO transcription factor DAF-16, which is the main target of 
DAF-2 ILS. In contrast, autosomal genes encoding major agonist ILPs that promote reproductive 
development are not repressed by DPY-21, SET-4, or DAF-16/FoxO. Our results implicate SET-
4 as a sensory rheostat that reinforces developmental fates in response to environmental cues by 
modulating autocrine and paracrine DAF-2 ILS. 
 
 
                                                
1 Originally published in Development (2017 Feb 16 doi:  10.1242/dev.145722 [Epub ahead of print]) with authors 
listed as Delaney, C.E., Chen, A.T., Graniel, J.V., Dumas, K.J., and Hu, P.J. 
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Introduction 
To maintain evolutionary fitness, organisms must react appropriately to environmental cues. The 
free-living nematode Caenorhabditis elegans has evolved a developmental strategy to optimize 
survival in changing environments. Under replete conditions, larvae progress through four stages 
(L1 – L4) to become reproductive adults. In adverse conditions such as overcrowding, heat, or 
food scarcity, larvae arrest in an alternative stage known as dauer. Adapted for survival in harsh 
environments, dauers are morphologically, metabolically, and behaviorally distinct from 
reproductive L3 larvae. Improvement of ambient conditions induces dauer exit and resumption 
of reproductive development (Fielenbach and Antebi, 2008; Riddle, 1988). The dominant 
environmental cue that influences dauer arrest is a constitutively elaborated pheromone that 
indicates population density (Butcher et al., 2008; Golden and Riddle, 1982). 
C. elegans dauer arrest has served as a useful paradigm for understanding the molecular basis for 
developmental plasticity. Genetic analysis has defined four conserved signaling pathways that 
promote reproductive development in favorable environments. The DAF-11 transmembrane 
guanylyl cyclase acts in chemosensory neurons to regulate dauer arrest through the cyclic 
nucleotide-gated channel subunits TAX-2 and TAX-4. Downstream of DAF-11, DAF-2 insulin 
receptor (InsR) and DAF-7 transforming growth factor-β (TGFβ)-like pathways act in parallel to 
promote reproductive development by inhibiting the activities of the FoxO transcription factor 
DAF-16 and the SMAD transcription factor DAF-3, respectively. Distal to DAF-16/FoxO and 
DAF-3/SMAD, bile-acid-like steroid hormones known as dafachronic acids (DAs) promote 
reproductive development by regulating the activity of the conserved nuclear receptor DAF-12 
(Fielenbach and Antebi, 2008).  
While genetic analysis has identified how components of the DAF-11, DAF-2/InsR, DAF-
7/TGFβ, and DAF-12 pathways interact to promote reproductive development in favorable 
conditions (Gottlieb and Ruvkun, 1994; Riddle et al., 1981; Thomas et al., 1993; Vowels and 
Thomas, 1992), the molecular nature of the upstream events that couple external cues to the 
activities of these pathways remains poorly understood. Laser ablation experiments demonstrated 
that the amphid sensory neurons are required for induction of dauer arrest by pheromone 
(Schackwitz et al., 1996; Vowels and Thomas, 1994). Indeed, the dauer-inhibitory ASI sensory 
 51 
neurons (Bargmann and Horvitz, 1991) are specific sites of expression of three insulin-like 
peptides (ILPs) that promote reproductive development through DAF-2/InsR (INS-4, INS-6, and 
DAF-28) (Chen and Baugh, 2014; Cornils et al., 2011; Hung et al., 2014; Li et al., 2003) as well 
as the DAF-7 TGFβ-like ligand that promotes reproductive development (Ren et al., 1996; 
Schackwitz et al., 1996). Furthermore, crude dauer pheromone reduces the expression of DAF-
28 and DAF-7 in ASI (Li et al., 2003; Schackwitz et al., 1996), suggesting that pheromone 
induces dauer arrest at least in part by reducing the expression of agonist ligands in sensory 
neurons that regulate DAF-2/InsR and TGFβ-like signaling. How pheromone represses these 
ligands remains a mystery.  
We previously reported an unforeseen role for the C. elegans dosage compensation protein DPY-
21 in promoting dauer arrest through inhibition of the DAF-2/InsR pathway (Dumas et al., 2013). 
DPY-21 is a component of the condensin-like dosage compensation complex (DCC) that 
equalizes X-linked gene expression between males and hermaphrodites by binding to both 
hermaphrodite X chromosomes during embryogenesis and repressing gene expression 
approximately two-fold (Meyer, 2010; Yonker and Meyer, 2003). Here we show that the 
conserved histone H4 lysine 20 (H4K20) methyltransferase SET-4, which also influences dosage 
compensation (Kramer et al., 2015; Vielle et al., 2012; Wells et al., 2012), promotes dauer arrest 
in a sex-specific manner by synergizing with DAF-16/FoxO to repress ins-9, an X-linked gene 
that encodes an ILP expressed specifically in ASI neurons (Chen and Baugh, 2014; Pierce et al., 
2001). These findings reveal a sexually dimorphic role for regulators of histone H4K20 
methylation in broadening the dynamic range of sensory responses to environmental cues that 
control developmental plasticity. 
 
Results 
SET-4 acts through DAF-2 ILS to promote dauer arrest in a sex-specific manner 
DAF-2/InsR promotes reproductive development by activating a conserved phosphoinositide 3-
kinase (PI3K)/Akt pathway to inhibit DAF-16/FoxO (Murphy and Hu, 2013). The conserved 
protein EAK-7 acts in parallel to AKT-1 to inhibit nuclear DAF-16/FoxO activity (Alam et al., 
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2010). In contrast to eak-7 and akt-1 single mutants, which develop reproductively, eak-7;akt-1 
double mutant animals arrest as dauers in a DAF-16/FoxO-dependent manner (Alam et al., 2010). 
To identify new DAF-16/FoxO regulators, we performed a forward genetic screen for 
suppressors of the eak-7;akt-1 dauer-constitutive phenotype (seak). The first seak mutants 
characterized harbored loss-of-function mutations in the dosage compensation gene dpy-21 
(Dumas et al., 2013). dpy-21 encodes a conserved component of the condensin-like dosage 
compensation complex (DCC) that binds to X chromosomes and represses X-linked gene 
expression (Meyer, 2010; Yonker and Meyer, 2003). One seak mutant strain contained a point 
mutation in set-4, which encodes a histone H4K20 methyltransferase homolog that influences 
dosage compensation (Vielle et al., 2012; Wells et al., 2012). set-4(dp268) is predicted to change 
the conserved SET domain catalytic residue serine 182 (Southall et al., 2014) to phenylalanine 
(Figure 1A, Figure S1A). In light of our findings on dpy-21 (Dumas et al., 2013), we tested the 
possibility that set-4(dp268) was the causative seak mutation in this strain. After outcrossing 
removed all but two closely linked single nucleotide variants, set-4(dp268) suppressed dauer 
arrest to a similar extent as two independently derived set-4 deletions, n4600 (Andersen and 
Horvitz, 2007) and ok1481 (Figure 1B). Furthermore, an integrated single-copy HA::set-4 
transgene rescued dauer arrest in set-4(n4600) animals (Figure 1C and S1B). Therefore, SET-4 
promotes dauer arrest. 
DPY-21 enhances dauer arrest by activating DAF-16/FoxO, indicating that it acts in the DAF-
2/InsR pathway to regulate dauer formation (Dumas et al., 2013). To determine whether SET-4 
functions in the DAF-2/InsR pathway, we tested the effect of set-4 mutation on dauer-
constitutive phenotypes caused by mutations in the daf-2/InsR, daf-7/TGFβ, and daf-12 
pathways. set-4 mutation suppressed the dauer-constitutive phenotypes of daf-2(e1368) mutants 
(Figure 1C) as well as akt-1(ok525) and eak-7(tm3188) single mutants, which develop 
reproductively at 25°C but arrest as dauers at 27°C (Figs. S1C-D) (Ailion and Thomas, 2003; 
Alam et al., 2010; Hu et al., 2006). In contrast, set-4 mutation had no effect on the dauer-
constitutive phenotypes caused by mutations in daf-1, which encodes a Type 1 TGF-β receptor 
homolog (Georgi et al., 1990), or daf-8, which encodes a SMAD homolog (Park et al., 2010) 
(Figs. 1D and S1E). Similarly, set-4 mutation did not suppress dauer arrest in animals harboring 
mutations in daf-9 or daf-36, which encode DA biosynthesis pathway components (Figs. 1E and 
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S1F) (Gerisch et al., 2001; Jia et al., 2002; Rottiers et al., 2006). Therefore, SET-4 acts 
specifically in the DAF-2/InsR pathway to promote dauer arrest. 
Since previous reports link H4K20 methylation status to dosage compensation (Vielle et al., 
2012; Wells et al., 2012), and DPY-21 promotes dauer arrest through dosage compensation 
(Dumas et al., 2013), we hypothesized that SET-4 may also regulate dauer arrest through dosage 
compensation. To test this, we determined the effect of set-4 mutation on the dauer-constitutive 
phenotype of eak-7;akt-1 double mutant hermaphrodites and males. If SET-4 promotes dauer 
arrest through the same mechanism as dosage compensation, then set-4 mutation should suppress 
dauer in hermaphrodites but not males, since the DCC is inactive in males (Meyer, 2010). dpy-21 
and set-4 mutations suppressed the dauer-constitutive phenotype of eak-7;akt-1 hermaphrodites 
but did not affect dauer arrest in males (Figure 1F). Therefore, SET-4 may act through dosage 
compensation to control dauer arrest. We verified the role of SET-4 in dosage compensation by 
showing that set-4 mutation suppressed lethality in xol-1 sex-1 mutant males, which die due to 
inappropriate activation of dosage compensation (Dawes et al., 1999) (Figure S1G).  
In order to determine whether SET-4 plays a role in regulating dauer entry in wild-type animals 
in response to physiologic stimuli, we tested the ability of dauer pheromone to induce dauer 
arrest in wild-type and set-4 mutant animals. Mutation of either set-4 or dpy-21 decreased the 
sensitivity of wild-type animals to pheromone (Figure 1G). Therefore, SET-4 and DPY-21 
promote dauer arrest in wild-type animals in response to increases in population density. 
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Figure 3.1. SET-4 promotes dauer arrest. (A) Schematic of the set-4 locus and three mutant alleles. 
Exons are indicated as boxes, separated by introns. Gray, green, and yellow denote untranslated regions, 
coding sequence, and SET domain coding sequence, respectively. Deletions are indicated by black bars. 
(B) set-4 mutations suppress the dauer-constitutive phenotype of eak-7;akt-1 mutants [N (left to right) = 
236, 627, 389, 521, 638]. (C) set-4(n4600) suppresses the dauer-constitutive phenotype of daf-2(e1368) 
mutants and is rescued by the single-copy set-4 transgene dpSi5 (N = 913, 1668, 1568, 1785). set-4 is 
dispensable for dauer arrest in (D) daf-1(m40) (N = 2215, 2189, 1816, 1899) and (E) daf-9(dh6) mutants 
(N = 1753, 1561, 2188, 2486). (F) set-4 and dpy-21 mutations suppress dauer arrest in XX 
hermaphrodites but not XO males (N = 567, 1330, 579, 1003, 1012, 700). (G) set-4 and dpy-21 mutations 
attenuate the response of wild-type animals to dauer pheromone [N (0uL, 2uL, 10uL): wild type = 542, 
461, 544; set-4 = 413, 246, 387; dpy-21 = 334, 220, 275.]. set-4 vs. wild type: p < 0.01 by two-way 
ANOVA. 
 
 55 
SET-4 is a H4K20 methyltransferase 
The mammalian SET-4 ortholog SUV420H2 is a H4K20 methyltransferase (Schotta et al., 2004), 
and C. elegans SET-4 promotes H4K20 trimethylation (Vielle et al., 2012; Webster et al., 2013; 
Wells et al., 2012). We confirmed the requirement of SET-4 for H4K20 di- and trimethylation in 
vivo (Figure 2A). Immunoblots showed no detectable SET-4 protein in set-4(n4600) and set-
4(ok1481) backgrounds, consistent with these being strong loss-of-function alleles. SET-4 
protein levels in set-4(dp268) are comparable to wild-type (Figure 2A). H4K20me2 and 
H4K20me3 levels are undetectable in all three set-4 mutant backgrounds (Figure 2A), suggesting 
that the S182F substitution in the SET domain abrogates catalytic activity. To test this possibility 
directly, we purified recombinant wild-type and mutant GST-SET-4 fusion proteins and tested 
their ability to methylate modified H4 peptides (H4K20me0, H4K20me1, and H4K20me2) in 
vitro. Mass spectrometry analysis revealed that both wild-type GST-SET-4 and GST-SUV420H2 
were capable of converting H4K20me1 to H4K20me2 (Figure 2B-C). Consistent with in vitro 
experiments using human SET-4 orthologs SUV420H1 and SUV420H2 (Southall et al., 2014; 
Wu et al., 2013), methylation was not detected with unmethylated or dimethylated substrates, nor 
were trimethylated products detected in any assay (Figure 2B-C). It is possible that an enzyme 
distinct from SET-4 catalyzes H4K20 trimethylation in vivo. Alternatively, conversion of 
H4K20me2 to H4K20me3 by SET-4 in vivo may require a cofactor that is absent from our in 
vitro reactions.  
GST-SET-4(S182F) did not methylate H4K20me1, indicating that the S182F mutation abolishes 
catalytic activity (Figure S2). Given that set-4(dp268) suppresses dauer to a similar extent as the 
two deletion alleles (Figure 1B), these data are consistent with SET-4 influencing dauer arrest 
through its conserved role in methylating H4K20. 
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Figure 3.2. SET-4 is a histone H4K20 methyltransferase. (A) SET-4 promotes H4K20 methylation in 
vivo. Anti-SET-4, H4K20me2, H4K20me3, and H3 immunoblots of lysates from wild-type and set-4 
mutant animals are shown. SET-4 protein is indicated by the arrowhead. Images are representative of 
four biological replicates. (B) Recombinant GST-SET-4 fusion protein methylates H4K20me1 in vitro. 
Percent methylation of H4K20 peptide substrates by GST proteins fused to wild-type SET-4, mutant SET-
4(S182F), or human SET-4 ortholog SUV420H2 is shown. Data represent mean values from three 
biological replicates. (C) MALDI spectra illustrating conversion of H4K20me1 to H4K20me2 by GST-SET-
4. Monoisotopic masses (protonated) of peptide substrates are indicated with arrowheads. Spectra are 
representative of three independent experiments. 
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SET-4 acts in neurons to promote dauer arrest 
To determine where SET-4 is expressed, we generated strains expressing reporter genes under 
the control of set-4 regulatory elements. Because two independent C-terminal SET-4::GFP 
translational fusions failed to rescue dauer arrest in set-4 mutants, we generated strains 
expressing a set-4p::GFP promoter fusion to determine the spatiotemporal activity of the set-4 
promoter. set-4p::GFP transgenic animals expressed GFP broadly in embryos (Figure S3). Post-
embryonically, we detected fluorescence predominantly in the head and tail regions of the animal, 
in a pattern consistent with neuronal expression. To confirm this, we established a transgenic 
strain that co-expressed set-4p::GFP and mCherry driven by the pan-neuronal rab-3 promoter 
(Nonet et al., 1997). At all developmental stages interrogated, we observed co-localization of 
green and red fluorescence (Figure 3A), consistent with somatic set-4p::GFP expression being 
predominantly neuronal. We did not observe significant GFP expression in intestine, body wall 
muscle, or hypodermis. 
As the amphid sensory neurons play a critical role in regulating dauer arrest (Bargmann and 
Horvitz, 1991; Schackwitz et al., 1996; Vowels and Thomas, 1994), we interrogated them for 
expression of set-4p::GFP. Amphid neurons possess ciliary dendrites that are in directcontact 
with the environment and can be labeled with the lipophilic dye DiI (Starich et al., 1995). The 
extent of co-localization of green and red fluorescence in set-4p::GFP transgenic animals 
exposed to DiI (Figure 3B) reveals that the set-4 promoter is active in amphid sensory neurons as 
well as in other cells. 
To test whether neuronal expression of set-4 is functionally important for dauer arrest, we 
generated tissue-specific set-4 transgenes and tested them for the ability to rescue dauer arrest in 
set-4 mutants. The neuronal rab-3p::set-4 transgene rescued dauer formation to a similar extent 
as a set-4 transgene driven by its native promoter (Figure 3C). In contrast, intestine-, 
hypodermis-, and muscle-specific set-4 transgenes did not rescue dauer arrest to a greater extent 
than a transgene expressing the set-4(dp268) mutant. Taken together, these data indicate that 
SET-4 functions in the nervous system to promote dauer arrest. 
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Figure 3.3. set-4 acts in the nervous system to promote dauer arrest. (A) Representative 
photomicrographs showing colocalization of GFP and mCherry in animals coexpressing set-4p::gfp and 
the pan-neuronal reporter rab-3p::mcherry (N = 15). (B) Representative photomicrographs showing 
colocalization of red and green fluorescence in amphid neurons of set-4p::gfp transgenic animals 
exposed to DiI (N = 21). (C) Rescue of dauer arrest in set-4;eak-7;akt-1 mutants by set-4 transgenes 
driven by native set-4 or tissue-specific promoters (N = 2328, 2143, 2058, 662, 811, 705, 936, 516, 541). 
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Transcriptome-wide influences of DPY-21 and SET-4 on dauer regulation  
We previously showed that the DCC component DPY-21 promotes DAF-16/FoxO activity 
(Dumas et al., 2013). To gain broader insight into how DPY-21 and SET-4 control dauer arrest, 
we performed whole transcriptome profiling to compare genome-wide regulatory influences 
(henceforth referred to as the “regulome”) of DPY-21 and SET-4 to those of the key 
transcription factors controlling dauer arrest in eak-7;akt-1 animals, DAF-16/FoxO and the 
nuclear receptor DAF-12 (Alam et al., 2010). We identified genes differentially expressed 
between wild-type and eak-7;akt-1 double mutant animals [fold change ≥ 1.5 and false discovery 
rate (FDR) < 0.05]. We then compared the transcriptomes of eak-7;akt-1 double mutants to those 
of eak-7;akt-1 animals harboring mutations in dpy-21, set-4, daf-16/FoxO, or daf-12, and 
identified genes that are differentially expressed in the opposite direction as in wild-type relative 
to eak-7;akt-1 (Table S1). Regulomes were validated by comparison with published data when 
possible (see below). 
We defined the SET-4 dauer regulome by identifying 333 genes common to set-4(n4600) and 
set-4(dp268) regulomes (Table S1). Comparison of this gene set with SET-4-regulated genes 
identified in wild-type embryos and L3 larvae (Kramer et al., 2015) revealed minimal overlap 
[one gene (MTCE.34) among 94 regulated by SET-4 in embryos, and one gene (B0511.11) 
among 18 SET-4-regulated genes in L3 larvae]. This lack of concordance could be due to 
differences in genetic background (eak-7;akt-1 vs. wild-type), developmental stage (early L2 
larvae vs. embryos/L3 larvae), and/or ambient temperature (25°C vs. 20°C).  
A similar analysis with eak-7;akt-1 dpy-21 mutants revealed 2,431 genes that comprise the DPY-
21 dauer regulome (Table S1). To validate the DPY-21 regulome, we found significant overlap 
between the set of 700 X-linked genes differentially expressed in eak-7;akt-1 dpy-21 vs. eak-
7;akt-1 animals with the 374 X-linked genes subject to dosage compensation in embryos (Jans et 
al., 2009) (119 genes; Figure S4A and Table S2; p = 2.1e-26). 308 of 333 genes that comprise the 
SET-4 dauer regulome (92.5%) are also part of the DPY-21 dauer regulome (Figure 4A and 
Table S1), suggesting that a functional relationship between DPY-21 and SET-4 may exist in 
post-embryonic dauer regulation. 
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The DAF-16/FoxO regulome consists of 2,957 genes (Table S1). This gene set overlapped 
significantly with both the 469-gene young adult DAF-16/FoxO regulome (Chen et al., 2015) 
(203 common genes; Figure S4B and Table S3, p = 3.2e-115) as well as the 1116-gene dauer 
regulome defined using daf-7 TGFβ-like pathway mutants (Liu et al., 2004) (522 common 
genes; Figure S4C and Table S4, p < 1e-100). Furthermore, 65 of the 132 genes regulated by the 
DAF-7 TGFβ-like pathway that contained at least one upstream DAF-16/FoxO binding motif 
(Liu et al., 2004) were part of the DAF-16/FoxO regulome [Figure S4D and Table S4 (bolded 
text), p = 6.5e-42]. Most genes in the DAF-16/FoxO regulome (2,282 of 2,957 genes; 77.2%) are 
also regulated by DAF-12 (Figure 4B and Table S1). Over two-thirds of genes comprising both 
DAF-16/FoxO (2,041 of 2,957 genes; 69.0%; Table S1) and DAF-12 (1804 of 2556 genes; 
70.6%; Table S1) regulomes are concordantly regulated by DPY-21. 
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Figure 3.4. Whole transcriptome profiling defines genes coordinately regulated by DPY-21/SET-4 
and DAF-16/FoxO. (A) Venn diagram of genes regulated by SET-4 and DPY-21. Genes coordinately 
regulated by SET-4 and DPY-21 are depicted in gray. (B) Venn diagram of X-linked genes regulated by 
DPY-21, DAF-16/FoxO, and DAF-12. 47 genes coordinately regulated by DPY-21 and DAF-16/FoxO but 
not by DAF-12 are depicted in purple and listed in Table S5. Data represents the aggregate of five 
biological replicate samples, each from thousands of progeny of no fewer than 200 animals per sample. 
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The X-linked ins-9 gene is repressed by DPY-21, SET-4 and DAF-16/FoxO 
Based on genetic epistasis experiments (Dumas et al., 2013) (Figure 1), we hypothesized that 
DPY-21 and SET-4 influence DAF-16/FoxO activity through repression of X-linked genes. 
Moreover, in light of the neuronal site of action of SET-4 (Figure 3C) and its expression in 
amphid sensory neurons (Figure 3B), we speculated that key dauer regulatory genes subject to 
dosage compensation might function in a signaling capacity in the nervous system, upstream of 
DAF-12. Therefore, we examined the set of X-linked genes common to DPY-21 and DAF-
16/FoxO regulomes that were not regulated by DAF-12, which acts downstream in the dauer 
regulatory cascade (Fielenbach and Antebi, 2008; Schaedel et al., 2012). This filtering strategy 
defined a set of 47 X-linked genes coordinately regulated by DPY-21 and DAF-16/FoxO but not 
influenced by daf-12 mutation (Figure 4B; Table S5). 
Among these X-linked genes was ins-9, which encodes one of 40 C. elegans ILPs (Pierce et al., 
2001). Transcriptome profiling revealed that ins-9 is silenced in eak-7;akt-1 animals in a manner 
that requires both daf-16/FoxO and dpy-21 (Table S2). We verified this by qPCR; ins-9 
expression was reduced more than 30-fold in eak-7;akt-1 double mutants compared to wild-type 
animals (Figure 5A). Full repression required DAF-16/FoxO as well as DPY-21 and SET-4 but 
was independent of daf-12. Notably, a daf-16/FoxO null mutation did not restore ins-9 transcript 
levels to wild-type levels. Furthermore, mutation of either dpy-21 or set-4 increased ins-9 
expression by substantially greater than two-fold (Figure 5A; 7.5-fold increase in set-4;eak-
7;akt-1 vs. eak-7;akt-1; 13.5-fold increase in eak-7;akt-1 dpy-21 vs. eak-7;akt-1). Taken together, 
these observations suggest that DAF-16/FoxO and DPY-21/SET-4 act synergistically to repress 
ins-9. 
 
ins-9 overexpression phenocopies dauer suppression caused by dpy-21 or set-4 mutation 
INS-9 was an attractive candidate regulator of dauer arrest and DAF-2 ILS, as multiple ILPs 
have been shown to control dauer arrest through DAF-2/InsR (Cornils et al., 2011; Fernandes de 
Abreu et al., 2014; Hung et al., 2014; Li et al., 2003; Murphy et al., 2003; Pierce et al., 2001). If 
derepression of ins-9 contributes to suppression of eak-7;akt-1 dauer arrest in dosage 
 63 
compensation mutants, then ins-9 overexpression should phenocopy dauer suppression caused by 
set-4 or dpy-21 mutation. We tested this by establishing transgenic strains harboring a 
polycistronic construct which permitted expression of both ins-9 and mNeonGreen (Shaner et al., 
2013) fused to an SL2 leader sequence (Blumenthal, 2005) under the control of native ins-9 5’ 
and 3’ regulatory elements (ins-9::SL2::mNG). In two independent transgenic lines, ins-9 
overexpression (indicated by mNeonGreen detection) suppressed the dauer-constitutive 
phenotype of eak-7;akt-1 double mutants (Figure 5B). Therefore, ins-9 overexpression 
recapitulated the phenotype caused by set-4 and dpy-21 mutations (Dumas et al., 2013) (Figure 
1B). These data are consistent with INS-9 acting as an agonist DAF-2/InsR ligand. 
 
ins-9 is expressed specifically in a single pair of amphid neurons 
Previous studies using reporters driven by the ins-9 promoter suggested that ins-9 is expressed in 
the ASI and ASJ amphid neurons as well as in additional tissues (Chen and Baugh, 2014; Pierce 
et al., 2001; Ritter et al., 2013). In contrast, in transgenic L2 larvae expressing ins-9::SL2::mNG, 
we consistently observed green fluorescence solely in one pair of sensory neurons. In animals in 
which neuronal morphology was discernable, we identified the fluorescent cells as the ASI 
amphid neurons (Figure 5C). We did not observe fluorescence in more than one pair of amphid 
neurons in any animal, nor did we detect fluorescence in other neurons or tissues. Since ins-
9::SL2::mNG contains genomic elements from the ins-9 locus that are missing from other 
reporters in the literature (Chen and Baugh, 2014; Pierce et al., 2001; Ritter et al., 2013), these 
observed patterns of expression are likely to be physiologically relevant. 
 
ins-9 and akt-2 are required for suppression of dauer arrest by set-4 mutation 
To determine the extent to which ins-9 derepression contributes to dauer suppression in set-4 
mutants, we tested the ability of set-4 to suppress the dauer-constitutive phenotype of daf-2/InsR 
mutants in wild-type and ins-9 loss-of-function backgrounds. We generated strong loss-of-
function ins-9 alleles using CRISPR/Cas9 genome editing (Paix et al., 2015). Two probable null 
alleles, dp675 and dp677, have nonsense mutations in the F-peptide region of ins-9 that lies N-
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terminal to the functional B and A peptides (Pierce et al., 2001) (Figure S5). Although neither 
allele induced dauer arrest in a wild-type background, both ins-9(dp675) and ins-9(dp677) 
partially rescued dauer arrest in set-4;daf-2 double mutants (Figure 5D), indicating that dauer 
suppression caused by set-4 mutation is due in part to de-repression of ins-9. 
We previously showed that the X-linked gene akt-2 is required for dauer suppression caused by 
dpy-21 mutation (Dumas et al., 2013). We verified that akt-2 transcripts increase two-fold in eak-
7;akt-1 double mutants when set-4 or dpy-21 is mutated (Figure S6A). Similar to ins-9 mutation, 
akt-2 mutation also partially rescued dauer arrest in animals lacking set-4 (Figure 5E), and the 
phenotypic effects of ins-9 and akt-2 mutations on dauer arrest may be additive (Figure 5E). 
However, set-4;daf-2;ins-9 akt-2 compound mutant animals still did not undergo dauer arrest to 
the same extent as daf-2 single mutant animals (Figure 5E), indicating that regulation of 
additional genes may contribute to dauer arrest. 
 
The autosomal ins-7 gene contributes to suppression of dauer arrest by set-4 mutation 
As the only X-linked ins gene, ins-9 is the sole ins gene subject to direct regulation by dosage 
compensation or other X-chromosome-specific mechanisms of gene regulation. However, it is 
conceivable that other ins genes could contribute to dauer regulation through indirect effects on 
their expression. Genes encoding three agonist ILPs, INS-4, INS-6, and DAF-28, are expressed 
in the ASI sensory neurons and have established roles in inhibiting dauer arrest and promoting 
reproductive development (Cornils et al., 2011; Hung et al., 2014; Li et al., 2003). To determine 
whether regulation of ins-4, ins-6, and/or daf-28 contributes to dauer suppression in this context, 
we measured ins-4, ins-6, and daf-28 transcript levels in wild-type, eak-7;akt-1 double mutant, 
and eak-7;akt-1 triple mutants with reduced DPY-21 or SET-4 activity. None of these genes was 
repressed in eak-7;akt-1 double mutants compared to wild-type animals, nor did loss of set-4 or 
dpy-21 cause significant increases in their expression (Figure S6B-D). Therefore, neither DPY-
21 nor SET-4 influences dauer arrest through regulation of ins-4, ins-6, and daf-28 expression. 
To determine whether other ILPs could contribute to dauer regulation by DPY-21 or SET-4, we 
searched the set of genes common to DAF-16/FoxO and DPY-21 regulomes for ins genes. Seven 
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ins genes are concordantly regulated by DAF-16/FoxO and DPY-21 based on FPKM counts 
from whole transcriptome data (Table S6). Two genes encoding putative antagonist ILPs, ins-20 
and ins-11 (Fernandes de Abreu et al., 2014), are repressed by DAF-16/FoxO and DPY-21; 
however, an increase in their expression in dpy-21 mutants would be expected to enhance, rather 
than suppress, dauer arrest. Similarly, two ins genes encoding agonist ILPs, ins-33 and ins-35 
(Fernandes de Abreu et al., 2014; Michaelson et al., 2010), are induced by DAF-16/FoxO and 
DPY-21; a decrease in their expression in dpy-21 mutants would also be expected to enhance 
dauer arrest if changes in their expression were functionally important in dauer regulation. DAF-
16/FoxO and DPY-21 induce the expression of two ins genes of unknown function, ins-16 and 
ins-29 (Fernandes de Abreu et al., 2014). Finally, ins-7, which encodes an agonist ILP (Murphy 
et al., 2007; Murphy et al., 2003), is repressed by DAF-16/FoxO and DPY-21 (Murphy et al., 
2007; Murphy et al., 2003) (Table S6). As ins-7 and ins-9 both encode agonist ILPs, are 
concordantly regulated by DAF-16/FoxO and DPY-21, and have been shown to influence dauer 
arrest (Murphy et al., 2007; Murphy et al., 2003) (Figure 5C-E), we tested ins-7 for a role in 
promoting reproductive development in dpy-21 and set-4 mutants. We verified ins-7 repression 
by DAF-16/FoxO, SET-4, and DPY-21 using qPCR (Figure S6E). The ins-7(tm1907) deletion 
allele partially rescued dauer in set-4;daf-2 animals and may have an additive effect with ins-9 
mutation on dauer suppression (Figure 5F). Thus, SET-4 may influence dauer arrest through both 
direct repression of X-linked genes such as ins-9 and akt-2 and perhaps indirect regulation of 
autosomal dauer regulatory genes such as ins-7. 
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Figure 3.5. SET-4 promotes dauer arrest by repressing the X-linked ins-9 gene. (A) ins-9 is 
repressed by DPY-21, SET-4, and DAF-16/FoxO but not DAF-12. Results are the mean and s.e.m. of five 
experiments. (B) ins-9 overexpression suppresses dauer arrest in eak-7;akt-1 animals. Non-transgenic 
(NT) and transgenic (T) progeny of transgenic hermaphrodites are shown. N = 1200, 1522, 718/156 
(NT/T), 702/210 (NT/T). (C) An ins-9::SL2::mNG transgene is expressed specifically in ASI sensory 
neurons. The arrowhead indicates the top of the nerve ring, and the arrow indicates the ASI axon. 
Representative images are shown (N = 20). (D) Two ins-9 nonsense mutations partially rescue dauer 
arrest in set-4;daf-2 mutants. N = 957, 1205, 1398 (left panel); N = 892, 1028, 897 (right panel). (E) ins-9 
and akt-2 mutations rescue dauer arrest in an additive fashion in set-4;daf-2 mutants (N = 949, 1281, 
1334, 1524, 1333, 1478) (F) ins-9 and ins-7 mutations rescue dauer arrest in an additive fashion in set-
4;daf-2 mutants (N = 1396, 1251, 754, 827, 1327). *p<0.05, **p<0.01. 
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Discussion 
Although much is known about the conserved signaling pathways that control C. elegans dauer 
arrest, how these pathways are regulated by upstream inputs is poorly understood. In the present 
study, we have established a framework for understanding how DPY-21 and SET-4 promote 
dauer arrest in the context of reduced DAF-2 ILS. Specifically, we have discovered that the 
conserved H4K20 methyltransferase SET-4 acts in the nervous system to promote dauer arrest. It 
does so in part by synergizing with DAF-16/FoxO to repress the X-linked insulin-like peptide 
gene ins-9. We hypothesize that SET-4 and DPY-21 act similarly to directly repress ins-9 and 
akt-2, thus attenuating DAF-2 ILS and promoting dauer arrest through activation of DAF-
16/FoxO (Figure 6).  
Although INS-9 has been predicted to function as an agonist ILP based on both structural models 
indicating similarity to the agonist ILPs INS-4, INS-6, and DAF-28 (Pierce et al., 2001) and 
expression changes upon starvation and feeding of larvae (Chen and Baugh, 2014), analysis of 
existing ins-9 mutants has not revealed phenotypes consistent with this (Fernandes de Abreu et 
al., 2014). This may be due to ins-9(tm3618) not being a strong loss-of-function allele. In 
contrast, our analysis of transgenic animals overexpressing ins-9 (Figure 5B) and mutant animals 
harboring nonsense ins-9 alleles (Figure 5D-F) provides the first experimental evidence 
demonstrating that INS-9 is an agonist ILP. 
Several ILPs have been implicated in dauer regulation (Cornils et al., 2011; Fernandes de Abreu 
et al., 2014; Hung et al., 2014; Li et al., 2003; Murphy et al., 2003; Pierce et al., 2001). However, 
the mechanistic basis for how environmental cues regulate ILPs remains obscure. The initial 
events that control dauer arrest through DAF-2 ILS likely take place in the amphid sensory 
neurons, which are required for dauer formation in response to pheromone (Schackwitz et al., 
1996; Vowels and Thomas, 1994). Indeed, genes encoding INS-4, INS-6, and DAF-28, which 
collectively play a major role in promoting reproductive development through DAF-2 ILS 
(Cornils et al., 2011; Hung et al., 2014; Li et al., 2003), are expressed in ASI (Chen and Baugh, 
2014; Cornils et al., 2011; Hung et al., 2014; Li et al., 2003), and the transcription of ins-6 and 
daf-28 is inhibited by dauer pheromone through unknown mechanisms (Cornils et al., 2011; Li et 
al., 2003). Our finding that DPY-21 and SET-4 influence dauer arrest in part by repressing the 
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X-linked ins-9 gene provides a potential mechanistic link between a dauer-regulatory 
environmental cue and an ILP expressed in sensory neurons that control the dauer decision. 
An intriguing but incompletely understood aspect of dauer morphogenesis is the mechanistic 
basis for the commitment of larvae to either the reproductive or dauer developmental fate. 
Assays in which larvae are shifted between favorable and unfavorable conditions at different 
times after hatching indicate the existence of commitment points beyond which animals develop 
reproductively or arrest as dauers regardless of ambient conditions (Golden and Riddle, 1984; 
Schaedel et al., 2012). Commitment to reproductive development correlates temporally with the 
activation of a feed-forward loop amplifying organismal DA biosynthesis through DA-dependent 
induction of DAF-9 expression in the hypodermis (Schaedel et al., 2012). However, the XXX 
cells (Ohkura et al., 2003), thought to be the sole source of DA biosynthesis prior to the 
commitment point (Schaedel et al., 2012), are not in direct contact with the environment. 
Therefore, they must receive upstream inputs from sensory neurons that convey information 
about ambient conditions. 
Our finding that DPY-21 and SET-4 synergize with DAF-16/FoxO to repress ins-9 is consistent 
with a hypothetical model in which INS-9 may function as a key node in an autocrine feed-
forward loop in the ASI sensory neurons that reinforces levels of its own expression in response 
to changing environments, upstream of DA biosynthesis in the XXX cells and hypodermis. In 
replete conditions, ins-9 expression in ASI is expected to lead to activation of DAF-2 ILS and 
inhibition of DAF-16/FoxO. Since DAF-16/FoxO inhibits ins-9 expression, decreased DAF-
16/FoxO activity would lead to increased ins-9 expression, which would presumably lead to 
further activation of DAF-2 ILS and inhibition of DAF-16/FoxO, both in an autocrine fashion in 
ASI as well as in other cells that express DAF-2/InsR. In the context of increased population 
density, pheromone would promote ins-9 repression through DPY-21 and SET-4 and reduce 
autocrine and paracrine engagement of DAF-2/InsR, resulting in DAF-16/FoxO activation, 
further repression of ins-9, and dauer arrest (Figure 6). The effect of DPY-21 and SET-4 would 
not be limited to sensory neurons, as they would also act in other cells responding to INS-9 to 
control their sensitivity to ILPs by repressing akt-2 (Dumas et al., 2013) (Figures 6 and S6A). In 
addition, ins-9 regulation may also be amplified through other ILPs such as INS-7, which 
 69 
functions in a feed-forward loop in adults to coordinate DAF-16/FoxO activity throughout the 
animal (Murphy et al., 2007). 
 
 
Figure 3.6. Hypothetical model of dauer regulation by pheromone through DPY-21/SET-4 and DAF-
2 ILS. DPY-21 and SET-4 act in concert to promote transduction of pheromone cues by repressing X-
linked genes encoding the DAF-2/InsR agonist INS-9 and the serine/threonine kinase AKT-2, resulting in 
increased DAF-16 activation and subsequent dauer arrest. 
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Materials and Methods 
C. elegans strains and maintenance 
Mutant alleles are listed in Supplementary Materials and Methods. Compound mutants were 
generated using standard protocols. All animals were maintained on nematode growth media 
(NGM) plates seeded with E. coli OP50 using standard techniques.   
 
Dauer arrest assays 
Dauer arrest assays were performed as previously described (Hu et al., 2006). daf-9(dh6) mutant 
animals were propagated on NGM plates supplemented with 10 nM ∆7-DA, then transferred to 
NGM plates for egglays as previously described (Dumas et al., 2013). For male dauer assays, 
males were crossed to isogenic L4 hermaphrodites, and the gender of dauer progeny was 
determined after dauer exit. 
 
Dauer pheromone assays 
Dauer pheromone was prepared as previously described (Golden and Riddle, 1982; Schroeder 
and Flatt, 2014). Details are provided in Supplementary Materials and Methods.  
 
Generation of transgenic strains 
Details pertaining to the generation of reporter constructs and transgenic strains are provided in 
Supplementary Materials and Methods.  
 
CRISPR/Cas9-based mutagenesis 
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ins-9(dp675) and ins-9(dp677) were generated using recombinant crRNA and tracrRNA 
(Dharmacon) and Cas9 (PNA Bio) as described (Paix et al., 2015). See Table S7 for sequences 
of guide RNAs and repair oligonucleotides. 
 
RNA isolation 
Greater than 200 gravid hermaphrodites were allowed to lay eggs for 6 hr at 20°C and then 
removed.  Eggs were transferred to 25°C for 24 hr.  Larvae were harvested, washed once in M9 
buffer and once in water, and resuspended in TRIzol (Invitrogen). After five sequential freeze-
thaws, RNA was extracted using chloroform. Extracted RNA was purified using a Direct-zol 
RNA Miniprep Kit (Zymo Research). 
 
qPCR 
cDNA was synthesized with oligo-dT priming using the SuperScript III First Strand Synthesis 
Kit (Invitrogen).  The equivalent of 10 ng of starting RNA was used as template in a 15 µL 
reaction using the Quantitect SYBRgreen qPCR Kit (Qiagen). Reactions were performed in a 
RotorGene 6000 (Corbett Research) and results analyzed using RotorGene 6000 Software 
(version 1.7). Samples were normalized to pmp-3 expression prior to comparison between groups 
(Hoogewijs et al., 2008). See Table S8 for primer sequences. Relative expression was calculated 
as described (Nolan et al., 2006). 
 
Confocal microscopy 
Animals were mounted on slides layered with a thin 3% agarose pad containing 25 mM sodium 
azide. Images were captured on a Leica Inverted SP5X Confocal Microscope (Leica) using LAS 
AF software. 
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RNA-seq analysis 
Whole transcriptome profiling was performed by the University of Michigan DNA Sequencing 
Core as previously described (Chen et al., 2015) using 100 ng input RNA per sample. Samples 
were barcoded and multiplexed, and 100-nucleotide paired end sequencing was performed using 
an Illumina HiSeq 2000 sequencer and Version 4 reagents. Five experimental replicates were 
analyzed. Correlation coefficients between replicates and genotypes are shown in Table S9. 
Annotated gene expression data output from CuffDiff v2.2.1 (Trapnell et al., 2013) was read into 
R version 3.2.1(2015-06-18; The R Foundation for Statistical Computing; http://www.r-
project.org/) for six comparisons: eak-7;akt-1 compared to (1) wild-type, (2) daf-16(mu86);eak-
7;akt-1, (3) daf-12;eak-7;akt-1, (4) set-4(n4600);eak-7;akt-1, (5) set-4(dp268);eak-7;akt-1, and 
(6) dpy-21;eak-7;akt-1. We filtered genes by the following criteria: (1) status = “OK” for wild-
type vs. eak-7;akt-1, (2) fold change (FC) ≥ 1.5 or FC ≤ 1/1.5 for wild-type vs. eak-7;akt-1 and 
(3) FDR < 0.05 for at least two separate comparisons. 
DAF-16 targets were defined as those filtered genes that also met (1) status = “OK” for eak-
7;akt-1 vs. daf-16;eak-7;akt-1, and (2) FC ≥ 1.5 for eak-7;akt-1 vs. daf-16;eak-7;akt-1 in the 
opposite direction as wild-type vs. eak-7;akt-1. DPY-21, SET-4, and DAF-12 targets were 
determined in an analogous fashion. For SET-4, we generated a list of SET-4 targets that showed 
FC ≥ 1.5 or FC ≤ 1/1.5 for both set-4 alleles, and a list that showed these changes for either one 
or both set-4 alleles. Lists of overlapping targets were then generated from these target lists. 
Significance of overlap with dosage-compensated X-linked genes (Jans et al., 2009), strongly 
regulated dauer genes (Liu et al., 2004), and DAF-16 targets in the daf-2(e1370) background 
(Chen et al., 2015) was calculated using a hypergeometric distribution, assuming 5863 X-linked 
transcripts and 46233 genome-wide transcripts in C. elegans detected in our RNA-seq analysis 
(by either the UCSCce10 reference transcriptome or de novo transcript assembly). If necessary, 
common WormBase Gene identifiers were downloaded from WormBase version WS250 
(intermine.wormbase.org). 
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Immunoblotting and antibodies 
To generate protein lysates, animals were washed in M9, then in sterile water. Pelleted animals 
were resuspended in equal volumes of worm lysis buffer (Webster et al., 2013), incubated at 
85°C for 5 min, then sonicated on ice for two cycles of 30 seconds each at 70% power using a 
Sonic Dismembrator Model 100 (Fisher Scientific). Homogenates were quantified using a DCTM 
Protein Quantification Kit (BioRad). 50 µg protein was loaded per lane using Criterion systems 
(BioRad) and transferred to Immobilon Psq (Millipore). Details pertaining to antibodies are 
provided in Supplementary Materials and Methods. Membranes were blocked with 5% milk in 
TBS + 0.5% Tween 20. Antibodies were diluted in Western Blocking Solution (Sigma) prior to 
incubation with membranes. Blots were washed with TBS + 0.5% Tween 20. Signal was 
detected by ECL (Pierce). 
 
Histone methyltransferase assay 
set-4 cDNAs were amplified from RNA isolated from wild-type or set-4(dp268) mutant animals. 
Human Suv420H2 cDNA was obtained from Origene. Clones were ligated into pGEX4T1 vector 
(GE Healthcare). Protein expression was induced overnight at 16°C with 0.1 mM IPTG in BL21-
CodonPlus(DE3)-RIPL cells (Agilent Technologies) grown in Terrific Broth (Invitrogen) + 4% 
glycerol (Sigma). Cells were disrupted using a Sonic Dismembrator Model 100 sonicator (Fisher 
Scientific), with four cycles of ten one-second on/off pulses of 10-30% intensity. Lysates were 
cleared by centrifugation at 20,000g for 5 min and incubated with Glutathione-Sepharose beads 
(GE Healthcare) rotating overnight at 4°C. Expression of recombinant protein was confirmed by 
Coomassie staining and anti-GST immunoblot. Beads bound to recombinant protein were 
incubated in 10 mM Tris pH 8.0, 2 µM β-mercaptoethanol, and 7 mM S-adenosylmethionine 
(Sigma) in the presence of 2 mM substrate peptide corresponding to amino acids 8-30 of C. 
elegans histone H4 (AnaSpec) rotating for 4 hr at 30°C. Reactions were analyzed using a Waters 
MicroMass MALDI-TOF mass spectrometer and analyzed with MassLynx software. Ratios of 
peak heights corresponding to reactant and product peptide were calculated to define percent 
conversion. 
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Male rescue assay 
Mated gravid hermaphrodites were placed on NGM plates to lay eggs for 24 hr at 20°C. 
Egglayers were removed, and the number of hatchlings and eggs were counted. After 72 hr, the 
animals were moved to 4°C to slow movement. Male rescue was calculated as the ratio of live 
males to total eggs laid. Each experiment was performed in triplicate. 
 
Statistics 
Two-tailed Student’s t-test was used to measure significance in experiments unless otherwise 
noted. Data is presented as the average and standard error of the means of at least three 
biological replicates, each replicate performed in triplicate. N’s for dauer assays are listed from 
left to right. 
 
Data availability 
Strains are available upon request. Whole transcriptome profiling data are available at GEO with 
the accession number: GSE89295. 
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Supplemental Information 
Supplemental Materials and Methods 
Strains 
The following mutant alleles were used: eak-7(tm3188) (Alam et al., 2010), akt-1(ok525) 
(Hertweck et al., 2004), set-4(n4600) (Andersen and Horvitz, 2007), set-4(ok1481), daf-2(e1368) 
(Kimura et al., 1997), daf-1(m40) (Georgi et al., 1990), daf-9(dh6) (Gerisch et al., 2001), dpy-
21(e428) (Yonker and Meyer, 2003), daf-16(mu86) (Lin et al., 1997), daf-12(rh61rh411) (Antebi 
et al., 2000), akt-2(ok393) (Hertweck et al., 2004), ins-7(tm1907) (Murphy et al., 2007), daf-
8(e1393) ((Park et al., 2010), and daf-36(k114) (Rottiers et al., 2006). set-4(n4600) and set-
4(ok1481) were a gift from Gyorgyi Csankovszki. 
 
Reporter constructs and transgenic strains 
DNA fragments were amplified and assembled using overlap PCR, and fusion products were 
cloned into pCRXL-TOPO (Invitrogen). GFP, mCherry, and mNeonGreen were amplified from 
pPD95.75, pSA120, and pDD268, respectively. The identities of fusion products were verified 
by Sanger sequencing. To generate the single-copy rescuing transgenic strain dpSi5, the 638 bp 
genomic fragment between set-4 and the upstream gene C32D5.6 (set-4p) was amplified and 
fused to sequence encoding a HA epitope tag followed by the set-4 open reading frame (HA::set-
4) and 350 bp of genomic DNA downstream of set-4 (set-4utr) to create set-4p::HA::set-4::set-
4utr. Single-copy mosSCI integration of set-4p::HA::set-4::set-4utr into strain EG6250 
(cxTi10882) was performed by Knudra Transgenics as described (Frokjaer-Jensen et al., 2008). 
The set-4p::GFP transcriptional reporter was generated by fusing set-4p to GFP and set-4utr to 
create set-4p::GFP::set-4utr. set-4p::GFP::set-4utr was mixed with 50 ng µL-1 rol-6(su1006) 
(pRF4) or 10 ng µL-1 rab-3p::mcherry::unc-54utr to a final DNA concentration of 100 ng µL-1 
or 50 ng µL-1, respectively. For tissue-specific rescue experiments, promoters defined by the 
Promoterome Project (worfdb.dfci.harvard.edu/promoteromedb) were amplified from wild-type 
genomic DNA and fused to HA:set-4:set-4utr. The sizes of promoter fragments amplified were 
as follows: set-4p: 638 bp; rab-3p: 4913bp; col-19p: 1321 bp; myo-3p: 2006 bp; elt-2p: 1988 bp. 
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Constructs were co-injected with myo-2p::mcherry::unc-54utr (pJK343) and pBlueScript at 
concentrations of 5, 2, and 43 ng µL-1, respectively. To generate the polycistronic ins-
9::SL2::mNG transgene, a 1939 bp genomic fragment upstream of ins-9 was fused to ins-9 and 
the intercistronic genomic fragment between gpd-2 and gpd-3, mNeonGreen, and a 1017 bp 
genomic fragment downstream of ins-9. 40 ng µL-1 ins-9::SL2::mNG was mixed with 10 ng µL-1 
rab-3p::mcherry::unc-54utr. Animals were injected as previously described (Mello et al., 1991) 
using a Leica DMI3000B microscope and Eppendorf FemtoJet pump. 
 
Antibodies 
For immunoblotting, both custom anti-SET-4 antisera, generated by immunizing rabbits with a 
C-terminal SET-4 peptide (NH3-ENAEPIISEKKTKYELRSRS-COOH) (Pierce), and anti-
H4K20me3 antibodies (Abcam #ab78517) were diluted 1:500. Anti-H4K20me2 antibodies 
(Abcam #ab9052) and anti-histone H3 antibodies (Abcam #ab12079) were diluted 1:2000 and 
1:1000, respectively. The specificity of anti-H4K20me2 and anti-H4K20me3 antibodies was 
verified using competitive peptide-binding arrays. Methodology and results are available at 
www.histoneantibodies.com. 
 
Dauer pheromone preparation 
Wild-type animals were washed into a 2.8L Fernbach flask containing 1L S medium to which 
25mL of 40X E. coli HB101 culture was added. After media clarified, another 25mL of 40X 
HB101 was added. Four days later, supernatant was filtered through a Buchner funnel, then 
vacuum filtered through 0.22 µm SteriTop units (Millipore). Clarified supernatant was 
evaporated to dryness using a V-10 evaporator (Biotage). Solids were extracted three times with 
100 mL 100% ethanol, then evaporated. Pheromone was resuspended in ethanol and effective 
doses determined empirically. 3.5 cm plates containing 2 mL NGM made with Noble Agar (BD) 
and lacking peptone were treated with 500 µL water containing the indicated volume of 
pheromone. Once dry, plates were seeded with 20 µL of 6X E. coli OP50 in S basal. Dauer 
assays were performed as above with animals scored after 84 hr at 25°C. 
 77 
Supplemental Figures 
 
Supplemental Figure 3.S1. SET-4 promotes dauer arrest and participates in dosage compensation. 
(A) Conservation of SET-4 serine 182 within the SET domain. Identical and conserved residues are 
denoted by black and gray shading, respectively. SET-4 serine 182 is denoted by the arrow. (B) The 
single-copy set-4 transgene dpSi5 rescues dauer arrest in set-4;eak-7;akt-1 animals (N = 720, 1555, 
1096, 1351). set-4 mutation partially suppresses the 27°C dauer-constitutive phenotype of (C) akt-1 (N = 
806, 1077, 1121) and (D) eak-7 mutants (N = 409, 472, 379, 318). set-4 is dispensable for dauer arrest in 
(E) daf-8 (N = 609, 530, 496) and (F) daf-36 mutants (N = 653, 247, 242). (G) set-4 (N = 4052, 3475, 
4486, 3845) and dpy-21 (N = 3383, 1886, 4171, 3441) mutations rescue viability of him-8;xol-1 sex-1 
mutant males. Data are representative of three biological replicates. 
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Supplemental Figure 3.S2. MALDI spectra of methyltransferase assays. Peptide substrates and GST 
fusion proteins (if any) are indicated. Data are representative of three independent experiments. 
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Supplemental Figure 3.S3. set-4p::gfp expression in embryos. Embryos from 3 independent 
transgenic lines were picked from plates and subjected to Nomarski and fluorescent imaging using an 
Olympus BX61 epifluorescence compound microscope outfitted with a Hamamatsu ORCA ER camera 
and Slidebook 4.0.1 software. Representative images shown. N = 10 
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Supplemental Figure 3.S4. Comparison of whole transcriptome profiling results from this study to 
published studies. Venn diagrams depicting significant overlap between (A) X-linked genes regulated by 
dpy-21 and direct DCC targets (Jans et al., 2009) (overlapping genes listed in Table S2); (B) DAF-
16/FoxO target genes in L2 larvae and in young adult animals (Chen et al., 2015) (overlapping genes 
listed in Table S3); (C) DAF-16/FoxO target genes in L2 larvae and “strongly regulated dauer genes” 
(SRDG) (Liu et al., 2004) (overlapping genes listed in Table S4); and (D) DAF-16/FoxO target genes in L2 
larvae and SRDG containing upstream DAF-16/FoxO binding motifs (Liu et al., 2004) (overlapping genes 
listed in Table S4). 
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Supplemental Figure 3.S5.  Schematic of the ins-9 genomic locus and two mutant alleles 
generated by CRISPR/Cas9-based genome editing. Nucleotide sequences encoding wild-type, dp675, 
and dp677 N-terminal F-peptides and predicted N-terminal protein sequences are shown. Targeted 
CRISPR/Cas9 PAM sites are indicated in bold enlarged black typeface. The putative RXRR prohormone 
convertase processing site between the F and B peptides is underlined. Inserted sequences in two 
mutant alleles are indicated in red bold text, and the resultant in-frame stop codons are shown in red, bold 
and enlarged typeface. 
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Supplemental Figure 3.S6. Influence of the DCM and DAF-16/FoxO on the expression of akt-2 and 
ins genes. Transcript levels of (A) akt-2, (B) ins-4, (C) ins-6, (D) daf-28, and (E) ins-7 in wild-type and 
mutant strains. Data presented is the mean plus s.e.m of at least three biological replicates. 
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Supplemental Table 3.1. RNAseq differentially expressed genes. Comparisons between dauer-deficient 
compound mutant strains and eak-7;akt-1 background and overlap across regulomes are shown.. 
 
Data found on the web: 
http://dev.biologists.org/content/develop/suppl/2017/03/22/dev.145722.DC1/DEV145722supp.pdf 
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Supplemental Table 3.2. Dosage compensated genes. DPY-21 dauer regulome genes previously 
identified as dosage-compensated genes (Jans et al., 2009). 
 
Wormbase	ID	 Gene	name	 NCBI	gene	ID	 Fold	Change*	
WBGene00007694	 C23H4.6	 181384	 1.536	
WBGene00019780	 M60.4	 187465	 1.587	
WBGene00001451	 flp-8	 181583	 1.670	
WBGene00015948	 C18A11.2	 182760	 1.696	
WBGene00007877	 C33A11.1	 181625	 1.510	
WBGene00001006	 dlg-1	 180819	 1.529	
WBGene00007958	 C35C5.9	 183231	 1.922	
WBGene00018257	 F41B4.1	 180952	 1.770	
WBGene00001462	 flp-19	 181260	 1.631	
WBGene00011154	 R09A8.5	 187724	 1.652	
WBGene00006372	 syx-2	 181505	 2.120	
WBGene00000277	 cab-1	 181382	 1.758	
WBGene00010605	 K06G5.1	 181531	 1.633	
WBGene00001674	 gpa-12	 181157	 1.706	
WBGene00018175	 F38B6.6	 185454	 1.778	
WBGene00014213	 ZK1073.1	 181689	 1.623	
WBGene00003517	 nac-1	 181585	 2.100	
WBGene00015947	 C18A11.1	 182759	 1.560	
WBGene00000072	 add-1	 180760	 1.641	
WBGene00006365	 syg-1	 180555	 1.713	
WBGene00016894	 C53B7.3	 180957	 1.715	
WBGene00003408	 mrp-2	 180408	 2.566	
WBGene00020339	 ttr-59	 188262	 1.597	
WBGene00001335	 erp-1	 180667	 1.561	
WBGene00010059	 F54E4.3	 181559	 1.878	
WBGene00004749	 sdn-1	 181259	 1.585	
WBGene00001824	 hbl-1	 180848	 1.708	
WBGene00008977	 iglr-1	 184720	 2.140	
WBGene00018837	 F54G2.1	 180562	 1.682	
WBGene00019102	 F59C12.3	 181718	 1.625	
WBGene00011880	 T21B6.3	 181284	 2.291	
WBGene00006757	 unc-18	 181030	 1.502	
WBGene00004719	 sad-1	 181471	 1.923	
WBGene00044698	 K09F5.6	 4363114	 2.235	
WBGene00006750	 unc-10	 180990	 1.929	
WBGene00004033	 pkc-2	 181166	 1.630	
WBGene00006068	 sto-6	 190619	 2.236	
WBGene00006742	 unc-2	 180570	 2.053	
WBGene00001116	 dyc-1	 181515	 1.768	
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WBGene00006642	 tsp-16	 192066	 1.835	
WBGene00007772	 egrh-1	 181580	 1.853	
WBGene00002123	 inx-1	 180968	 1.651	
WBGene00044061	 tbc-12	 180556	 1.679	
WBGene00010329	 F59D12.1	 181656	 1.969	
WBGene00004370	 rig-3	 180958	 2.338	
WBGene00001708	 grk-1	 181212	 1.801	
WBGene00003733	 nhx-5	 181258	 1.788	
WBGene00006672	 twk-18	 181139	 2.329	
WBGene00006792	 unc-58	 181224	 1.734	
WBGene00004727	 sax-1	 180655	 1.539	
WBGene00016898	 C53C9.2	 181031	 1.987	
WBGene00002991	 lin-2	 181400	 1.763	
WBGene00015926	 C17H11.6	 181076	 1.620	
WBGene00004862	 sma-9	 181271	 1.694	
WBGene00009932	 F52D10.6	 186110	 1.892	
WBGene00000103	 akt-2	 181524	 1.658	
WBGene00000522	 clc-1	 181293	 2.176	
WBGene00020921	 W01C8.5	 180836	 1.613	
WBGene00021527	 aakg-3	 189836	 2.674	
WBGene00003623	 nhr-25	 181432	 1.855	
WBGene00003530	 nas-11	 180938	 1.717	
WBGene00001490	 frm-3	 181346	 2.181	
WBGene00007944	 C34F6.10	 181313	 1.583	
WBGene00001149	 bcat-1	 181423	 1.671	
WBGene00003561	 ncr-1	 180719	 1.937	
WBGene00003635	 nhr-45	 180738	 1.927	
WBGene00002124	 inx-2	 181318	 2.180	
WBGene00015294	 C01C10.2	 182067	 2.421	
WBGene00020158	 T02C5.1	 180568	 1.692	
WBGene00014215	 obr-3	 181495	 1.824	
WBGene00007285	 C04A11.1	 181486	 2.479	
WBGene00008571	 prmn-1	 181330	 1.650	
WBGene00008926	 F17H10.2	 184623	 2.518	
WBGene00001441	 fkh-9	 180670	 1.879	
WBGene00016866	 coel-1	 180700	 3.026	
WBGene00020633	 aakg-2	 181736	 1.762	
WBGene00017447	 F14B8.5	 180965	 2.104	
WBGene00017898	 F28C10.3	 180405	 2.263	
WBGene00009801	 F47A4.5	 181196	 1.902	
WBGene00022861	 dve-1	 180398	 1.754	
WBGene00008940	 F18H3.4	 181474	 2.149	
WBGene00009793	 pkn-1	 181244	 2.013	
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WBGene00015182	 B0416.7	 181986	 3.052	
WBGene00016659	 C45B2.2	 180877	 2.791	
WBGene00015177	 tmc-2	 181161	 2.190	
WBGene00016423	 tag-275	 180886	 1.719	
WBGene00004789	 sgk-1	 181697	 2.724	
WBGene00015494	 C05E11.3	 180730	 2.401	
WBGene00010701	 ent-2	 181648	 2.204	
WBGene00010009	 F53H4.4	 181675	 1.594	
WBGene00018374	 tag-343	 181722	 2.095	
WBGene00011824	 T18D3.7	 188577	 2.174	
WBGene00003986	 mct-4	 180766	 1.908	
WBGene00010935	 M163.1	 181546	 2.396	
WBGene00020920	 set-20	 180835	 1.950	
WBGene00011444	 T04F8.6	 181354	 1.839	
WBGene00022200	 fard-1	 180582	 2.036	
WBGene00017449	 otpl-3	 259710	 1.933	
WBGene00015295	 acl-12	 181001	 2.216	
WBGene00017687	 ets-4	 180927	 1.904	
WBGene00008951	 F19C6.2	 181213	 2.117	
WBGene00020919	 set-19	 180834	 2.325	
WBGene00009800	 rrc-1	 181195	 2.546	
WBGene00018607	 F48E3.8	 181010	 3.160	
WBGene00012261	 lpr-3	 181295	 1.864	
WBGene00019518	 K08B5.1	 187132	 2.609	
WBGene00011642	 T09B9.1	 181188	 3.814	
WBGene00006640	 tsp-14	 180761	 2.428	
WBGene00015822	 C16B8.2	 180680	 3.229	
WBGene00001690	 grd-1	 181300	 2.502	
WBGene00000902	 daf-6	 181584	 3.363	
WBGene00007174	 mboa-1	 181681	 4.943	
WBGene00007935	 C34E11.2	 181359	 5.672	
WBGene00001608	 R07B1.8	 187649	 12.511	
WBGene00016662	 C45B2.8	 180879	 4.202	
WBGene00016106	 C25F6.7	 180816	 7.304	
WBGene00044724	 R02E4.3	 4363121	 9.592	
WBGene00002983	 lgx-1	 180825	 12.749	
WBGene00018031	 F35B3.4	 185255	 34.952	
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Supplemental Table 3.3. DAF-16 target genes (Chen). DAF-16 dauer regulome genes previously 
identified as DAF-16 targets in young adult animals (Chen et al., 2015). 
 
Wormbase	ID	 Gene	name	 NCBI	gene	ID	 Fold	Change*	
WBGene00010614	 cri-1	 187082	 0.097	
WBGene00014046	 clec-60	 191384	 2.140	
WBGene00000853	 cut-6	 176520	 0.151	
WBGene00007131	 B0284.1	 181902	 0.276	
WBGene00019021	 F57H12.6	 177593	 0.218	
WBGene00007452	 C08F11.3	 182419	 0.079	
WBGene00001387	 far-3	 179785	 0.088	
WBGene00008390	 D1086.3	 179907	 0.109	
WBGene00022546	 ZC196.2	 191101	 0.057	
WBGene00015043	 cyp-34A8	 181850	 0.222	
WBGene00007440	 C08E8.4	 182409	 0.342	
WBGene00009805	 F47B8.4	 179930	 0.115	
WBGene00004932	 sod-3	 181748	 0.030	
WBGene00000968	 dhs-4	 172810	 0.317	
WBGene00001067	 dpy-5	 172197	 84.644	
WBGene00017128	 E04F6.9	 174185	 0.198	
WBGene00018448	 F45D11.1	 185779	 0.031	
WBGene00014047	 clec-61	 174613	 0.133	
WBGene00015889	 C17C3.3	 182714	 0.283	
WBGene00008482	 cut-4	 184037	 12.155	
WBGene00000649	 col-73	 184366	 83.927	
WBGene00014030	 glb-1	 176261	 0.092	
WBGene00022324	 fbxa-26	 190756	 0.024	
WBGene00017698	 F22B7.9	 176213	 0.213	
WBGene00013516	 Y73F4A.3	 177721	 0.395	
WBGene00011596	 T07G12.5	 177946	 0.256	
WBGene00008123	 ent-6	 178339	 3.022	
WBGene00022072	 cpg-9	 177087	 5.251	
WBGene00001074	 dpy-13	 177187	 80.909	
WBGene00019472	 cyp-35B1	 178803	 0.058	
WBGene00003473	 mtl-1	 179060	 0.052	
WBGene00015041	 cyp-34A6	 181848	 0.182	
WBGene00007929	 dmd-10	 183202	 0.186	
WBGene00008336	 C55A6.7	 183836	 0.367	
WBGene00003096	 lys-7	 178772	 0.228	
WBGene00011539	 fbxa-135	 188184	 0.133	
WBGene00012398	 Y6E2A.4	 189374	 0.102	
WBGene00008301	 dct-3	 183784	 0.203	
WBGene00022545	 ZC196.1	 191100	 0.188	
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WBGene00012399	 Y6E2A.5	 189376	 0.471	
WBGene00015223	 B0507.6	 182013	 0.475	
WBGene00016052	 dod-3	 178737	 0.160	
WBGene00002055	 ifc-1	 178747	 0.392	
WBGene00012381	 Y2H9A.4	 189352	 0.388	
WBGene00008341	 ttr-44	 179835	 0.453	
WBGene00021081	 W08A12.4	 189288	 0.527	
WBGene00007833	 oac-6	 180094	 2.441	
WBGene00018540	 btb-21	 185908	 3.593	
WBGene00017262	 F08F3.4	 178924	 2.789	
WBGene00020947	 W02F12.2	 189124	 2.717	
WBGene00008793	 F14D7.6	 184466	 3.871	
WBGene00007807	 C29F3.7	 180036	 4.771	
WBGene00013904	 ugt-6	 179755	 3.616	
WBGene00009982	 F53F1.4	 179822	 6.558	
WBGene00000734	 col-161	 179812	 39.509	
WBGene00009620	 fip-5	 181237	 1.725	
WBGene00007812	 C29F7.3	 181464	 1.780	
WBGene00018779	 F53H8.3	 186195	 2.021	
WBGene00003999	 pgp-5	 181276	 2.373	
WBGene00004000	 pgp-6	 181278	 2.701	
WBGene00002267	 lec-4	 175488	 0.363	
WBGene00010593	 gsnl-1	 179328	 0.351	
WBGene00000627	 col-50	 189050	 0.002	
WBGene00077701	 poml-3	 6418581	 0.249	
WBGene00012959	 Y47H10A.3	 190008	 0.138	
WBGene00010135	 F55H12.4	 186344	 0.335	
WBGene00011935	 scrm-1	 173053	 0.568	
WBGene00010422	 H32K16.2	 3565869	 0.591	
WBGene00012140	 T28F4.5	 172503	 0.391	
WBGene00007302	 C04F12.8	 182228	 0.541	
WBGene00002112	 ins-29	 3565850	 0.544	
WBGene00016663	 C45E1.4	 171885	 1.603	
WBGene00012961	 Y47H10A.5	 173091	 3.210	
WBGene00009964	 fip-6	 172707	 1.502	
WBGene00000660	 col-85	 188672	 0.003	
WBGene00008842	 chil-28	 174888	 0.007	
WBGene00020741	 T23F4.3	
	
0.027	
WBGene00019311	 K02E7.6	 173488 0.131	
WBGene00001768	 gst-20	 175008	 0.226	
WBGene00017135	 EEED8.4	 173921	 0.258	
WBGene00018195	 btb-16	 173674	 0.144	
WBGene00017247	 F08D12.3	 3565148	 0.490	
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WBGene00016628	 C44B7.6	 174125	 0.259	
WBGene00021797	 Y52E8A.4	 190188	 0.608	
WBGene00020329	 bath-26	 173531	 0.204	
WBGene00009663	 hda-5	 174811	 0.250	
WBGene00013220	 ctl-3	 175086	 0.356	
WBGene00018200	 btb-17	 173673	 0.441	
WBGene00010322	 F59B10.6	 174617	 0.646	
WBGene00007414	 C07E3.3	 174601	 0.402	
WBGene00011042	 R05H10.1	 175144	 0.364	
WBGene00006464	 bath-47	 173532	 0.471	
WBGene00008483	 E04D5.4	 184038	 1.939	
WBGene00011888	 cutl-15	 174426	 1.597	
WBGene00015894	 acdh-2	 173940	 1.673	
WBGene00015829	 math-15	 182659	 5.540	
WBGene00009904	 F49E12.12	 3565627	 2.488	
WBGene00005552	 sri-40	 191914	 3.163	
WBGene00004155	 pqn-73	 174366	 2.794	
WBGene00005291	 srh-70	 188678	 6.582	
WBGene00015828	 math-14	 182658	 6.273	
WBGene00012592	 Y38E10A.14	 174896	 4.612	
WBGene00012727	 Y39G8B.7	 189765	 22.443	
WBGene00189956	 Y34F4.6	 13188384	 0.045	
WBGene00021337	 Y34F4.2	 175262	 0.099	
WBGene00021865	 fbxa-66	 190275	 0.129	
WBGene00006533	 tba-7	 176568	 0.428	
WBGene00022325	 fbxa-5	 3565750	 0.467	
WBGene00021339	 Y34F4.4	 175263	 0.600	
WBGene00008040	 ttr-5	 176312	 0.480	
WBGene00000973	 dhs-9	 175737	 0.435	
WBGene00017806	 F26A1.8	 184948	 1.954	
WBGene00000932	 dao-6	 3564991	 2.171	
WBGene00020551	 T17H7.7	 175229	 8.532	
WBGene00022245	 acp-6	 177407	 0.255	
WBGene00011424	 dhs-31	 188051	 0.176	
WBGene00194646	 Y105C5A.1270	 13206883	 0.258	
WBGene00007507	 C10C5.3	 177767	 0.193	
WBGene00013633	 Y105C5A.8	 190873	 0.164	
WBGene00008028	 scl-6	 183343	 0.655	
WBGene00007509	 C10C5.5	 177769	 0.452	
WBGene00000535	 cpi-1	 177372	 0.326	
WBGene00016877	 C52D10.3	 3565402	 0.568	
WBGene00020445	 T12B3.2	 188439	 0.560	
WBGene00002013	 hsp-12.6	 177778	 0.189	
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WBGene00000002	 aat-1	 177793	 0.493	
WBGene00016848	 klo-1	 177557	 0.488	
WBGene00021156	 Y4C6B.2	 189355	 0.369	
WBGene00021872	 clec-85	 177068	 0.608	
WBGene00017592	 F19C7.2	 184678	 2.711	
WBGene00023486	 K08B4.7	 259573	 1.972	
WBGene00012130	 T28F3.4	
	
1.919	
WBGene00007508	 C10C5.4	 177768 3.537	
WBGene00009895	 scl-2	 178251	 2.571	
WBGene00000683	 col-109	 176988	 34.008	
WBGene00007930	 dmd-11	 183203	 0.043	
WBGene00044201	 H39E23.3	 3565355	 0.075	
WBGene00017660	 F21C10.11	 179293	 0.028	
WBGene00001852	 hil-1	 179993	 0.098	
WBGene00045338	 M01B2.13	 13216887	 0.104	
WBGene00010791	 sodh-2	 179628	 0.251	
WBGene00013903	 ugt-3	 191174	 0.326	
WBGene00020593	 ugt-11	 178882	 0.295	
WBGene00005644	 srp-3	 178672	 0.367	
WBGene00015042	 cyp-34A7	 181849	 0.149	
WBGene00000111	 alh-5	 178680	 0.314	
WBGene00005703	 sru-40	 187650	 0.194	
WBGene00016046	 C24B5.4	 182835	 0.304	
WBGene00015402	 C03G6.17	 182179	 0.419	
WBGene00008220	 C50B6.7	 179813	 0.409	
WBGene00007835	 oac-7	 180096	 0.567	
WBGene00020276	 T05H4.15	 179030	 0.458	
WBGene00017082	 DC2.5	 183970	 0.478	
WBGene00015393	 C03G6.5	 179123	 0.372	
WBGene00015076	 B0238.12	 178914	 0.629	
WBGene00005602	 srj-14	 179124	 0.416	
WBGene00138721	 C54D10.14	 13215782	 0.191	
WBGene00010062	 lipl-1	 179771	 0.625	
WBGene00018055	 F35F10.5	 185310	 0.536	
WBGene00001591	 glc-1	 180086	 0.416	
WBGene00002263	 lea-1	 3564838	 0.288	
WBGene00020182	 ugt-53	 178744	 0.610	
WBGene00011894	 ttr-23	 188688	 0.637	
WBGene00012491	 Y20C6A.1	 180151	 0.268	
WBGene00019885	 R05D8.7	 187608	 0.492	
WBGene00009840	 fbxa-189	 185955	 0.335	
WBGene00012185	 W01F3.2	 180351	 0.499	
WBGene00011931	 srsx-19	 188760	 0.445	
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WBGene00009803	 F47B8.2	 185895	 0.580	
WBGene00008296	 cdr-2	 183779	 0.484	
WBGene00045401	 T26F2.3	 6418775	 1.631	
WBGene00009488	 oac-20	 185375	 2.892	
WBGene00013900	 ugt-18	 179759	 1.707	
WBGene00009429	 F35E12.5	 185307	 7.848	
WBGene00012339	 W07G4.5	 179791	 2.187	
WBGene00019565	 cyp-35A3	 187209	 3.605	
WBGene00012683	 asp-17	 180250	 5.681	
WBGene00011185	 R10D12.1	 179888	 2.976	
WBGene00175027	 W02F12.8	 13213356	 2.630	
WBGene00019763	 galt-1	 187430	 4.832	
WBGene00009857	 clec-28	 186005	 6.149	
WBGene00044514	 R09E12.9	 3896848	 9.324	
WBGene00019089	 clec-206	 186582	 12.397	
WBGene00005018	 sqt-3	 179693	 8.684	
WBGene00018616	 F48G7.5	 178578	 4.838	
WBGene00020237	 phat-4	 178812	 22.051	
WBGene00000756	 col-183	 184081	 0.000	
WBGene00009303	 lips-8	 185178	 0.332	
WBGene00013975	 ZK455.5	 191321	 0.313	
WBGene00020135	 aakg-4	 187928	 0.166	
WBGene00001790	 gst-42	 183911	 0.452	
WBGene00018466	 F45E1.5	 185794	 0.219	
WBGene00015802	 flu-2	 180883	 0.641	
WBGene00019780	 M60.4	 187465	 0.366	
WBGene00019738	 clec-265	 180590	 0.662	
WBGene00004987	 spp-2	 259714	 0.229	
WBGene00016407	 C34D10.2	 181059	 0.412	
WBGene00000176	 aqp-8	 180744	 1.677	
WBGene00019318	 K02E10.4	 180552	 2.901	
WBGene00007397	 C07A4.2	 182351	 1.566	
WBGene00015355	 C02F12.5	 180656	 1.948	
WBGene00043980	 F11D5.7	 184345	 10.033	
WBGene00007344	 C05E7.2	 182266	 14.875	
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Supplemental Table 3.4. DAF-16 target genes (Liu). DAF-16 dauer regulome genes previously identified 
as strongly regulated dauer genes and whether those genes contain nearby DAF-16 binding sites (Liu et 
al., 2004).  
 
Wormbase	IDα	 Gene	name	 NCBI	gene	ID	 Fold	Change*	
WBGene00010614	 cri-1	 187082	 0.097	
WBGene00014046	 clec-60	 191384	 2.140	
WBGene00000853	 cut-6	 176520	 0.151	
WBGene00007131	 B0284.1	 181902	 0.276	
WBGene00019021	 F57H12.6	 177593	 0.218	
WBGene00007452	 C08F11.3	 182419	 0.079	
WBGene00001387	 far-3	 179785	 0.088	
WBGene00008390	 D1086.3	 179907	 0.109	
WBGene00022546	 ZC196.2	 191101	 0.057	
WBGene00015043	 cyp-34A8	 181850	 0.222	
WBGene00007440	 C08E8.4	 182409	 0.342	
WBGene00009805	 F47B8.4	 179930	 0.115	
WBGene00004932	 sod-3	 181748	 0.030	
WBGene00000968	 dhs-4	 172810	 0.317	
WBGene00001067	 dpy-5	 172197	 84.644	
WBGene00017128	 E04F6.9	 174185	 0.198	
WBGene00018448	 F45D11.1	 185779	 0.031	
WBGene00014047	 clec-61	 174613	 0.133	
WBGene00015889	 C17C3.3	 182714	 0.283	
WBGene00008482	 cut-4	 184037	 12.155	
WBGene00000649	 col-73	 184366	 83.927	
WBGene00014030	 glb-1	 176261	 0.092	
WBGene00022324	 fbxa-26	 190756	 0.024	
WBGene00017698	 F22B7.9	 176213	 0.213	
WBGene00013516	 Y73F4A.3	 177721	 0.395	
WBGene00011596	 T07G12.5	 177946	 0.256	
WBGene00008123	 ent-6	 178339	 3.022	
WBGene00022072	 cpg-9	 177087	 5.251	
WBGene00001074	 dpy-13	 177187	 80.909	
WBGene00019472	 cyp-35B1	 178803	 0.058	
WBGene00003473	 mtl-1	 179060	 0.052	
WBGene00015041	 cyp-34A6	 181848	 0.182	
WBGene00007929	 dmd-10	 183202	 0.186	
WBGene00008336	 C55A6.7	 183836	 0.367	
WBGene00003096	 lys-7	 178772	 0.228	
WBGene00011539	 fbxa-135	 188184	 0.133	
WBGene00012398	 Y6E2A.4	 189374	 0.102	
WBGene00008301	 dct-3	 183784	 0.203	
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WBGene00022545	 ZC196.1	 191100	 0.188	
WBGene00012399	 Y6E2A.5	 189376	 0.471	
WBGene00015223	 B0507.6	 182013	 0.475	
WBGene00016052	 dod-3	 178737	 0.160	
WBGene00002055	 ifc-1	 178747	 0.392	
WBGene00012381	 Y2H9A.4	 189352	 0.388	
WBGene00008341	 ttr-44	 179835	 0.453	
WBGene00021081	 W08A12.4	 189288	 0.527	
WBGene00007833	 oac-6	 180094	 2.441	
WBGene00018540	 btb-21	 185908	 3.593	
WBGene00017262	 F08F3.4	 178924	 2.789	
WBGene00020947	 W02F12.2	 189124	 2.717	
WBGene00008793	 F14D7.6	 184466	 3.871	
WBGene00007807	 C29F3.7	 180036	 4.771	
WBGene00013904	 ugt-6	 179755	 3.616	
WBGene00009982	 F53F1.4	 179822	 6.558	
WBGene00000734	 col-161	 179812	 39.509	
WBGene00009620	 fip-5	 181237	 1.725	
WBGene00007812	 C29F7.3	 181464	 1.780	
WBGene00018779	 F53H8.3	 186195	 2.021	
WBGene00003999	 pgp-5	 181276	 2.373	
WBGene00004000	 pgp-6	 181278	 2.701	
WBGene00007855	 C31H5.4	 172724	 0.603	
WBGene00012176	 W01C9.2	 189089	 0.267	
WBGene00014254	 cyp-13A10	 174522	 0.651	
WBGene00016970	 C56E6.2	 174077	 0.560	
WBGene00020357	 T08E11.1	 188287	 0.380	
WBGene00010945	 chil-13	 174500	 0.488	
WBGene00008809	 cyp-13A11	 184472	 0.062	
WBGene00003588	 nex-1	 175714	 0.335	
WBGene00007132	 B0284.2	 175567	 0.313	
WBGene00016612	 C43G2.3	 183418	 0.219	
WBGene00016845	 C50F7.5	 177554	 0.209	
WBGene00013294	 Y57G11B.1	 190365	 0.336	
WBGene00019019	 frpr-10	 186481	 0.571	
WBGene00002012	 hsp-12.3	 177777	 0.545	
WBGene00019510	 K07H8.10	 177621	 1.785	
WBGene00015394	 C03G6.6	 182169	 0.012	
WBGene00001712	 grl-3	 186928	 0.016	
WBGene00016922	 swt-2	 183804	 0.015	
WBGene00018211	 oac-24	 185503	 0.015	
WBGene00011948	 T23F1.5	 180041	 0.065	
WBGene00008850	 F15B9.6	 184523	 0.056	
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WBGene00017200	 F07C4.6	 184131	 0.279	
WBGene00000723	 col-150	 181814	 0.117	
WBGene00018414	 nstp-8	 178698	 0.393	
WBGene00017640	 F20D6.11	 179196	 0.323	
WBGene00001789	 gst-41	 179127	 0.355	
WBGene00018260	 cyp-33C7	 185589	 0.540	
WBGene00001770	 gst-22	 180088	 3.264	
WBGene00007141	 pitr-4	 179355	 3.251	
WBGene00000718	 col-145	 179297	 27.509	
WBGene00011763	 T14B1.1	 181181	 0.249	
WBGene00010705	 cyp-14A1	 187183	 0.195	
WBGene00010706	 cyp-14A2	 187184	 0.292	
WBGene00016995	 D1005.1	 180485	 0.560	
WBGene00003778	 nnt-1	 180884	 0.069	
WBGene00002116	 ins-33	 189313	 0.276	
WBGene00008477	 clec-17	 173111	 0.256	
WBGene00020397	 pcbd-1	 188368	 0.318	
WBGene00007660	 C17H1.7	 182749	 0.236	
WBGene00013698	 Y106G6D.1	 190915	 0.646	
WBGene00010370	 ctg-1	 172431	 0.525	
WBGene00007992	 fipr-24	 183286	 0.127	
WBGene00007856	 C31H5.5	 183103	 0.569	
WBGene00007739	 C26C6.4	 182933	 0.409	
WBGene00020710	 T23B3.2	 188772	 0.666	
WBGene00019006	 F57B10.9	 172369	 0.529	
WBGene00000138	 amx-2	 173146	 0.591	
WBGene00013958	 ZK265.6	 191277	 1.524	
WBGene00010111	 F55D12.2	 172558	 1.684	
WBGene00020382	 T09B4.8	 172301	 1.757	
WBGene00002077	 imb-3	 3565440	 1.558	
WBGene00021026	 W04C9.4	 171636	 1.619	
WBGene00003062	 lpd-6	 171886	 1.594	
WBGene00001234	 eif-6	 173169	 1.588	
WBGene00018891	 F55F8.3	 172224	 1.553	
WBGene00010582	 K05C4.5	 173339	 1.559	
WBGene00021660	 Y48G1A.4	 171622	 1.582	
WBGene00004237	 ptr-23	 173362	 1.776	
WBGene00016607	 C43E11.9	 172028	 1.689	
WBGene00020036	 R12E2.11	 172008	 2.100	
WBGene00016653	 C44E4.4	 172070	 1.804	
WBGene00020915	 nol-5	 171901	 1.849	
WBGene00010644	 K07G5.5	 187123	 2.345	
WBGene00000931	 dao-5	 266845	 1.923	
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WBGene00013895	 ZC434.9	 172908	 1.588	
WBGene00008763	 F13G3.3	 172475	 3.574	
WBGene00009824	 gpdh-1	 173272	 5.000	
WBGene00003664	 nhr-74	 191723	 5.709	
WBGene00018786	 hmbx-1	 171679	 4.629	
WBGene00004225	 ptr-11	 171609	 7.101	
WBGene00020258	 T05E7.1	 172309	 7.793	
WBGene00020283	 T06A4.3	 171668	 6.271	
WBGene00016329	 osr-1	 172161	 13.913	
WBGene00010291	 F58H10.1	 186556	 14.165	
WBGene00003548	 nas-30	 190803	 6.288	
WBGene00022517	 ZC123.1	 171671	 19.420	
WBGene00017068	 D2092.8	 172380	 9.489	
WBGene00014184	 ZK1025.4	 191493	 28.846	
WBGene00008652	 F10D11.6	 172635	 13.698	
WBGene00003552	 nas-36	 172506	 18.038	
WBGene00013891	 ZC434.3	 172903	 25.135	
WBGene00020033	 R12E2.7	 172002	 21.577	
WBGene00008565	 F08A8.2	 173163	 51.546	
WBGene00000641	 col-65	 187138	 27.985	
WBGene00050875	 bah-1	 173031	 47.561	
WBGene00016733	 phat-2	 172130	 35.266	
WBGene00020039	 R12E2.14	 172001	 38.594	
WBGene00020040	 R12E2.15	 172000	 42.077	
WBGene00000631	 col-54	 185226	 55.197	
WBGene00016731	 C46H11.7	 183524	 64.298	
WBGene00008290	 C54C8.2	 183769	 180.339	
WBGene00014182	 ZK1025.2	 173030	 Inf	
WBGene00018461	 F45D11.16	 173480	 0.000	
WBGene00000613	 col-36	 174178	 0.003	
WBGene00000851	 cut-1	 174720	 0.001	
WBGene00020232	 T05A8.6	 188091	 0.011	
WBGene00022713	 ZK355.3	 191298	 0.007	
WBGene00020503	 T14B4.9	 188494	 0.271	
WBGene00019208	 lips-14	 186750	 0.365	
WBGene00011673	 cyp-13A6	 188357	 0.252	
WBGene00015598	 fbxa-163	 182398	 0.295	
WBGene00019906	 R05G9R.1	 24104792	 0.186	
WBGene00015597	 fbxa-162	 182397	 0.246	
WBGene00022572	 ZC239.14	 191124	 0.379	
WBGene00011672	 cyp-13A5	 188356	 0.361	
WBGene00017133	 EEED8.2	 173923	 0.292	
WBGene00009778	 F46C5.1	 174411	 0.144	
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WBGene00006367	 sym-2	 174461	 0.494	
WBGene00021725	 bath-9	 173681	 0.650	
WBGene00009146	 F26C11.1	 184959	 0.471	
WBGene00018275	 F41C3.11	 173816	 0.593	
WBGene00001755	 gst-7	 173842	 0.390	
WBGene00010043	 F54C9.7	 186225	 0.594	
WBGene00011052	 arrd-11	 187635	 0.043	
WBGene00001753	 gst-5	 187537	 0.556	
WBGene00016302	 fbxc-7	 183113	 0.129	
WBGene00000372	 cyp-13A7	 188362	 0.632	
WBGene00012589	 nspe-4	 189658	 0.313	
WBGene00000971	 dhs-7	 174183	 0.389	
WBGene00012987	 Y48C3A.3	 190020	 0.566	
WBGene00015569	 C07D10.5	 174209	 0.637	
WBGene00023407	 cex-1	 186376	 0.615	
WBGene00011167	 chil-23	 187739	 0.473	
WBGene00001764	 gst-16	 175009	 0.626	
WBGene00022867	 ZK1240.2	 191538	 1.647	
WBGene00015064	 B0228.7	 174252	 1.797	
WBGene00006497	 tag-151	 173812	 1.507	
WBGene00008458	 E02H1.6	 174511	 1.684	
WBGene00021715	 Y49F6B.2	 173696	 1.563	
WBGene00012978	 Y48B6A.1	 175069	 1.579	
WBGene00017210	 F07E5.5	 173564	 1.557	
WBGene00021074	 W07E6.2	 173439	 1.566	
WBGene00020576	 T19D12.1	 24104905	 1.614	
WBGene00015941	 C18A3.3	 173968	 1.664	
WBGene00021073	 nol-1	 173437	 1.732	
WBGene00018271	 F41C3.5	 173818	 1.975	
WBGene00009947	 F52H3.5	 174562	 2.240	
WBGene00006893	 spon-1	 174169	 2.213	
WBGene00019280	 K01A2.5	 173418	 2.991	
WBGene00001523	 gbh-2	 174358	 2.180	
WBGene00004300	 ram-2	 174687	 2.167	
WBGene00013007	 Y48E1B.8	 175002	 5.070	
WBGene00004221	 ptr-6	 173898	 3.542	
WBGene00012591	 nspe-1	 189660	 2.648	
WBGene00004259	 pyr-1	 174385	 5.909	
WBGene00022649	 ZK84.1	 174008	 3.241	
WBGene00003388	 moe-3	 174960	 5.871	
WBGene00001522	 gbh-1	 174648	 6.554	
WBGene00004232	 ptr-18	 174940	 7.304	
WBGene00003888	 osm-8	 187684	 12.825	
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WBGene00008500	 F01D5.10	 184059	 9.124	
WBGene00017841	 F26G1.5	 173823	 7.284	
WBGene00020327	 clec-21	 188250	 9.715	
WBGene00003526	 nas-7	 182368	 10.076	
WBGene00016805	 C50D2.1	 173396	 14.907	
WBGene00014245	 ZK1307.2	 191559	 9.447	
WBGene00013171	 Y53F4B.25	 175163	 17.876	
WBGene00006947	 wrt-1	 174223	 24.766	
WBGene00012032	 T26C5.2	 174465	 35.058	
WBGene00007560	 C14A4.9	 174637	 28.280	
WBGene00015841	 C16C8.2	
	
24.938	
WBGene00010760	 K10H10.4	 175109 11.179	
WBGene00012917	 Y46G5A.29	 174922	 36.851	
WBGene00000653	 col-77	 174336	 22.853	
WBGene00008964	 mltn-9	 175122	 39.426	
WBGene00011530	 T06D8.10	 174717	 23.286	
WBGene00018573	 oac-30	 185942	 29.006	
WBGene00017218	 dct-5	 184148	 31.111	
WBGene00005017	 sqt-2	 173382	 79.353	
WBGene00005016	 sqt-1	 174731	 92.085	
WBGene00015646	 mlt-10	 173445	 82.177	
WBGene00004397	 rol-6	 174397	 81.701	
WBGene00000606	 col-17	 173839	 92.842	
WBGene00007611	 C15H7.4	 182640	 0.082	
WBGene00022333	 fbxa-27	 190764	 0.021	
WBGene00001242	 elo-4	 183367	 0.341	
WBGene00001633	 gly-8	 176595	 0.440	
WBGene00020458	 fbxa-70	 188449	 0.380	
WBGene00020703	 T22F7.4	 188758	 0.558	
WBGene00015518	 C06E1.1	 176205	 0.479	
WBGene00000668	 col-93	 259335	 0.259	
WBGene00007963	 cyp-25A1	 183247	 0.293	
WBGene00000669	 col-94	 259336	 0.326	
WBGene00015559	 npr-17	 176124	 0.489	
WBGene00011112	 R07E5.4	 175568	 0.434	
WBGene00000666	 col-91	 184269	 0.407	
WBGene00016219	 C29F9.4	 175178	 0.464	
WBGene00000276	 byn-1	 175968	 1.542	
WBGene00003577	 ndg-4	 175582	 1.757	
WBGene00017356	 F10E9.4	 184304	 1.654	
WBGene00020600	 T20B12.1	 176055	 1.723	
WBGene00011408	 T04A8.6	 175614	 1.602	
WBGene00044318	 tag-267	 175220	 1.638	
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WBGene00012964	 Y48A6B.3	 176531	 1.790	
WBGene00010478	 K01G5.5	 176504	 1.880	
WBGene00018241	 F40G9.5	 185554	 2.841	
WBGene00011559	 umps-1	 176453	 2.257	
WBGene00003887	 osm-7	 176790	 2.645	
WBGene00010540	 K03H1.5	 176404	 3.277	
WBGene00022180	 Y71H2AM.15	 175391	 3.399	
WBGene00001386	 far-2	 176284	 2.821	
WBGene00001570	 gei-13	 176364	 14.020	
WBGene00015335	 acdh-6	 182112	 8.449	
WBGene00015544	 C06E8.5	 182336	 5.086	
WBGene00017807	 F26A1.9	 184949	 14.487	
WBGene00008655	 lips-3	 184306	 23.560	
WBGene00011278	 R74.2	 175539	 44.755	
WBGene00001724	 grl-15	 190707	 82.098	
WBGene00000665	 col-90	 176117	 95.531	
WBGene00000676	 col-102	 182802	 0.001	
WBGene00000697	 col-123	 177823	 0.008	
WBGene00018143	 oac-23	 185419	 0.019	
WBGene00000690	 col-116	 184617	 0.009	
WBGene00010528	 K03D3.2	 186933	 0.007	
WBGene00019153	 H04M03.3	 177359	 0.019	
WBGene00008072	 C43F9.4	 183414	 0.065	
WBGene00021183	 Y9C9A.16	 189421	 0.018	
WBGene00015999	 prmt-4	 182806	 0.209	
WBGene00021585	 clec-74	 189948	 0.263	
WBGene00012783	 Y43C5A.3	 189848	 0.266	
WBGene00020373	 gpx-6	 188313	 0.215	
WBGene00017051	 afmd-1	 177499	 0.253	
WBGene00019047	 F58E2.3	 177110	 0.235	
WBGene00013882	 ZC410.5	 177728	 0.244	
WBGene00020728	 T23E1.1	 188794	 0.336	
WBGene00019368	 K03H6.2	 176959	 0.414	
WBGene00009077	 F23B2.10	 184885	 0.179	
WBGene00000691	 col-117	 177694	 0.276	
WBGene00007886	 ethe-1	 177783	 0.295	
WBGene00007777	 C27D8.1	 178226	 0.525	
WBGene00018547	 clec-78	 185915	 0.432	
WBGene00008708	 F11E6.4	 184358	 0.457	
WBGene00011171	 R09E10.1	 177920	 0.483	
WBGene00011484	 T05E11.8	 188133	 0.550	
WBGene00001751	 gst-3	 177883	 0.339	
WBGene00019540	 K08D12.6	 176980	 0.416	
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WBGene00007384	 swt-3	 177972	 0.517	
WBGene00021195	 Y17G9A.2	 177257	 0.450	
WBGene00001477	 fmo-2	 177958	 0.276	
WBGene00016768	 cyp-33E1	 183602	 0.513	
WBGene00001975	 hmg-5	 177543	 0.575	
WBGene00011021	 R05A10.4	 187595	 0.565	
WBGene00009215	 thn-2	 178187	 1.622	
WBGene00020981	 W03D2.6	 177163	 1.598	
WBGene00011744	 T13F2.4	 188476	 2.783	
WBGene00008151	 C47E12.7	 177853	 1.544	
WBGene00019164	 H06H21.8	 186700	 1.817	
WBGene00010128	 F55G11.8	 186340	 2.355	
WBGene00017075	 nap-1	 177636	 1.911	
WBGene00014136	 ZK896.5	 178239	 2.176	
WBGene00019931	 R07C12.1	 177179	 5.291	
WBGene00018470	 F45E4.5	 185796	 2.544	
WBGene00010125	 dod-22	 178247	 6.354	
WBGene00020688	 T22D1.11	 177459	 4.261	
WBGene00010887	 M7.12	 187458	 3.801	
WBGene00044620	 bus-4	 188726	 9.913	
WBGene00021083	 W08E12.2	 189291	 8.649	
WBGene00000005	 aat-4	 177388	 18.601	
WBGene00001730	 grl-21	 177967	 5.807	
WBGene00009133	 bed-3	 184940	 11.648	
WBGene00000699	 col-125	 178029	 9.007	
WBGene00016596	 C42D4.3	 177492	 8.153	
WBGene00011594	 T07G12.3	 188242	 27.698	
WBGene00021084	 W08E12.3	 177098	 19.907	
WBGene00010673	 K08E7.5	 178211	 49.792	
WBGene00001079	 dpy-20	 178105	 74.576	
WBGene00022680	 ZK180.6	 177219	 42.525	
WBGene00022725	 ZK381.2	 191306	 100.440	
WBGene00001066	 dpy-4	 178414	 76.874	
WBGene00015719	 C13A2.2	 182550	 0.000	
WBGene00015724	 C13A2.7	 182555	 0.004	
WBGene00015725	 C13A2.9	 182556	 0.000	
WBGene00015726	 C13A2.10	 182557	 0.000	
WBGene00017229	 F07G11.2	 184157	 0.013	
WBGene00019526	 K08D9.5	 187148	 0.040	
WBGene00015722	 C13A2.5	 182553	 0.000	
WBGene00015721	 C13A2.4	 182552	 0.001	
WBGene00017230	 F07G11.3	 184158	 0.002	
WBGene00019524	 K08D9.2	 187146	 0.024	
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WBGene00017231	 F07G11.4	 184159	 0.015	
WBGene00017819	 F26D11.2	 184973	 0.003	
WBGene00015718	 C13A2.1	 182549	 0.018	
WBGene00019527	 K08D9.6	 178760	 0.022	
WBGene00000731	 col-158	 179619	 0.023	
WBGene00017228	 F07G11.1	 184156	 0.007	
WBGene00019567	 K09D9.9	 187211	 0.014	
WBGene00015723	 C13A2.6	 182554	 0.001	
WBGene00009990	 F53F4.7	 179847	 0.086	
WBGene00017634	 F20D6.2	 184723	 0.013	
WBGene00001718	 grl-9	 179066	 0.006	
WBGene00009338	 F32G8.2	 185211	 0.007	
WBGene00019851	 oac-41	 187551	 0.014	
WBGene00001726	 grl-17	 183855	 0.019	
WBGene00005617	 srj-32	 191944	 0.026	
WBGene00009988	 F53F4.4	 186177	 0.030	
WBGene00015465	 C05C8.8	 182247	 0.051	
WBGene00008010	 C38D9.2	 183313	 0.049	
WBGene00020871	 T28A11.4	 189011	 0.046	
WBGene00015720	 C13A2.3	 182551	 0.080	
WBGene00001388	 far-4	 191633	 0.107	
WBGene00000722	 col-149	 179431	 0.266	
WBGene00019202	 H14N18.2	 186745	 0.037	
WBGene00015682	 C10G8.3	 182502	 0.048	
WBGene00018406	 F44A2.7	 185721	 0.133	
WBGene00021731	 Y49G5A.1	 190090	 0.652	
WBGene00010216	 F57G8.7	 186468	 0.332	
WBGene00002118	 ins-35	 180334	 0.209	
WBGene00010205	 F57F5.3	 179646	 0.219	
WBGene00010100	 F55C9.3	 186291	 0.315	
WBGene00011004	 R04B5.6	 179404	 0.105	
WBGene00019978	 hacd-1	 178638	 0.256	
WBGene00010102	 F55C9.5	 186293	 0.307	
WBGene00008334	 sdz-8	 183834	 0.203	
WBGene00009710	 F44G3.10	 185758	 0.517	
WBGene00020748	 nhr-221	 188826	 0.286	
WBGene00017363	 F10G2.2	 184313	 0.410	
WBGene00019652	 K11G9.1	 179057	 0.315	
WBGene00011752	 fbxa-2	 180091	 0.404	
WBGene00015397	 nhr-149	 182174	 0.286	
WBGene00019648	 K11D12.8	 187294	 0.366	
WBGene00016285	 C31B8.12	 183081	 0.421	
WBGene00015040	 cyp-34A5	 181847	 0.228	
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WBGene00008335	 C55A6.6	 183835	 0.273	
WBGene00005931	 fbxa-199	 188182	 0.439	
WBGene00009600	 F40G12.5	 185565	 0.374	
WBGene00020881	 T28A11.19	 189024	 0.531	
WBGene00016785	 C49G7.7	 183621	 0.324	
WBGene00013078	 ttr-25	 180210	 0.359	
WBGene00009804	 F47B8.3	 185896	 0.462	
WBGene00019348	 K02H11.4	 186913	 0.423	
WBGene00021963	 lipl-6	 179081	 0.596	
WBGene00021412	 cyp-29A3	 189649	 0.441	
WBGene00003861	 oig-3	 190105	 0.385	
WBGene00020941	 W02D7.5	 189117	 0.360	
WBGene00022653	 ZK105.1	 191220	 0.416	
WBGene00000982	 dhs-19	 179578	 0.497	
WBGene00004811	 skr-5	 180148	 0.337	
WBGene00008985	 F20G2.1	 184742	 0.563	
WBGene00015769	 C14C11.7	 182612	 0.525	
WBGene00016860	 cyp-33C9	 178752	 0.567	
WBGene00016281	 C31B8.4	 183078	 0.481	
WBGene00016101	 C25E10.12	 182896	 0.637	
WBGene00019477	 K07C11.4	 179198	 0.575	
WBGene00008453	 E02A10.3	 179722	 0.649	
WBGene00000599	 col-10	 179298	 0.584	
WBGene00011286	 ttr-29	 187890	 0.618	
WBGene00008669	 acs-14	 179330	 1.513	
WBGene00004910	 snf-11	 191770	 1.554	
WBGene00018762	 F53E10.6	 178728	 1.580	
WBGene00010080	 F55A11.7	 179614	 1.568	
WBGene00015464	 C05C8.7	 179120	 2.040	
WBGene00010214	 F57G8.5	 180097	 1.642	
WBGene00009993	 F53F4.11	 179849	 1.635	
WBGene00000007	 aat-6	 188421	 1.831	
WBGene00010627	 K07C5.4	 179442	 1.666	
WBGene00001423	 fib-1	 179999	 1.744	
WBGene00019117	 nhr-144	 186627	 2.340	
WBGene00012058	 T26F2.2	 179892	 1.931	
WBGene00017430	 F13H6.1	 179019	 1.575	
WBGene00007950	 C35A5.6	 183224	 1.888	
WBGene00011090	 R07B7.6	 179658	 2.283	
WBGene00022538	 ZC190.4	 179248	 2.748	
WBGene00003248	 mig-17	 179575	 2.638	
WBGene00011212	 R10E8.6	 180195	 2.564	
WBGene00019090	 F59A7.2	 178682	 1.709	
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WBGene00015758	 nhr-155	 182602	 8.492	
WBGene00002259	 lbp-7	 191701	 3.084	
WBGene00000003	 aat-2	 184126	 3.073	
WBGene00009722	 F45D3.2	 179716	 5.468	
WBGene00000373	 cyp-14A5	 178926	 2.595	
WBGene00007748	 C26E1.2	 182940	 3.699	
WBGene00003763	 nlp-25	 189877	 3.831	
WBGene00000726	 col-153	 179517	 6.781	
WBGene00016146	 C26F1.1	 179157	 2.909	
WBGene00021309	 Y32G9B.1	 178662	 4.570	
WBGene00000602	 col-13	 179452	 3.436	
WBGene00000728	 col-155	 186301	 4.701	
WBGene00001479	 fmo-4	 179845	 10.863	
WBGene00022577	 nstp-3	 191128	 10.110	
WBGene00010472	 cdr-7	 24104698	 7.969	
WBGene00018706	 F52F10.2	 178644	 11.287	
WBGene00011624	 T08G5.3	 179901	 18.156	
WBGene00000601	 col-12	 179453	 11.645	
WBGene00019644	 cpt-4	 178889	 21.546	
WBGene00019761	 M03F8.1	 187429	 16.833	
WBGene00004230	 ptr-16	 191750	 19.123	
WBGene00019754	 M03E7.2	 178948	 13.618	
WBGene00015340	 C02E7.7	 178884	 13.597	
WBGene00001716	 grl-7	 179569	 29.490	
WBGene00007754	 C27A7.2	 179664	 46.841	
WBGene00012046	 T26E4.4	 188930	 62.995	
WBGene00012346	 W08G11.1	 180099	 44.842	
WBGene00007804	 C29F3.3	 183004	 18.305	
WBGene00000729	 col-156	 186439	 40.694	
WBGene00015339	 C02E7.6	 178885	 38.460	
WBGene00003057	 lon-3	 179673	 57.123	
WBGene00007806	 clec-230	 183006	 31.044	
WBGene00006954	 wrt-8	 180035	 30.675	
WBGene00007177	 oac-1	 181961	 55.349	
WBGene00000730	 col-157	 188426	 89.265	
WBGene00018297	 F41F3.3	 178856	 46.147	
WBGene00001691	 grd-2	 180349	 58.566	
WBGene00021625	 Y47D7A.13	 178841	 44.047	
WBGene00001695	 grd-6	 24104900	 40.262	
WBGene00009983	 cut-2	 179823	 66.508	
WBGene00010468	 K01D12.9	 186847	 70.682	
WBGene00010467	 K01D12.8	 186846	 170.781	
WBGene00000737	 col-164	 180523	 0.000	
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WBGene00019570	 K09E2.1	 187215	 0.011	
WBGene00001696	 grd-7	 191661	 0.049	
WBGene00009849	 F48F7.3	 185989	 0.063	
WBGene00011104	 cut-5	 187677	 0.041	
WBGene00017149	 EGAP4.1	 184049	 0.362	
WBGene00006534	 tba-8	 191455	 0.394	
WBGene00009635	 F42F12.3	 185670	 0.393	
WBGene00010504	 K02D3.1	 186872	 0.583	
WBGene00007694	 C23H4.6	 181384	 0.547	
WBGene00017464	 sulp-2	 180828	 0.416	
WBGene00020569	 lgc-32	 188603	 0.429	
WBGene00006980	 zig-3	 192088	 0.343	
WBGene00000212	 asm-2	 181323	 0.647	
WBGene00009813	 haly-1	 181279	 0.625	
WBGene00017226	 fbxa-53	 184154	 0.588	
WBGene00011108	 R07E3.7	 187679	 0.540	
WBGene00007691	 C23H4.2	 182818	 0.180	
WBGene00015783	 C15B12.1	 180921	 1.587	
WBGene00016714	 C46F2.1	 183512	 2.186	
WBGene00019493	 catp-5	 181067	 1.986	
WBGene00022200	 fard-1	 180582	 1.636	
WBGene00004245	 puf-9	 180850	 1.678	
WBGene00010341	 glo-3	 186637	 2.021	
WBGene00010521	 K03A11.4	 186918	 1.661	
WBGene00008354	 gcsh-1	 183902	 2.180	
WBGene00019572	 K09E2.3	 187217	 1.802	
WBGene00019779	 M60.2	 181079	 1.884	
WBGene00009057	 cept-1	 184847	 2.553	
WBGene00015865	 C16E9.1	 182693	 2.096	
WBGene00009483	 F36G3.2	 181192	 2.700	
WBGene00007811	 C29F7.2	 181463	 3.818	
WBGene00017625	 cgt-2	 181790	 3.424	
WBGene00010396	 H13N06.2	 181636	 4.270	
WBGene00019404	 K05B2.4	 187017	 4.831	
WBGene00002067	 ifp-1	 181182	 4.098	
WBGene00010835	 M03B6.3	 181498	 8.950	
WBGene00015545	 C06G1.1	 181720	 5.591	
WBGene00020484	 T13C5.3	 188473	 20.856	
WBGene00003554	 nas-38	 180407	 5.776	
WBGene00008602	 oac-14	 181226	 6.293	
WBGene00019547	 K09C4.1	 180621	 11.718	
WBGene00003553	 nas-37	 181208	 18.642	
WBGene00044623	 bus-8	 180821	 15.563	
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WBGene00011077	 R07B1.5	 187646	 16.664	
WBGene00017716	 F22F4.1	 180868	 19.560	
WBGene00017307	 F09F9.2	 184263	 21.776	
WBGene00001703	 grd-14	 187934	 29.375	
WBGene00018031	 F35B3.4	 185255	 23.835	
WBGene00000746	 col-173	 180960	 43.937	
WBGene00010118	 F55F3.4	 186318	 42.509	
WBGene00014039	 ZK662.2	 181660	 28.660	
WBGene00006950	 wrt-4	 181664	 55.166	
WBGene00000755	 col-182	 187723	 52.586	
WBGene00000618	 col-41	 181610	 63.306	
WBGene00017673	 F21F3.3	 172106	 0.004	
WBGene00009345	 F32H2.8	 185215	 4.818	
WBGene00018755	 bcmo-2	 173733	 0.244	
WBGene00008052	 ctns-1	 174308	 0.481	
WBGene00021436	 Y39A3B.1	 189721	 11.303	
WBGene00015538	 sams-3	 177355	 2.204	
WBGene00019464	 K07B1.4	 179314	 0.277	
WBGene00019113	 F59E11.7	 179277	 0.211	
WBGene00017312	 pitr-5	 179104	 1.693	
WBGene00010360	 fbxa-96	 186676	 0.073	
WBGene00001693	 grd-4	 24104827	 0.101	
WBGene00022500	 lfi-1	 180771	 0.666	
WBGene00009816	 F47B10.5	 185904	 2.431	
WBGene00002057	 ifd-1	 187585	 2.986	
WBGene00018591	 npax-2	 185967	 7.178	
WBGene00002267	 lec-4	 175488	 0.363	
WBGene00010593	 gsnl-1	 179328	 0.351	
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Supplemental Table 3.5. X-linked genes regulated by both DPY-21 and DAF-16, but not regulated by 
DAF-12. 
 
Wormbase	ID	 Gene	name	 NCBI	gene	ID	 Fold	Change	daf-16*	 Fold	Change	dpy-21*	
WBGene00000756	 col-183	 184081	 0.000	 0.003	
WBGene00194674	 F23D12.11	 13223834	 0.276	 0.277	
WBGene00008350	 CE7X_3.2	 353483	 0.493	 0.562	
WBGene00000745	 col-172	 180934	 0.441	 0.209	
WBGene00008462	 E02H4.4	 183995	 0.500	 0.502	
WBGene00004987	 spp-2	 259714	 0.229	 0.550	
WBGene00007691	 C23H4.2	 182818	 0.180	 0.462	
WBGene00000929	 dao-3	 181065	 0.602	 0.595	
WBGene00006897	 ver-4	 186632	 0.376	 0.620	
WBGene00018877	 aman-1	 180749	 0.635	 0.613	
WBGene00009620	 fip-5	 181237	 1.725	 1.882	
WBGene00020160	 igcm-3	 180569	 1.755	 2.403	
WBGene00015783	 C15B12.1	 180921	 1.587	 1.903	
WBGene00010971	 R01E6.7	 187507	 1.598	 1.962	
WBGene00000176	 aqp-8	 180744	 1.677	 2.573	
WBGene00019493	 catp-5	 181067	 1.986	 2.549	
WBGene00015382	 C03B1.14	 182152	 1.781	 1.721	
WBGene00022200	 fard-1	 180582	 1.636	 2.036	
WBGene00017449	 otpl-3	 259710	 1.738	 1.933	
WBGene00015295	 acl-12	 181001	 1.617	 2.216	
WBGene00016998	 D1005.4	 183882	 1.666	 2.160	
WBGene00002203	 kin-20	 181620	 1.662	 1.985	
WBGene00022201	 Y71H10B.1	 180573	 1.656	 2.031	
WBGene00004245	 puf-9	 180850	 1.678	 2.218	
WBGene00016660	 C45B2.3	 183467	 2.313	 1.520	
WBGene00008951	 F19C6.2	 181213	 1.832	 2.117	
WBGene00019960	 ztf-16	 180756	 1.561	 1.617	
WBGene00045272	 F59C12.4	 6418857	 1.591	 1.751	
WBGene00017938	 F31A3.3	 185135	 1.722	 2.774	
WBGene00018779	 F53H8.3	 186195	 2.021	 2.037	
WBGene00019572	 K09E2.3	 187217	 1.802	 1.988	
WBGene00020725	 cnp-3	 181752	 1.847	 2.790	
WBGene00010336	 F59F4.1	 181668	 2.181	 1.541	
WBGene00044151	 W04G3.12	 3896893	 2.963	 2.449	
WBGene00019518	 K08B5.1	 187132	 1.558	 2.609	
WBGene00019782	 M60.7	 187467	 1.803	 1.986	
WBGene00019779	 M60.2	 181079	 1.884	 2.488	
WBGene00015714	 C12D12.3	 182545	 2.016	 3.283	
WBGene00001468	 flr-4	 181604	 2.710	 2.054	
WBGene00219376	 C28G1.10	 13222010	 2.045	 2.003	
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WBGene00009852	 arrd-24	 185991	 3.204	 2.066	
WBGene00206361	 K02G10.15	 13220381	 2.529	 3.137	
WBGene00011081	 R07B1.9	 181201	 1.779	 5.141	
WBGene00019404	 K05B2.4	 187017	 4.831	 3.231	
WBGene00022616	 hsd-3	 260026	 12.275	 4.825	
WBGene00010118	 F55F3.4	 186318	 42.509	 7.732	
WBGene00002092	 ins-9	 3564850	 Inf	 Inf	
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Supplemental Table 3.6. Insulin-like peptides regulated by both DPY-21 and DAF-16. 
 	
ILP	 chromosome	 fold	change	
daf-16*	
fold	change	
dpy-21!	
daf-2	interaction	
ins-33	 I	 0.28	 0.30	 agonist**	
ins-29	 I	 0.54	 0.48	 ?	
ins-20	 II	 2.65	 13.32	 antagonist@	
ins-11	 II	 2.49	 6.69	 antagonist@	
ins-16	 III	 0.03	 0.07	 ?	
ins-7	 IV	 10.83	 7.99	 agonist***	
ins-35	 V	 0.21	 0.27	 agonist@	
ins-9	 X	 infinite	 infinite	 agonist#		*daf-16;eak-7;akt-1	vs.	eak-7;akt-1	!eak-7;akt-1	dpy-21	vs.	eak-7;akt-1	@Fernandes	de	Abreu	et	al,	2014	**Michaelson	et	al,	2010	***Murphy	et	al,	2003	#this	study	
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Supplemental Table 3.7. CRISPR guide sequences and repair oligos. 
 	 Sequence	5’	to	3’	
ins-9 guide #1 GAUGAUGAUACUGACGGUGG 
 
ins-9 guide #2 GAUUUCCAUGGUGAUGGUGG 
 
ins-9 repair oligo TTCTTAAATCCATTTGATTTGTCTCAATGGAGCGAAGAAATTC
TCTAACTGACTAACCATCGGGCGAGAAGAACCTTGGAAACCG
AAAAAATCTACCGCT 
 
dpy-10 guide GCUACCAUAGGCACCACGAG 
 
dpy-10 repair 
oligo 
CACTTGAACTTCAATACGGCAAGATGAGAATGACTGGAAACC
GTACCGCATGCGGTGCCTATGGTAGCGGAGCTTCACATGGC
TTCAGACCAACAGCCTAT 
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Supplemental Table 3.8. qPCR primer sequences. 
 Gene	 	 Sequence	5’	to	3’	
akt-2 F TCGTGATATGAAACTCGAAAATTTGC 
 R ATTCTGGTGTTCCGCAAAAGGTG 
daf-28 F AGTCCGTGTTCCAGGTGTG 
 R TGTTGCGATGTCAATTCCTT 
ins-4 F AAAATCAACTCTCCCGAGCA 
 R GCAATGTCCATGTCCTCTTGT 
ins-6 F CGAGCAAGACGTGTTCCAG 
 R TCGCAATGTCCTTTCCTTCT 
ins-9 F GAAGAAATCCTCCACCGTCA 
 R GTTCTTCTCGCCCGATTTC 
ins-7 F GTTGTGGAAGAAGAATACATTCGTATG 
 R TCTTCACGGCAACATTTTGATG 
pmp-3 F GTTCCCGTGTTCATCACTCAT 
 R ACACCGTCGAGAAGCTGTAGA 
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Supplemental Table 3.9. RNAseq correlation coefficients between replicates and between strains. 
 
Data found on the web: 
http://dev.biologists.org/content/develop/suppl/2017/03/22/dev.145722.DC1/DEV145722supp.pdf 
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Chapter 4 
Crosstalk between conserved signal transduction pathways mediates 
developmental plasticity in response to environmental stress 
 
Abstract 
Animals have evolved distinct responses to environmental stimuli to maximize their reproductive 
fitness. In the free-living nematode Caenorhabditis elegans, unfavorable conditions and 
overpopulation lead to animals’ entry into an alternative larval state of diapause known as dauer. 
Population stress is detected through local concentrations of a complex pheromone mixture, but 
how pheromone triggers downstream signals to coordinate the dauer decision remains poorly 
understood. Sensory neurons are required to respond to dauer pheromone and are a major source 
of neuroendocrine ligands including insulin-like peptides (ILPs), which may activate or inhibit 
the conserved insulin-like signaling pathway (IIS). IIS promotes reproductive development 
through inhibition of the transcription factor DAF-16/FoxO. We previously reported that 
epigenetic modifiers SET-4 and DPY-21 promote dauer arrest through repression of the ILP ins-
9. Loss of SET-4 or DPY-21 also leads to defects in response to dauer pheromone. Here we 
show that loss of ins-9 rescues pheromone-induced dauer arrest in set-4 mutants. ins-9 is 
primarily expressed in ASI sensory neurons, and expression of set-4 solely in ASI is sufficient to 
rescue dauer arrest. Dauer arrest in response to pheromone requires DAF-16/FoxO, while 
pheromone represses ins-9 expression in a DAF-16/FoxO independent manner. INS-9 and DAF-
28 promote reproductive development in parallel, indicating that pheromone signaling engages 
multiple regulatory pathways that converge on DAF-16/FoxO to promote dauer arrest.  
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Introduction 
How organisms use environmental signals to coordinate their own development to compete and 
cooperate with others of their species is critical for the fitness of a population. In the free-living 
nematode Caenorhabditis elegans, animals progress through four larval stages (L1 through L4) 
to reach adulthood (Corsi et al., 2015). They sense population density through detection of a 
continuously elaborated mixture of ascarosides that collectively are referred to dauer pheromone 
(Golden and Riddle, 1984a; Golden and Riddle, 1984b; Ludewig and Schroeder, 2013). 
Pheromone perception is integrated with temperature sensation and certain food signals that may 
include bacterial fatty acids (Kaul et al., 2014) to control developmental strategy at the transition 
from L1 to L2	(Fielenbach and Antebi, 2008). Under replete conditions, animals commit to 
reproductive development. In contrast, when population density reaches a critical tipping point, 
larvae enter an alternate state of diapause known as dauer (Hu, 2007).  
Dauers exhibit many gross morphological differences from non-dauer L3 larvae including 
constriction of the body and pharynx, the presence of longitudinal ridges called alae, and a 
thickened cuticle (Blaxter, 1993; Cassada and Russell, 1975). Arrested animals also remodel 
neuromuscular junctions and exhibit increased dendritic branching (Dixon et al., 2008; 
Schroeder et al., 2013). These morphological changes may contribute to behaviors associated 
with dispersal from unfavorable environments. The thickening of the cuticle also creates a buccal 
plug, leading to cessation of feeding and continued reliance on fatty acid metabolism for energy 
(Popham, 1979; Wadsworth and Riddle, 1989). Dauers are highly stress-resistant and can persist 
in diapause far longer than typical adults live as they await improving environmental conditions 
(Klass and Hirsh, 1976). How pheromone sensing drives the metabolic and anatomical changes 
associated with dauer arrest remains poorly understood. 
C. elegans sense environmental cues through amphid sensory neurons that have dendritic 
projections exposed to the environment. These amphid neurons are required for proper 
integration of environmental conditions, resulting in the decision on whether to arrest or proceed 
with reproductive development (Bargmann and Horvitz, 1991; Birnby et al., 2000; Schackwitz et 
al., 1996). The paired ASI amphid neurons are a source of neuroendocrine ligands for conserved 
developmental pathways, including the TGFβ-like pathway and the insulin and insulin-like 
growth factor signaling (IIS) pathway (Cornils et al., 2011; Hung et al., 2014; Pierce et al., 2001; 
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Ren et al., 1996). Activation of the insulin receptor DAF-2/IGFR induces a PI3Kinase 
phosphorylation cascade activating the serine/threonine kinase AKT. AKT phosphorylates the 
Fork head transcription factor DAF-16/FoxO, leading to its export from the nucleus (Brunet et 
al., 1999; Lee et al., 2001; Lin et al., 2001). DAF-16/FoxO is a master regulator of stress 
responses and maintenance of homeostasis and is required for the highly penetrant dauer-
constitutive (daf-c) phenotype observed in reduced insulin-signaling mutant animals	(Gottlieb 
and Ruvkun, 1994; Lin et al., 1997; Ogg et al., 1997). 
The interaction of pheromone sensing and genetic pathways implicated in promoting 
reproductive development is complex. Pheromone is known to enhance the daf-c phenotype of 
TGFβ pathway mutants at permissive temperatures (Thomas et al., 1993). Further, pheromone 
down-regulates expression of the daf-7/ TGFβ-like ligand	(Ren et al., 1996; Schackwitz et al., 
1996). Whether DAF-16/FoxO is required for dauer arrest induced by population stress is less 
clear. Strains expressing different mutant alleles of daf-16 showed variable response to dauer 
pheromone in liquid culture (Gottlieb and Ruvkun, 1994). These animals demonstrated abnormal 
tissue remodeling as compared to wild type dauers (Vowels and Thomas, 1992). 
Insulin-like peptides (ILPs) serve as the ligands for DAF-2/IGFR. C. elegans possesses 40 
known ILPs with diverse structures and activities (Li et al., 2003; Pierce et al., 2001) For 
example, DAF-28, INS-4 and INS-6 activate DAF-2/IGFR while INS-1 and INS-18 are believed 
to be DAF-2 antagonists (Cornils et al., 2011; Hung et al., 2014; Li et al., 2003; Pierce et al., 
2001). Many ILPs are synthesized in ASI and may act to coordinate morphological changes in 
response to environmental conditions at the organismal level (Gruner et al., 2016; Murphy et al., 
2007). Attempts have been made to understand the complex interaction(s) of ILPs in 
development and longevity	(Artan et al., 2016; Chen and Baugh, 2014; Fernandes de Abreu et 
al., 2014); however, contributions of individual ILPs to developmental decisions remain difficult 
to define using genetics due to functional redundancy and overlapping temporospatial expression 
patterns (Chen and Baugh, 2014; Pierce et al., 2001; Ritter et al., 2013). Interestingly, certain 
ILPs expressed in ASI, including DAF-28 and INS-6, have been shown to be responsive to 
pheromone through an unknown mechanism (Cornils et al., 2011; Li et al., 2003). 
We previously demonstrated that the conserved epigenetic regulators DPY-21 and SET-4 
promote dauer arrest in response to pheromone and reduced insulin signaling through the 
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inhibition of INS-9, an incompletely characterized type B ILP expressed primarily in ASI 
(Delaney et al., 2017). Here we expand our understanding of how pheromone regulates insulin-
like signaling and find that ins-9 is required for dauer bypass in set-4 mutants, while SET-4 
activity in ASI is sufficient to rescue dauer arrest in animals with reduced insulin-like signaling. 
We show that pheromone-induced dauer arrest requires DAF-16/FoxO. We demonstrate that ins-
9 expression is sensitive to pheromone like other type β ILPs. Pheromone regulates ins-9 
expression itself in a DAF-16/FoxO independent manner. These findings suggest crosstalk 
between multiple pathways converges on ILP production to control developmental fate in 
response to population stress. 
 
Results 
ins-9 expression in ASI sensory neurons promotes reproductive development  
Having previously identified ins-9 as an X-linked DAF-2/IGFR agonist subject to SET-4 and 
DPY-21 mediated suppression (Delaney et al., 2017), we asked whether INS-9 was required for 
the observed defect in dauer formation in response to pheromone in set-4 mutants. Loss of ins-9 
rescued pheromone-induced dauer arrest in set-4 animals and enhanced response to pheromone 
relative to wild type siblings (Fig. 4.1A). akt-2 was not required for this enhancement of dauer 
arrest in set-4 animals (data not shown). This result implicates ins-9 in promoting reproductive 
development in replete environments. 
INS-9 transgenes were expressed in ASI sensory neurons, which are critical for dauer arrest 
(Bargmann and Horvitz, 1991; Chen and Baugh, 2014; Pierce et al., 2001). We previously 
showed the histone methyltransferase SET-4 acts in neurons to promote dauer arrest at least in 
part through silencing of ins-9 (Delaney et al., 2017). If SET-4 in ASI is important for dauer 
regulation, we reasoned that restoring expression of set-4 in ASI alone should be sufficient to 
rescue the dauer-defective phenotype caused by set-4 mutation. We used CRISPR-Cas9 to 
replace the native set-4 promoter with the ASI-specific gpa-4 promoter upstream of the 
endogenous set-4 locus (Fig. 4.S1, (Jansen et al., 1999). After outcrossing the resulting gpa-
4p::set-4(dp682) allele, we found that animals with reduced IIS expressing set-4 exclusively in 
ASI underwent dauer arrest at levels comparable to animals expressing set-4 driven by its native 
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promoter, and at a significantly greater rate than set-4 null siblings (Fig. 4.1B). These findings 
suggest SET-4 promotes dauer arrest in ASI neurons, consistent with its role in repressing ins-9 
expression. 
 
 
Figure 4.1. SET-4 promotes dauer arrest in ASI sensory neurons upstream of INS-9. (A) Loss of ins-
9 rescues dauer arrest in set-4 mutants in response to dauer pheromone. Results are the mean and 
s.e.m. of one experiment performed in duplicate. N (0uL, 2uL, 10uL): wild type = 43, 95, 252; set-4 =38, 
41, 110; set-4;ins-9 = 119, 70, 57. (B) set-4 expression in ASI specifically is sufficient for dauer arrest. 
Results are the mean and s.e.m. of 3 experiments. N = 349, 896, 721. *p<0.05 
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DAF-16 is required for pheromone-induced dauer arrest  
Upregulation of ins-9 expression is predicted to activate DAF-2/IGFR that then inhibits DAF-
16/FoxO, promoting reproductive development. Further, DAF-16 is required for silencing of ins-
9 (Delaney et al., 2017). Therefore, we speculated that pheromone-induced dauer arrest may be 
DAF-16 dependent. Previous results addressing this question were equivocal, owing to modest 
arrest rates observed in wild type controls (Gottlieb and Ruvkun, 1994; Ogg et al., 1997). We 
found animals lacking daf-16 to be far less responsive to dauer pheromone than their wild type 
siblings (Fig 4.2). Loss of ins-9 did not rescue this defect in daf-16 mutants, placing DAF-
16/FoxO downstream of ins-9 expression. These results are consistent with the empirically 
deduced logic of the insulin-like signaling pathway and suggest that population stress induces 
dauer arrest in a manner requiring DAF-16 as well as silencing of ins-9 in ASI sensory neurons. 
 
 
Figure 4.2. DAF-16 is required for response to dauer pheromone. Results are the mean and s.e.m. of 
one experiment performed in duplicate. N (0uL, 2uL, 10uL): wild type = 168, 183, 253; daf-16 =179, 191, 
141; daf-16;ins-9 = 171, 170, 127. 
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ins-9 expression is controlled by dauer pheromone in parallel with DAF-16 
To better understand how ins-9 expression is regulated, we created an single-copy reporter for 
ins-9 expression, using CRISPR-Cas9 to insert the operon-like gpd-2 SL2 sequence coupled to 
mNeonGreen into the endogenous ins-9 locus immediately after the stop codon (Blumenthal, 
2012; Shaner et al., 2013). The ins-9::sl2::mNeonGreen(dp690) reporter allele (henceforth 
referred to as the ins-9 reporter) allows the in vivo monitoring of expression dynamically via 
green fluorescence without disrupting ins-9 activity. Expression was detectable from late L2 to 
adulthood. Previous reports using extrachromosomal arrays demonstrated that ins-9 is primarily 
expressed in ASI with some expression reported in ASJ. Both ASI and ASJ are paired sensory 
neurons implicated in regulating dauer arrest (Delaney et al., 2017; Pierce et al., 2001). Using the 
ins-9 reporter we consistently observed two neurons expressing mNeonGreen; however, 
sporadically we observed green fluorescence in a third neuron (Fig 4.3A). 
Since we observed that ins-9 expression promotes reproductive development in the context of 
pheromone or reduced insulin signaling (Delaney et al., 2017), Fig 4.1), we used the ins-9 
reporter to test whether ins-9 expression itself is regulated by pheromone. Growing reporter 
animals in the presence of pheromone was sufficient to silence the reporter (Fig 4.3B). Notably, 
this silencing was independent of DAF-16, as loss of daf-16 did not rescue mNeonGreen 
expression in the presence of pheromone. Therefore, it is likely that multiple pathways control 
ins-9 expression, including one downstream of dauer pheromone. 
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Figure 4.3. ins-9 is expressed in ASI sensory neurons. (A) Representative images of the single-copy, 
endogenous locus ins-9::sl2::mNeonGreen(dp690) reporter. L4 animals shown. N = 21. (B) ins-9 reporter 
animals and daf-16;dp690 animals in the absence and presence of dauer pheromone. Arrows indicate 
green neurons. N(no treatment) = 12, 13; N(pheromone) = 21, 11. 
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Pheromone regulates multiple insulin-like peptides in parallel 
Previous reports suggest that a major ILP, daf-28, is expressed in ASI neurons and is repressed 
by dauer pheromone. daf-28 loss of function mutants exhibit low dauer penetrance at 25°C, but 
daf-28 mutation in combination with loss of ins-4, ins-5, and ins-6, causes penetrant dauer arrest 
(Hung et al., 2014). Given that both ins-9 and daf-28 are responsive to dauer pheromone, we 
tested whether ins-9 augmented daf-28 dauer arrest like other ILPs. We found a modest but 
significant increase in dauer arrest in daf-28;ins-9 animals over daf-28 single mutants (Fig 4.4). 
Therefore, these insulins may be regulated in parallel despite both being regulated by pheromone 
signaling (Li et al., 2003). This is consistent with previous observations that DAF-7/TGF-B-like 
signaling controls daf-28 expression while ins-9 expression is DAF-16/FoxO dependent 
(Delaney et al., 2017; Honda et al., 2011). 
 
 
Figure 4.4. ins-9 acts in parallel with daf-28. Results are the mean and s.e.m. of 3 experiments. N = 
688, 697, 1018, 792. *p<0.05 
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Discussion 
In the present study we expand on how pheromone signaling mediates developmental strategy 
through insulin-like signaling. Not only is population stress sufficient to suppress DAF-2/IGFR 
agonists daf-28 and ins-6 (Cornils et al., 2011; Li et al., 2003)	but also ins-9 (Fig. 4.3). Similarly, 
DAF-16/FoxO is required for diapause in response to dauer pheromone and acts downstream of 
ins-9 (Fig. 4.2). We strengthen the evidence that ins-9 expression promotes reproductive 
development. We demonstrate that SET-4 activity in ASI, where ins-9 is expressed, is sufficient 
for dauer arrest in reduced insulin signaling mutants. We establish that pheromone silences ins-9 
expression in parallel with DAF-16. Taken together with previous findings, these data suggest 
that multiple inputs converge on insulin-like peptide expression to promote dauer arrest under 
conditions of perceived population stress. 
Animals’ perception of their environment dictates which developmental strategy is most 
appropriate. In C. elegans, amphid sensory neuron processes are directly exposed to their 
environment to sense population density, presence of food, and temperature (Golden and Riddle, 
1984a). These environmental cues regulate TGFβ and IIS signaling cascades through 
mechanisms that remain incompletely understood (Hu, 2007). These inputs converge on the 
synthesis of steroid hormones known as dafachronic acids (DAs) that promote reproductive 
development (Gerisch and Antebi, 2004). DA ligands the DAF-12 bile acid-like receptor, which 
then drives forward reproductive development (Antebi et al., 2000). Dauer pheromone 
antagonizes DA signaling by repressing daf-9 expression in the hypodermis that is associated 
with the commitment to reproductive development. (Schaedel et al., 2012). 
The bilaterally paired amphid neuron ASI is known to be a critical regulator of dauer arrest 
(Ailion and Thomas, 2000; Bargmann and Horvitz, 1991). ASI is the primary site of synthesis of 
the TGFβ-like DAF-7 (Meisel et al., 2014; Ren et al., 1996; Schackwitz et al., 1996) and is also a 
primary source for ILP production, including DAF-2 agonists INS-4, INS-6, DAF-28, and INS-
9, as well as antagonists INS-1 and INS-18 (Hung et al., 2014; Pierce et al., 2001). Interestingly, 
unlike ins-9, daf-28 production is independent of DAF-16; rather, daf-28 is directly dependent on 
DAF-7/TGFβ, revealing creating crosstalk between the TGFβ and IIS pathways (Li et al., 2003). 
As a result, in reduced insulin signaling mutants undergoing dauer arrest, daf-28 expression 
remains high, arguing that daf-28 expression may not be sufficient for dauer bypass. 
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DAF-28 is the only type-β ILP to demonstrate a dauer phenotype as a loss-of-function mutant	
(Hung et al., 2014). Mutating one of the several putative agonist ILPs in combination with daf-28 
loss of function modestly augments dauer arrest (Hung et al., 2014). However, no findings were 
reported regarding ins-9. While nonsense alleles of ins-9 have no dauer phenotype, similar to ins-
2 through ins-8, we find that loss of ins-9 increased dauer arrest in daf-28 mutants to a similar 
degree as reported for daf-28 in combination with either ins-4 or ins-6 (Fig. 4.4)	(Hung et al., 
2014). Hung et al. argue that INS-4, INS-6 and DAF-28 promote reproductive development by 
activating DAF-2 in the intestine, which then relays signals to increase dafachronic acid 
synthesis. ins-9 expression, on the other hand, may be regulated in a feed-forward loop within 
ASI (Delaney et al., 2017), like the DAF-2/IGFR agonist ins-7 in the intestine (Murphy et al., 
2007) and the antagonist ins-18 in neurons (Matsunaga et al., 2012). Expression of both daf-28 
and ins-9 is inhibited in the presence of high concentrations of dauer pheromone (Fig. 4.3) (Li et 
al., 2003). Therefore, multiple signaling networks work in concert and in response to pheromone 
detection in ASI to coordinate developmental strategy in larvae. Which additional pathways 
mediate the response of ILPs to pheromone remains to be elucidated. 
We have demonstrated that INS-9 is regulated from downstream by DAF-16/FoxO and upstream 
by pheromone and the epigenetic regulators DPY-21 and SET-4 (Fig. 4.3) (Delaney et al., 2017; 
Dumas et al.). However, SET-4 and DPY-21 inhibit multiple insulin signaling genes to promote 
dauer arrest, including neuronally expressed akt-2 and, possibly indirectly, the ASI- and 
intestine-expressed ins-7 (Murphy et al., 2007; Paradis and Ruvkun, 1998). We show that SET-4 
acts in ASI to promote dauer arrest (Fig. 4.1B). Given that loss of ins-9 rescues the dauer-
defective phenotype of set-4 mutants, it is likely that SET-4 promotes dauer arrest in ASI 
primarily through inhibiting ins-9. However, that does not exclude SET-4 acting through 
inhibition of other IIS genes as well. Similarly, our data places DAF-16 downstream of INS-9 in 
the dauer decision, but whether DAF-16 is necessary in ASI or whether it acts in downstream 
tissues like the intestine to coordinate the organismal commitment to dauer remain unclear 
(Hung et al., 2014; Libina et al., 2003). 
Crude pheromone extract has previously been demonstrated to extend longevity of adult animals, 
and this lifespan extension is dependent on DAF-16/FoxO, implicating that pheromone regulates 
insulin-like signaling (Kawano et al., 2005; Ludewig et al., 2013). Interestingly, specific 
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ascarosides present in dauer pheromone extend lifespan in a manner requiring the histone H4 
lysine 16 deacetylase SIR-2.1 (Ludewig et al., 2013). H4K16 deacetylation has been reported to 
promote the establishment of H4K20 trimethylation in mammalian cells (Sarg et al., 2002; 
Serrano et al., 2013). SET-4 promotes dauer arrest and is required for higher order H4K20 
methylation (Delaney et al., 2017; Vielle et al., 2012; Wells et al., 2012). These data are 
consistent with a model where pheromone may exert its effects through conserved epigenetic 
regulation of gene expression. 
Surprisingly, whether DAF-16/FoxO is required for response to pheromone was unresolved 
(Gottlieb and Ruvkun, 1994; Ogg and Ruvkun, 1998). We demonstrate that pheromone induced 
dauer arrest is indeed DAF-16/FoxO dependent (Fig. 4.2). These findings are consistent with 
pheromone-sensitive ILPs including INS-9 regulating DAF-16/FoxO and more broadly with 
dauer arrest in C. elegans larvae being a useful surrogate for DAF-16/FoxO mediated longevity. 
Reduced insulin signaling in metazoans leads to long life (Bluher et al., 2003; Kenyon et al., 
1993; Yamamoto and Tatar, 2011). In C. elegans, this increased longevity is due in part to 
downregulation of ILP production (Artan et al., 2016), and is accompanied by a decrease in 
translation in muscle tissue without compromising muscle mass (Depuydt et al., 2013). 
Similarly, mammals experiencing reduced insulin-like signaling are long lived and show 
decreased translation in skeletal muscle in a cell-nonautonomous fashion, suggesting a role for 
insulin-like growth factor signaling in regulation of tissue homeostasis (Essers et al., 2016). 
Further, axonal degeneration is delayed or prevented when animals pass through dauer diapause 
in a manner dependent on increased DAF-16/FoxO activity (Calixto et al., 2012). Therefore, 
continuing to develop our understanding of conserved mechanisms of insulin-like peptidergic 
signaling may lead to insights leading to increased years of life free from age-associated diseases 
like frailty, cancer, diabetes, and dementia. 
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Materials and Methods 
Strains and maintenance. 
The following strains were used in this study: daf-16(mu86), ins-9(dp677), set-4(n4600), akt-
2(ok393), and daf-28(tm2804). Some strains were provided by the CGC, which is funded by NIH 
Office of Research Infrastructure Programs (P40 OD010440). 
 
Dauer induction assays 
Gravid adults were transferred to fresh NGM plates to lay eggs. Egg layers were then removed 
and embryos were transferred to 25°C. After 54-60 hr, progeny were scored as dauer or not dauer 
(i.e. L4/young adult).  
 
Generation of transgenic strains. 
CRISPR genome editing was performed using custom crRNA and tracrRNA (Dharmacon) and 
recombinant Cas9 (PNA Bio) as described (Paix et al., 2015). HDR amplicons were generated by 
overlap PCR (8 reactions per amplicon in 100 µL reaction volume), purified individually with 
GeneJet PCR purification columns (Invitrogen), eluted and combined in Buffer QF (Qiagen), 
precipitated using 0.7 volumes of isopropanol, and resuspended in 10 µL of water. gpa-4p::set-
4(dp682) was made by targeting the set-4(n4600) locus using the crRNA guide sequence 5’-
GUAUCUGACUGCGCAUCAUG-3’ that overlaps both ends of the n4600 deletion. The HDR 
amplicon contained the 1.4 kb upstream of gpa-4 fused to the 633 bp of set-4 genomic sequence 
absent in the n4600 deletion. For ins-9::sl2::mNeonGreen(dp690), the intergenic sequence 
between gpd-2 and gpd-3 was fused to mNeonGreen derived from pDD268 (Dickinson2013). 
This repair amplicon was inserted between the ins-9 stop codon and ins-9 3’ UTR using the 
crRNA guide sequence 5’-GGUGCCGACAAAUUGUAACC-3’. 
 
Pheromone assays 
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Crude pheromone extracts were prepared as described (Delaney et al., 2017), with the exception 
that evaporation steps were carried out using a Savant SC210A SpeedVac Plus with RVT4104 
refrigerated vapor trap (Thermo). Effective doses were determined empirically. 500 µL of water 
containing the indicated volume of pheromone extract were added to 2mL NGM lacking peptone 
made with Noble Agar (BD) and containing 30 µg/mL streptomycin in 35 mm dishes. 20 µL 6X 
live OP50 resuspended in S Basal was spotted onto dried plates. Gravid adults were transferred 
to these plates to lay eggs. After removing egg layers, eggs were transferred to 25°C and scored 
as dauer or not dauer after 84 hr. 
 
Fluorescence microscopy 
Animals were mounted on a 2% agar pad slide and immobilized in a drop of 25mM sodium 
azide. Detection of green fluorescence was imaged using a Leica M165FC microscope with a 
(Leica) DFC9000 GT camera and a Lumencor sola light engine fluorescence lamp. Confocal 
images were acquired using a Leica Inverted SP5X Confocal Microscope (Leica) and LAS AF 
software. 
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Supplementary Information 
 
 
Supplemental Figure 4.S1. Construction of ASI-specific set-4(dp682) allele. 
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Chapter 5 
Histone methyltransferase SET-4 promotes longevity in 
Caenorhabditis elegans 
 
Abstract 
Multiple conserved pathways control aging in metazoans. Several pathways act together and in 
parallel to control aging, including growth factor signaling, energy/nutrient sensing, and cellular 
stress responses. Changes in the amount and distribution of epigenetic modifications are also 
associated with aging. Loss of heterochromatin is a hallmark of aging; however, how specific 
epigenetic modifications contribute to the aging process is poorly understood. Here we show that 
the conserved histone H4 lysine 20 methyltransferase SET-4 promotes longevity in 
Caenorhabditis elegans. set-4 overexpression extends lifespan in parallel with DAF-16/FoxO 
and causes animals to abstain from feeding. This fasting behavior induces expression of 
longevity-associated HLH-30 target genes which are required for full lifespan extension. 
Animals overexpressing set-4 phenocopy models of dietary restriction, and SET-4 is required for 
viability in eat-2 DR mimetics.  Overexpression of set-4 leads to increased H4K20 
trimethylation, and H4K20 trimethylation is increased in eat-2 animals. Taken together, these 
data support a role for higher order H4K20 methylation in promoting longevity and establish a 
novel epigenetic model of dietary restriction. 
 
Introduction 
Advanced age is strongly associated with the onset of chronic diseases including atherosclerosis, 
metabolic syndrome, diabetes, and dementia. Understanding the aging process may create new 
opportunities to prevent or treat these conditions. In recent years, it has become apparent that 
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organisms ranging from budding yeast to mammals age through conserved mechanisms 
including energy and nutrient sensing and regulation of growth factor signaling	(Lamming, 2016; 
Mathew et al., 2017; Salminen et al., 2016). In metazoans insulin and insulin-like growth factor 
signaling activates a PI3-kinase phosphorylation cascade that leads to inhibition of FoxO 
transcription factors via nuclear exclusion (Brunet et al., 1999; Lee et al., 2001; Lin et al., 2001). 
Enhanced FoxO activity is associated with increased stress resistance and/or longevity in model 
organisms, while extreme longevity in humans is associated with FoxO single nucleotide 
polymorphisms (Anselmi et al., 2009; Bluher et al., 2003; Flachsbart et al., 2009; Kenyon et al., 
1993; Li et al., 2003; Willcox et al., 2008; Yamamoto and Tatar, 2011). In parallel with FoxO 
transcription factor activity, moderate reduction in food intake, known as dietary restriction, is 
one of the most robust interventions to extend healthy lifespan across taxa (Kennedy et al., 
2007). Dietary restriction protects against heart disease, cancer, diabetes and kidney failure in 
animal models and promotes stress resistance (Berrigan et al., 2005; Guarente and Picard, 2005). 
In addition to metabolic perturbations, aging is associated with the loss of genomic integrity 
(Lopez-Otin et al., 2013). Genome stability is maintained by epigenetic mechanisms including 
DNA methylation and histone tail modification (Field and Adams, 2016). Skewed chromatin 
modifications are found in natural aging and in diseases associated with accelerated aging (Imai 
and Kitano, 1998; Shumaker et al., 2006; Vanyushin et al., 1973; Villeponteau, 1997). Histone 
tail methylation is highly conserved and contributes to the regulation of gene expression; histone 
H3 lysine 4 (H3K4), H3K36, and H3K79 methylation are associated with transcriptionally active 
regions while H3K9, H3K27, and H4K20 methylation typically mark repressed genes and 
heterochromatin (Davie et al., 2016; Lan and Shi, 2009; Schotta et al., 2004). Previous reports 
have shown that interventions that facilitate heterochromatin formation or maintenance promote 
longevity. For example, in the free-living nematode Caenorhabditis elegans, perturbing 
euchromatin-associated H3K4 methylation levels is associated with increased longevity (Greer et 
al., 2010). Decreased removal of heterochromatic H3K27 methylation also increased lifespan, 
potentially through maintenance of H3K27 methylation at insulin-like signaling genes (Jin et al., 
2011). Disrupting genes that promote synthesis of the methyltransferase co-substrate S-
adenosylmethionine (SAM) also promotes longevity (Hansen et al., 2005). Nevertheless, how 
epigenetic modifications interact with known longevity programs remains poorly understood. 
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In C. elegans, the histone methyltransferase SET-4 is required for both histone H4 lysine 20 di- 
and tri-methylation (H4K20me2 and H4K20me3, respectively) (Delaney et al., 2017; Vielle et 
al., 2012; Wells et al., 2012). We recently demonstrated a role for SET-4 in promoting the 
activity of the FoxO transcription factor DAF-16 in development (Delaney et al., 2017). Here we 
show that SET-4 promotes longevity in parallel with DAF-16/FoxO through the induction of 
fasting behavior that phenocopies a dietary restriction regimen. Downstream of decreased food 
consumption, genes involved in detoxification and fat metabolism are upregulated. H4K20 
trimethylation is enriched in larvae undergoing DR, and set-4 is required for viability in these 
animals. Overexpression of set-4 results in H4K20 hypermethylation, consistent with increased 
catabolism of the methyl donor S-adenosylmethionine. We define a novel model for chronic 
dietary restriction that can be compared with existing genetic and environmental interventions to 
define conserved programs that enhance longevity. 
 
Results 
H4K20 methyltransferase SET-4 promotes longevity 
We previously established a role for SET-4 in promoting DAF-16/FoxO activity in development 
(Delaney et al., 2017). Since DAF-16/FoxO is a well-described master regulator of lifespan in 
model organisms (Bluher et al., 2003; Kenyon et al., 1993; Yamamoto and Tatar, 2011), we 
tested whether SET-4 is required for normal lifespan. We found three independently-derived set-
4 functionally null alleles marginally decreased longevity relative to wild type siblings (Fig 
5.1A, Fig. 5.S1A-B). Consistent with SET-4 promoting longevity, overexpression of HA::set-4 
from two independently integrated transgenes, dpIs7 and dpIs9, was sufficient to significantly 
extend lifespan relative to wild type siblings (Fig 5.1B). The mean lifespan observed in dpIs7 
and dpIs9 was 24.7 ± 0.55 and 24.6 ± 0.65 days compared to wild type siblings at 21.1 ± 0.40 
and 21.2 ± 0.65 days, respectively.  Integration of a single copy of HA::set-4, dpIs5, also 
extended lifespan, suggesting that the lifespan extension we observed from set-4 overexpression 
is physiologically relevant (mean 20.1 ± 0.4 days dpSi5 vs. 18.6 ± 0.3 days wild type) (Fig. 
5.1C). The magnitude of lifespan extension due to set-4 overexpression was similar to that 
previously attributed to set-4 knockdown using RNAi (Greer et al., 2010). We recapitulated the 
lifespan extension due to set-4 RNAi (Fig. 5.S1C); however, RNAi may not reproduce findings 
	 137	
in mutants due to incomplete knockdown, differences in tissue sensitivity, bacterial food source, 
and/or temporal differences. Indeed, we previously observed somatic set-4 expression is 
primarily restricted to neurons, which are RNAi resistant (Delaney et al., 2017; Timmons et al., 
2001). Taken together, these data suggest SET-4 promotes longevity in C. elegans. 
 
 
Figure 5.1. SET-4 promotes longevity. (A) set-4 mutants are short-lived relative to wild type siblings. 
Results are representative of two experiments. P < 0.001. (B) overexpression of HA::set-4 increases 
longevity relative to wild type siblings. Results are representative of three experiments. P < 0.0001. (C) A 
strain that contains two copies of set-4 is long-lived relative to wild type siblings. Results are 
representative of three experiments. P < 0.001. Curves are significant as calculated by the log-rank test.  
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set-4 promotes longevity independently of DAF-16/FoxO activity 
SET-4 is required for dauer arrest when DAF-16/FoxO is activated by reduced insulin-like 
signaling and/or eak pathway mutation (Delaney et al., 2017). We demonstrated set-4 
overexpression rescues dauer arrest in set-4 mutants, indicating that these integrated transgenes 
are functional like the single copy insertion strain (Fig. 5.2A) (Delaney et al., 2017). However, 
we were surprised to observe that set-4 overexpression promoted longevity in the context of the 
daf-16(mu86) null allele (Fig. 5.2B) or when daf-16 was inactivated by RNAi (Fig. 5.2C). 
Therefore, set-4 overexpression promotes longevity independent of DAF-16/FoxO activity. 
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Figure 5.2. set-4 overexpression extends lifespan independently of DAF-16. (A) set-4 
overexpression rescues dauer in set-4 null animals. Results are the mean and s.e.m. of three 
experiments. N = 1125, 662, 396. P < 0.05 by student’s t-test. (B) Overexpression of HA::set-4 increases 
longevity in the absence of daf-16. Results are representative of two experiments. P < 0.0001. (C) 
Overexpression of HA::set-4 increases longevity in the context of daf-16 RNAi. Results are from one 
experiment. P < 0.0001. Curves are significant as calculated by the log-rank test. 
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set-4 overexpression induces fasting behavior 
Visual examination revealed set-4 overexpressing strains were smaller, thinner, and more 
transparent than their wild type siblings as young adults, and they remained so throughout 
adulthood (Fig. 5.3A). These animals also demonstrated a delay in development most 
pronounced in the L4 larval stage, delayed onset of egglaying, an extended period of fertility, 
and fewer progeny overall relative to wild type (Fig 5.3B-C, Fig 5.S2). These phenotypes are 
similar to those manifested in animals undergoing dietary restriction (DR) (Bishop and Guarente, 
2007). 
We found this DR-like phenotype intriguing because multiple models of DR extend longevity 
independently of DAF-16/FoxO, like set-4 (Lan et al., 2015). Therefore, we investigated the 
nature of this fasted appearance. SET-4 is expressed primarily in neurons during development 
(Delaney et al., 2017). A genetic mimetic of DR, eat-2, disrupts a nicotinic acetylcholine 
receptor gene in neurons to decrease the pumping rate of the pharynx. Defective pumping results 
in eat-2 animals eating less food throughout life, leading to increased lifespan. We tested 
whether set-4 overexpression disrupts normal pharyngeal pumping like eat-2 mutation (Raizen et 
al., 1995). Strains overexpressing set-4 did not demonstrate any defect in pumping rates relative 
to wild type siblings (Fig 5.3D-E), suggesting a mechanism distinct from a physical defect in 
feeding. We next examined whether set-4 overexpressor strains exhibited distinct feeding 
behaviors. We found fewer young adult animals overexpressing set-4 to be on food at a given 
time point compared to wild type siblings (Figs. 5.3F-H), consistent with less feeding behavior. 
A defect in food perception could explain this behavior; however, raising overexpressor animals 
on lawns of bacterial food that covered the entire plate did not rescue animal size (Fig 5.3I). 
Taken together, these data suggest these animals are less inclined to engage in feeding behavior 
independently of a mechanical or food-sensing defect. 
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Figure 5.3. set-4 overexpressors exhibit decreased feeding behavior. (A) set-4 overexpressing 
strains are smaller than their wild type siblings throughout adulthood. Representative images of day one 
adults shown. Scale bar = 250 µM. N = 10, 10, 7, 18. (B, C) set-4 overexpressors have decreased total 
fertility. P < 0.05, P < 0.001, respectively. (D, E) Overexpressor strains exhibit no defect in pumping rate 
at young adulthood. (F) set-4 overexpressors avoid food to a greater extent than wild type siblings. 
Representative images of young adult animals shown. (G, H) Quantification of phenotype shown in (F). N 
(dpIs9) = 1356, 804; N (dpIs7) = 1247, 770. P < 0.05, P < 0.01, respectively. (I) Overexpressing strains 
raised on bacterial lawns remain smaller than wild type siblings. N = 14, 13, 11, 12.  
	 142	
set-4 overexpression induces fasting response genes 
Animals deprived of food upregulate HLH-30 transcription factor activity through down-
regulation of the binding site competitor mxl-3 and upregulation of hlh-30 expression itself 
(Lapierre et al., 2013; O'Rourke and Ruvkun, 2013). HLH-30 is required for the induction of 
genes associated with stress-resistance like the conserved monooxygenase fmo-2 as well as 
increased fatty acid metabolism genes like lipases lipl-2 and lipl-3 (Leiser et al., 2015; O'Rourke 
and Ruvkun, 2013). Upregulation of hlh-30 either through loss of mxl-3 or through 
overexpression of hlh-30 promotes longevity, presumably through hlh-30 target genes. Similarly, 
hlh-30 is required in multiple models of longevity including reduced insulin signaling and 
dietary restriction (Lapierre et al., 2013). We found hlh-30 and target gene transcripts were 
upregulated in set-4 overexpressing animals, consistent with observations demonstrating these 
animals engage in fasting behavior (Fig 5.4A). In contrast, neither mxl-3 nor genes associated 
with other longevity associated transcription factors were different between overexpressors and 
wild type siblings. Genes tested include sod-2 (PHA-4), sod-3 (DAF-16), gcs-1 (SKN-1), alg-2 
(DAF-12) and pat-10 (HSF-1) (An and Blackwell, 2003; Baird et al., 2014; Hochbaum et al., 
2011; Honda and Honda, 1999; Panowski et al., 2007). 
HLH-30 is required for the upregulation of lipl-2 and lipl-3 during fasting (O'Rourke and 
Ruvkun, 2013). Because set-4 overexpression promotes fasting behavior, we asked whether set-4 
is necessary for the induction of these fasting response genes. In set-4 null animals, we found a 
defect in lipl-3 expression in both fed and fasted animals (Fig 5.4B). lipl-2, on the other hand, 
was not different between set-4 and wild type animals in the fed condition but may be less 
induced in set-4 animals when fasted (Fig. 5.4C). Preliminary findings show both lipl-2 and lipl-
3 may be required for longevity in set-4 overexpressing lines (Figs. 3.4D-E). These data support 
the hypothesis that HLH-30 promotes longevity through induction of target genes controlling 
fatty acid metabolism. 
Previously, it was established that longevity in a liquid DR regimen required the B isoform of the 
NRF2 ortholog skn-1 that is expressed solely in ASI neurons (Bishop and Guarente, 2007). 
However, those findings were based on overexpression systems and RNAi. Given that set-4 is 
expressed primarily in neurons, and that set-4 expression in ASI is sufficient for dauer arrest 
(Fig. 4.2) (Delaney et al., 2017), we wanted to test whether skn-1B was required for the induction 
	 143	
of HLH-30 target genes observed in set-4 overexpressors. We used CRISPR-Cas9 to create the 
skn-1B-specific null allele, skn-1(dp685) by inserting a stop codon and frameshift in the B-
specific exon 1. Preliminary data suggests that skn-1B is indeed required for downstream 
activation of lipl-2 and lipl-3 expression (Fig. 5.4F-G). 
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Figure 5.4. set-4 overexpression activates HLH-30 and fasting response genes. (A) Independent 
transgenic lines demonstrate specific upregulation of genes associated with fasting. Results are the mean 
and s.e.m. of three experiments. (B) lipl-3 expression requires set-4 in both fed and fasted conditions. 
Results are the mean and s.e.m. of three experiments. *P < 0.05, **P < 0.01. (C) lipl-2 expression in 
fasted conditions may be SET-4 dependent. Results are from one experiment performed in duplicate. (D, 
E) Full lifespan extension in set-4 overexpressors may require both LIPL-3 and LIPL-2. Results shown 
are one experiment. dpIs7 vs. lipl-3;dpIs7 P < 0.05; dpIs7 vs. lipl-2;dpIs7 P < 0.0001 by the log-rank test. 
(F) SKN-1B is required for lipl-3 induction in set-4 overexpression. Results are from one experiment 
performed in duplicate. (G) SKN-1B promotes lipl-2 expression. Results are from one experiment 
performed in duplicate. 
 
SET-4 is required for viability in a developmental model of dietary restriction 
The epigenetic contribution to longevity in models of dietary restriction remain poorly 
understood. Because we observed a DR-like phenotype in animals that also demonstrated greater 
H4K20me3, we asked whether H4K20 methylation was altered in DR animals during 
development. We observed greater H4K20me3 in eat-2 L4 larvae to wild type siblings (Fig. 
5.5A). Whether H4K20me3 is required for increased longevity in this background could not be 
addressed because set-4;eat-2 double mutants were sterile. These animals exhibited a much 
greater developmental delay compared to eat-2 single mutants, and while they laid a similar 
number of eggs as eat-2, only rarely did larvae hatch or grow to adulthood. These observations 
were unexpected because loss of set-4 does not lead to obvious fertility or growth defects in 
other genetic backgrounds, including animals with decreased total fertility due to reduced insulin 
signaling. H4K20 methylation is associated with dosage compensation (Delaney et al., 2017; Lau 
et al., 2014; Vielle et al., 2012; Wells et al., 2012), but sterility was not due to disruption of 
dosage compensation because eat-2;dpy-21 animals were fertile. We then tested whether set-4 is 
required for increased longevity in a late-life model of intermittent fasting known as sDR (Greer 
et al., 2007). Like wild type siblings, animals lacking set-4 experienced a modest increase in 
mean life span (Fig. 5.5B). sDR requires DAF-16, but SET-4 promotes longevity in parallel with 
DAF-16. Therefore, it was not surprising the effect of this DR regimen was not different between 
wild type animals and set-4 mutants. Finally, we exposed eat-2 animals to set-4 RNAi from 
hatching throughout life. These animals did not live shorter than eat-2 animals eating empty 
vector-expressing bacteria (Fig. 5.5C). In contrast, both daf-16 and hlh-30 RNAi shortened the 
lifespan of both wild type and eat-2 animals relative to vector only control (data not shown). The 
fact that set-4 RNAi did not disrupt eat-2 lifespan is consistent with set-4 expression being 
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restricted to RNAi-resistant neurons post-embryonically (Delaney et al., 2017; Timmons et al., 
2001). Taken together, these data implicate SET-4 mediated H4K20 methylation as required for 
viability in chronically fasted animals during larval development. 
 
 
Figure 5.5. H4K20 trimethylation is associated with dietary restriction. (A) H4K20 trimethylation is 
greater in eat-2 animals compared to wild type siblings. Results show three experiments. (B) set-4 is 
dispensable for the late-life intermittent fasting model, sDR. Results are from one experiment. For wild 
type ad libitum (AL) vs DR P < 0.0001; for set-4 AL vs. DR, P < 0.001. (C) set-4 RNAi does not affect eat-
2 lifespan. Results are from one experiment. Curves are significantly different as calculated by the log-
rank test. 
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Overexpression of set-4 increases H4K20 methylation 
SET-4 is a histone H4 lysine 20 (H4K20) methyltransferase which converts a monomethylated 
substrate to a dimethylated product and is required for trimethylation as well (Delaney et al., 
2017; Vielle et al., 2012; Wells et al., 2012). We wondered whether overexpressing set-4 alters 
chromatin state. We used immunofluorescence to detect H4K20 trimethylation in embryos and 
normalized signal to DAPI nuclear staining. We observed a 71% and 44% increase in 
H4K20me3 in dpIs7 and dpIs9 overexpressor strains, respectively (Fig. 5.6A-B). Methylation 
reactions require consumption of the methyl donor S-adenosylmethionine (SAM) (Mentch and 
Locasale, 2016). S-adenosylmethionine synthetase (sams) proteins synthesize SAM (Lieber, 
2002). Knockdown of sams-1 also has been shown to increase longevity, delay reproductive 
development, decrease brood size, and promote food avoiding behavior to a similar degree as 
set-4 overexpression (Hansen et al., 2005; Melo and Ruvkun, 2012). Reduction of dietary 
methionine, an essential metabolic precursor of SAM, has been shown to increase longevity in 
mammals (Miller et al., 2005; Orentreich et al., 1993). Furthermore, increasing SAM catalysis in 
Drosophila is sufficient to extend lifespan (Obata and Miura, 2015). sams-1 is X-linked, and we 
have shown set-4 promotes silencing of X-linked genes during development (Delaney et al., 
2017). W tested whether set-4 regulates sams-1 expression. However, sams-1 mRNA levels were 
not different between set-4 overexpressors and wild type siblings (Fig 5.6C). These findings are 
consistent with set-4 overexpression leading to increased consumption of SAM through 
methylation reactions while not affecting SAM synthesis itself. 
 
 
Figure 5.6. set-4 overexpression increases H4K20 methylation. (A) Representative images of 
embryos stained for H4K20 trimethylation and DAPI. N = 10 each for WT, dpIs7 and dpIs9. (B) 
Quantification of H4K20me3 signal normalized to DAPI, from (A). P < 0.01 by two-sided T test. (C) set-4 
overexpression does not affect sams-1 expression. Results are the mean and s.e.m. of three experiments 
performed in duplicate.  
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Discussion 
In the present study, we find that increased set-4 expression promotes longevity through 
induction of fasting behavior. Accompanying the DR-like phenotype and behavior of these 
animals is an increase in H4K20 trimethylation in embryos. More methylation would be 
consistent with increased consumption of the methylation co-factor SAM. Disrupting genes 
involved in SAM synthesis or increasing SAM catabolism has been linked with food avoidance, 
decreased brood size and increased longevity (Hansen et al., 2005; Melo and Ruvkun, 2012; 
Obata and Miura, 2015). Fasting leads to the induction of the longevity-promoting hlh-30 
transcription factor and its target genes which may be required for set-4 mediated longevity. 
Finally, we find evidence that H4K20 methylation levels are increased in eat-2 mutants, while 
set-4;eat-2 animals are sterile, suggesting this epigenetic mark may be critical for viability under 
conditions of dietary restriction during development. 
Histone H4 lysine 20 (H4K20) methylation plays an important role in cell cycle control, DNA 
origin of replication licensing, and promoting double strand break repair (Jorgensen et al., 2013). 
Different methylation states of H4K20 are associated with different functions that promote 
genomic integrity in mammals and fission yeast (Botuyan et al., 2006; Sanders et al., 2004; 
Schotta et al., 2008). H4K20 monomethylation (H4K20me1) enrichment marks active 
transcription and is important for successful progression through mitosis (Barski et al., 2007; Liu 
et al., 2010), while H4K20 dimethylation (H4K20me2) marks greater than 80% of histone H4 in 
G1 phase (Schotta et al., 2008). H4K20me2 is also important for recruiting 53BP1 and 
associated DNA damage response (DDR) proteins to double strand breaks in both fission yeast 
and mammalian HeLa cells (Botuyan et al., 2006; Pei et al., 2011). It remains to be tested 
whether SET-4 promotes longevity through maintenance of genomic integrity by promoting 
repair of DNA damage.  
The role of H4K20 trimethylation (H4K20me3) in maintenance of chromatin is less well 
understood. In mammalian cells H4K20 trimethylation is concentrated in constitutive 
heterochromatin in a manner dependent on HP1 and histone H3 lysine 9 trimethylation (Schotta 
et al., 2004; Souza et al., 2009). H4K20me3 is enriched in aged mammals relative to other 
histone marks (Sarg et al., 2002). A similar enrichment was observed in fibroblasts derived from 
progeria patients (Shumaker et al., 2006). However, whether H4K20me3 promotes an aging 
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phenotype or is a defense response to the progressive loss of heterochromatin remains unclear. 
Because SET-4 is required for both di- and tri-methylation of H4K20, at present we are unable to 
parse whether SET-4 promotes longevity through deposition of H4K20 dimethylation, 
trimethylation, or both. 
Signals from multiple tissues control longevity in C. elegans, including the intestine, germline, 
and neurons (Bishop and Guarente, 2007; Chen et al., 2009; Greer et al., 2010; Hsu et al., 2003). 
SET-4 activity in neurons promotes dauer arrest during development, but in adult animals 
intestinal DAF-16 is believed to mediate longevity (Libina et al., 2003). Also, set-4 expression in 
the soma is detectable only in neurons post-embryonically (Delaney et al., 2017). These 
observations may explain how SET-4 promotes DAF-16/FoxO activity during development 
while promoting longevity independently of DAF-16/FoxO (Fig. 5.2B-C). It is unlikely that 
SET-4 promotes longevity through the germline for two reasons. Despite endogenous set-4 being 
expressed in the germline (Jianhao Jiang, personal communication), transgenic constructs like 
those used in this study typically are silenced in the germline via endogenous RNAi mechanisms 
(Kelly et al., 1997; Shirayama et al., 2012). Second, one of the two integrated arrays (dpIs7) we 
empirically determined is X-linked, and X chromosome expression is silenced in the germline 
(Strome et al., 2014).  
Dietary restriction can increase lifespan through cell-nonautonomous signaling between neurons 
and the intestine. The hypoxia inducible factor HIF-1 acts in neurons to upregulate the longevity-
promoting flavin monooxygenase FMO-2 in the intestine (Leiser et al., 2015). Similarly, the 
NRF2 homolog SKN-1 B isoform is expressed exclusively in ASI sensory neurons and is 
required for increased longevity under a liquid DR regimen (Bishop and Guarente, 2007). We 
have shown set-4 is neuronally expressed in larvae, including in sensory neurons, and it 
functions in ASI to promote dauer arrest (Fig. 4.1B). Also, we showed that skn-1b is required for 
lipase gene expression in set-4 overexpressing strains (Fig. 5.4). Therefore, it is conceivable that 
SET-4 acts in neurons to induce a neuron-intestine longevity signal that shifts metabolism 
towards fatty acid catabolism through induction of HLH-30 activity. Whether this signal stems 
from locally reduced levels of SAM or results from increased higher order methylation of 
H4K20 remains unknown. It is conceivable that multiple consequences of methyltransferase 
activity may contribute to the longevity phenotype. 
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Multiple lines of evidence suggest the maintenance of heterochromatin promotes longevity. 
Aging is associated with loss of heterochromatin globally and skewed distribution locally 
(Oberdoerffer and Sinclair, 2007; Tsurumi and Li, 2012). Decreasing heterochromatin in 
Drosophila dramatically decreases lifespan while increasing heterochromatin formation robustly 
extends lifespan (Larson et al., 2012). How specific epigenetic modifiers participate in this 
phenomenon are also becoming clear. For example, sirtuin proteins deacetylate histone H4 lysine 
16, which promotes chromatin compaction and the establishment of heterochromatin marks 
(Sarg et al., 2004; Serrano et al., 2013a). SirT1 has H4K16 deacetylase activity and acts to 
stabilize the H3K9 trimethylase SUV39H1 protein to maintain genomic integrity at centromeres 
and telomeres (Bosch-Presegue et al., 2011; Garcia-Cao et al., 2004; Peters et al., 2001; Vaquero 
et al., 2007). Mammalian studies also suggest H3K9 trimethylation recruits SUV420H2 via HP1 
to trimethylate H4K20 in regions of constitutive heterochromatin (Schotta et al., 2004; Souza et 
al., 2009). H4K20, in turn, antagonizes the acetylation of H4K16 (Sarg et al., 2004; Serrano et 
al., 2013b). Interrogating the dynamics of these interrelated heterochromatin marks in long-lived 
model systems may reveal a virtuous cycle that promotes longevity through maintenance of 
heterochromatin, minimizing genomic damage and transcriptional drift during aging. 
Here we describe a novel epigenetic manipulation that recapitulates many of the phenotypes of 
dietary restriction, most notably long life. Importantly, epigenetic modifications are malleable. 
Not only are they altered under conditions of environmental toxicity and during aging 
(Oberdoerffer and Sinclair, 2007; Talens et al., 2012; Tsurumi and Li, 2012), but straightforward 
interventions like diet can lead to maintenance of heterochromatin-associated marks and down-
regulation of inflammation throughout life (Delaney et al., 2013; Delaney et al., 2012). Further 
investigation into epigenetic interventions that stabilize the genome may lead to more effective 
therapies for the chronic diseases of aging like rheumatoid arthritis, obesity, and dementia. 
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Materials and Methods 
Worm strains and maintenance 
Strains used in this study are as follows: set-4(n4600), set-4(ok1481), set-4(dp268), daf-
16(mu86), lipl-2(tm4324), lipl-3(gk224717), eat-2(ad1116), dpSi5 [set-4p::HA::set-4::set-4utr, 
unc-119(+,CB)] IV, dpEx18 [set-4p::HA::set-4::set-4utr, myo-2p::RFP]. Animals were 
propagated on nematode growth media (NGM) plates and fed E. coli OP50 using standard 
techniques. 
 
Generation of transgenic strains 
Extrachromosomal arrays were integrated as previously described (Mello et al., 1991) using a 
Stratalinker 1800 (Stratagene) at 325 µJ/cm2 x 100. L4 animals with the dpEx18 array were 
irradiated, then allowed to lay eggs until food was consumed. Transgenic animals were then 
singled and propagated. Transgenic animals whose progeny were 100% positive for the myo-
2p::RFP marker were considered integrated. Independent integrated transgenic lines were 
backcrossed ten times prior to analysis. CRISPR mutagenesis was performed as described (Paix 
et al., 2015) using recombinant Cas9 (PNA Bio) and crRNA and tracrRNA (Dharmacon). skn-1B 
exon 1 was targeted with the crRNA guide sequence 5’-GGCUGCUGGAGCGGUGUUGG-3’. 
The result is a stop codon after amino acid 22 and a +1 frameshift. 
 
Lifespan Assays 
Lifespan assays were performed at 20°C as previously described (Chen et al., 2015). Briefly, 
young adult (day 0) or day 1 adult animals were transferred to NGM plates seeded with 20X 
OP50 containing 50 µM 5-fluoro-2’-deoxyuridine (FUDR; Sigma-Aldrich, St. Louis, MO, USA) 
to control progeny and 10 µg/mL nystatin (Sigma-Aldrich) to inhibit fungal growth. 25 µg/ml 
carbenicillin was used in sDR plates to attenuate bacterial growth. RNAi experiments were 
conducted using dsRNA-expressing HT115 bacteria as previously described (Kamath et al., 
2001) and included 5 mM IPTG and 25 µg/ml carbenicillin. Completely paralyzed animals that 
did not respond to prodding were scored as dead and removed. Animals that left the plate or 
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exploded were censored. Statistical significance was calculated in Prism (GraphPad Software; La 
Jolla, CA, USA) using the log rank test. 
 
Microscopy 
DIC images of animals were taken using a Leica M165FC with a DFC9000 GT camera (Leica). 
Animal size was calculated in Image J by measuring the area of each animal.  
 
Immunofluorescence 
Embryos were fixed and stained with DAPI (1 µg/mL, Thermo D1306) and antibodies against 
H4K20me3 (1:200, Abcam, ab78517) as previously described (Chuang et al., 1994). Antibody 
specificity is reported on the Histone Antibodies Database (Rothbart et al., 2015). Anti-mouse 
FITC (1:100, Jackson ImmunoResearch) secondary antibodies were then applied. Fluorescent 
images were captured using an Olympus BX61 compound microscope using a 60X oil-
immersion objective, a Hamamatsu ORCA ERGA CCD camera, and Slidebook software 
(Intelligent Imaging Innovations). Mean intensity of antibody signal was measured using Image J 
and normalized to DAPI signal. 
 
Fertility Assay 
Late L4 animals were singled to new plates and allowed to lay eggs at 20°C. Egg-layers were 
transferred to new plates every 24 hr for 4 days. Living larvae on each plate were then counted to 
determine total fertility. 
 
Pumping assay 
L4 animals were transferred to fresh plates and allowed to recover. Pharyngeal pumps were 
counted at 120X magnification using the Leica M165FC microscope for 20 sec for each animal, 
after which the animal was removed from the plate. 
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Food avoidance assay 
Animals were grown on 3cm NGM plates with spotted with 50 µL of 4X concentrated OP50. 
Young adults were scored as on food or off food, from which the percent feeding was 
determined. 
 
Fasting assay 
Young adult animals were washed in M9 to remove all bacteria, then transferred to plates seeded 
with OP50 or plates without food. After 6 hr, animals were harvested for RNA as described 
below. 
 
RNA preparation 
Animals were washed three times in M9 buffer, once in water, then resuspended in 500 µL 
Trizol (Invitrogen). After 5 freeze/thaw cycles, RNA was extracted with chloroform and further 
purified using the Direct-zol RNA Miniprep Kit (Zymo Research). 
 
Quantitative PCR 
cDNA was reverse-transcribed with the SuperScript III First Strand Synthesis Kit (Invitrogen) 
using dT primers. cDNA was amplified using the Quantitect SYBRgreen qPCR Kit (Qiagen) in a 
total volume of 15 µL, performed in a RotorGene 6000(Corbett Research). RotorGene 6000 
Software (version 1.7) was used to calculate Ct. pmp-3 was used as a housekeeping gene, and 
relative expression was calculated using the ∆∆Ct method (Hoogewijs et al., 2008; Nolan et al., 
2006). Primer sequences are provided in Supplementary Table 5.1. 
 
Western blotting 
Gravid adults were dissolved in sodium hypochlorite to release eggs, which were allowed to 
hatch while rotating overnight in M9 buffer. Synchronized progeny were transferred to NGM 
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and grown to early L4. Animals were washed thrice in M9, once in water, and then resuspended 
in one pellet volume of worm lysis buffer (Webster et al., 2013) and frozen at -80°C until use. 
Protein preparation, transfer, and antibody detection were performed as previously described 
(Delaney et al., 2017). Briefly, animals were dissolved at 85C for 5 minutes then sonicated on ice 
for 2 cycles of 30 sec. Lysates were cleared by centrifugation at 21,000g for 15 minutes. Protein 
concentration was determined using the DC Protein Quantification Kit (BioRad). 50 µg protein 
per lane was added to Criterion XT gels using XT-MES buffer (BioRad) and transferred to 
Immobilon Psq PVDF (Millipore). Membranes were incubated with antibodies against 
H4K20me3 (1:500, Abcam ab78517) or H2B (1:1000, Abcam ab1790), diluted in Western 
Blocking Solution (Sigma), incubated overnight at 4°C, and washed three times with TBS + 
0.5% Tween 20 (TBST). Secondary antibodies conjugated to HRP were applied for at least one 
hour at room temperature. After three washes with TBST, signal was detected using ECL 
(Pierce). 
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Supplementary Information 
 
Supplementary Figure 5.S1. SET-4 regulates longevity. (A, B) set-4 mutants are short-lived relative to 
wild type siblings. Results are representative of two experiments. P < 0.05. (C) RNAi against set-4 begun 
at young adulthood extends lifespan. Results are representative of three experiments. P < 0.0001. Curves 
are significant as calculated by the log-rank test. 
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Supplementary Figure 5.S2. Strains overexpressing set-4 show altered egglaying dynamics. 
Animals were synchronized at L4 prior to beginning the experiment. (A) N = 8 WT, 8 dpIs7. (B) N = 8 WT, 
7 dpIs9. 
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Supplemental Table 5.1. qPCR primer sequences. 
Gene Forward primer Reverse primer 
alg-2 TGGTCGATAGGGATCATGG TCGAGTCGGGATGAACCT 
fmo-2 GACGTGGCAGTTGAGCAATC  ACACACGATGAGCTGGCTTT  
gcs-1 GGAATGCCTTACGGAGGTC CGATAGACATGTTTCATCCTTCTTT 
hlh-30 GGTGATAATGATCCGGAGGAC TCTTCGTCGGCGTTCAAT 
lipl-1 CGGTTTGCGCTGGACTTA GAACACGAGTTGCGTTAA 
lipl-2 CCCGAATTTGATGGTTGGTA ATCACAGAGTTCAGCCTC 
lipl-3 GCCCGAGCAAAGTGCAGC CCTTCAAGTTTTTGTGCT 
lipl-5 CATATGACTACCCCCCAAATCA CCATGTTACGTTTGTTTTCCCAAA 
mxl-3 ACTCGGATTCTTCCGATGAC TTCAAGTTCGTTGTGATGTGC 
pat-10 ACTCCGACAACATGGCTGA TGAGTGGCCATGATGTATCC 
pmp-3 GTTCCCGTGTTCATCACTCAT ACACCGTCGAGAAGCTGTAGA 
sod-2 TCGACCAGATTATGTCAATGCT GCATTAATTCTTGTGATTCAGCTC 
sod-3 TATTAAGCGCGACTTCGGTTCCCT CGTGCTCCCAAACGTCAATTCCAA 
 
  
	 157	
References 
An, J. H. and Blackwell, T. K. (2003). SKN-1 links C. elegans mesendodermal specification to a 
conserved oxidative stress response. Genes Dev 17, 1882-1893. 
Anselmi, C. V., Malovini, A., Roncarati, R., Novelli, V., Villa, F., Condorelli, G., Bellazzi, R. 
and Puca, A. A. (2009). Association of the FOXO3A locus with extreme longevity in a 
southern Italian centenarian study. Rejuvenation Res 12, 95-104. 
Baird, N. A., Douglas, P. M., Simic, M. S., Grant, A. R., Moresco, J. J., Wolff, S. C., Yates, J. 
R., 3rd, Manning, G. and Dillin, A. (2014). HSF-1-mediated cytoskeletal integrity 
determines thermotolerance and life span. Science 346, 360-363. 
Barski, A., Cuddapah, S., Cui, K., Roh, T. Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I. 
and Zhao, K. (2007). High-resolution profiling of histone methylations in the human 
genome. Cell 129, 823-837. 
Berrigan, D., Lavigne, J. A., Perkins, S. N., Nagy, T. R., Barrett, J. C. and Hursting, S. D. 
(2005). Phenotypic effects of calorie restriction and insulin-like growth factor-1 treatment 
on body composition and bone mineral density of C57BL/6 mice: implications for cancer 
prevention. In Vivo 19, 667-674. 
Bishop, N. A. and Guarente, L. (2007). Two neurons mediate diet-restriction-induced longevity 
in C. elegans. Nature 447, 545-549. 
Bluher, M., Kahn, B. B. and Kahn, C. R. (2003). Extended longevity in mice lacking the insulin 
receptor in adipose tissue. Science 299, 572-574. 
Bosch-Presegue, L., Raurell-Vila, H., Marazuela-Duque, A., Kane-Goldsmith, N., Valle, A., 
Oliver, J., Serrano, L. and Vaquero, A. (2011). Stabilization of Suv39H1 by SirT1 is part 
of oxidative stress response and ensures genome protection. Mol Cell 42, 210-223. 
Botuyan, M. V., Lee, J., Ward, I. M., Kim, J. E., Thompson, J. R., Chen, J. and Mer, G. (2006). 
Structural basis for the methylation state-specific recognition of histone H4-K20 by 
53BP1 and Crb2 in DNA repair. Cell 127, 1361-1373. 
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. 
C., Blenis, J. and Greenberg, M. E. (1999). Akt promotes cell survival by 
phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868. 
Chen, A. T., Guo, C., Itani, O. A., Budaitis, B. G., Williams, T. W., Hopkins, C. E., McEachin, 
R. C., Pande, M., Grant, A. R., Yoshina, S., et al. (2015). Longevity Genes Revealed by 
Integrative Analysis of Isoform-Specific daf-16/FoxO Mutants of Caenorhabditis 
elegans. Genetics 201, 613-629. 
Chen, D., Thomas, E. L. and Kapahi, P. (2009). HIF-1 modulates dietary restriction-mediated 
lifespan extension via IRE-1 in Caenorhabditis elegans. PLoS Genet 5, e1000486. 
Chuang, P. T., Albertson, D. G. and Meyer, B. J. (1994). DPY-27:a chromosome condensation 
protein homolog that regulates C. elegans dosage compensation through association with 
the X chromosome. Cell 79, 459-474. 
Davie, J. R., Xu, W. and Delcuve, G. P. (2016). Histone H3K4 trimethylation: dynamic interplay 
with pre-mRNA splicing. Biochem Cell Biol 94, 1-11. 
Delaney, C., Garg, S. K., Fernandes, C., Hoeltzel, M., Allen, R. H., Stabler, S. and Yung, R. 
(2013). Maternal diet supplemented with methyl-donors protects against atherosclerosis 
in F1 ApoE(-/-) mice. PLoS One 8, e56253. 
	 158	
Delaney, C., Hoeltzel, M., Garg, S. K., Warner, R., Johnson, K. and Yung, R. (2012). Maternal 
micronutrient supplementation suppresses T cell chemokine receptor expression and 
function in F1 mice. J Nutr 142, 1329-1335. 
Delaney, C. E., Chen, A. T., Graniel, J. V., Dumas, K. J. and Hu, P. J. (2017). A histone H4 
lysine 20 methyltransferase couples environmental cues to sensory neuron control of 
developmental plasticity. Development. 
Dumas, K. J., Guo, C., Shih, H. J. and Hu, P. J. (2013). Influence of steroid hormone signaling 
on life span control by Caenorhabditis elegans insulin-like signaling. G3 (Bethesda) 3, 
841-850. 
Field, A. E. and Adams, P. D. (2016). Targeting chromatin aging - The epigenetic impact of 
longevity-associated interventions. Exp Gerontol. 
Flachsbart, F., Caliebe, A., Kleindorp, R., Blanche, H., von Eller-Eberstein, H., Nikolaus, S., 
Schreiber, S. and Nebel, A. (2009). Association of FOXO3A variation with human 
longevity confirmed in German centenarians. Proc Natl Acad Sci U S A 106, 2700-2705. 
Garcia-Cao, M., O'Sullivan, R., Peters, A. H., Jenuwein, T. and Blasco, M. A. (2004). Epigenetic 
regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone 
methyltransferases. Nat Genet 36, 94-99. 
Greer, E. L., Dowlatshahi, D., Banko, M. R., Villen, J., Hoang, K., Blanchard, D., Gygi, S. P. 
and Brunet, A. (2007). An AMPK-FOXO pathway mediates longevity induced by a 
novel method of dietary restriction in C. elegans. Curr Biol 17, 1646-1656. 
Greer, E. L., Maures, T. J., Hauswirth, A. G., Green, E. M., Leeman, D. S., Maro, G. S., Han, S., 
Banko, M. R., Gozani, O. and Brunet, A. (2010). Members of the H3K4 trimethylation 
complex regulate lifespan in a germline-dependent manner in C. elegans. Nature 466, 
383-387. 
Guarente, L. and Picard, F. (2005). Calorie restriction--the SIR2 connection. Cell 120, 473-482. 
Hansen, M., Hsu, A. L., Dillin, A. and Kenyon, C. (2005). New genes tied to endocrine, 
metabolic, and dietary regulation of lifespan from a Caenorhabditis elegans genomic 
RNAi screen. PLoS Genet 1, 119-128. 
Hochbaum, D., Zhang, Y., Stuckenholz, C., Labhart, P., Alexiadis, V., Martin, R., Knolker, H. J. 
and Fisher, A. L. (2011). DAF-12 regulates a connected network of genes to ensure 
robust developmental decisions. PLoS Genet 7, e1002179. 
Honda, Y. and Honda, S. (1999). The daf-2 gene network for longevity regulates oxidative stress 
resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. 
FASEB J 13, 1385-1393. 
Hoogewijs, D., Houthoofd, K., Matthijssens, F., Vandesompele, J. and Vanfleteren, J. R. (2008). 
Selection and validation of a set of reliable reference genes for quantitative sod gene 
expression analysis in C. elegans. BMC Mol Biol 9, 9. 
Hsu, A. L., Murphy, C. T. and Kenyon, C. (2003). Regulation of aging and age-related disease 
by DAF-16 and heat-shock factor. Science 300, 1142-1145. 
Imai, S. and Kitano, H. (1998). Heterochromatin islands and their dynamic reorganization: a 
hypothesis for three distinctive features of cellular aging. Exp Gerontol 33, 555-570. 
Jin, C., Li, J., Green, C. D., Yu, X., Tang, X., Han, D., Xian, B., Wang, D., Huang, X., Cao, X., 
et al. (2011). Histone demethylase UTX-1 regulates C. elegans life span by targeting the 
insulin/IGF-1 signaling pathway. Cell Metab 14, 161-172. 
Jorgensen, S., Schotta, G. and Sorensen, C. S. (2013). Histone H4 lysine 20 methylation: key 
player in epigenetic regulation of genomic integrity. Nucleic Acids Res 41, 2797-2806. 
	 159	
Kamath, R. S., Martinez-Campos, M., Zipperlen, P., Fraser, A. G. and Ahringer, J. (2001). 
Effectiveness of specific RNA-mediated interference through ingested double-stranded 
RNA in Caenorhabditis elegans. Genome Biol 2, RESEARCH0002. 
Kelly, W. G., Xu, S., Montgomery, M. K. and Fire, A. (1997). Distinct requirements for somatic 
and germline expression of a generally expressed Caernorhabditis elegans gene. Genetics 
146, 227-238. 
Kennedy, B. K., Steffen, K. K. and Kaeberlein, M. (2007). Ruminations on dietary restriction 
and aging. Cell Mol Life Sci 64, 1323-1328. 
Kenyon, C., Chang, J., Gensch, E., Rudner, A. and Tabtiang, R. (1993). A C. elegans mutant that 
lives twice as long as wild type. Nature 366, 461-464. 
Lamming, D. W. (2016). Inhibition of the Mechanistic Target of Rapamycin (mTOR)-
Rapamycin and Beyond. Cold Spring Harb Perspect Med 6. 
Lan, F. and Shi, Y. (2009). Epigenetic regulation: methylation of histone and non-histone 
proteins. Sci China C Life Sci 52, 311-322. 
Lan, J., Zhang, X. and Chen, D. (2015). Molecular mechanisms of dietary restriction in aging-
insights from Caenorhabditis elegans research. Sci China Life Sci 58, 352-358. 
Lapierre, L. R., De Magalhaes Filho, C. D., McQuary, P. R., Chu, C. C., Visvikis, O., Chang, J. 
T., Gelino, S., Ong, B., Davis, A. E., Irazoqui, J. E., et al. (2013). The TFEB orthologue 
HLH-30 regulates autophagy and modulates longevity in Caenorhabditis elegans. Nat 
Commun 4, 2267. 
Larson, K., Yan, S. J., Tsurumi, A., Liu, J., Zhou, J., Gaur, K., Guo, D., Eickbush, T. H. and Li, 
W. X. (2012). Heterochromatin formation promotes longevity and represses ribosomal 
RNA synthesis. PLoS Genet 8, e1002473. 
Lau, A. C., Nabeshima, K. and Csankovszki, G. (2014). The C. elegans dosage compensation 
complex mediates interphase X chromosome compaction. Epigenetics Chromatin 7, 31. 
Lee, R. Y., Hench, J. and Ruvkun, G. (2001). Regulation of C. elegans DAF-16 and its human 
ortholog FKHRL1 by the daf-2 insulin-like signaling pathway. Curr Biol 11, 1950-1957. 
Leiser, S. F., Miller, H., Rossner, R., Fletcher, M., Leonard, A., Primitivo, M., Rintala, N., 
Ramos, F. J., Miller, D. L. and Kaeberlein, M. (2015). Cell nonautonomous activation of 
flavin-containing monooxygenase promotes longevity and health span. Science 350, 
1375-1378. 
Li, W., Kennedy, S. G. and Ruvkun, G. (2003). daf-28 encodes a C. elegans insulin superfamily 
member that is regulated by environmental cues and acts in the DAF-2 signaling 
pathway. Genes Dev 17, 844-858. 
Libina, N., Berman, J. R. and Kenyon, C. (2003). Tissue-specific activities of C. elegans DAF-16 
in the regulation of lifespan. Cell 115, 489-502. 
Lieber, C. S. (2002). S-Adenosyl-L-methionine and alcoholic liver disease in animal models: 
implications for early intervention in human beings. Alcohol 27, 173-177. 
Lin, K., Hsin, H., Libina, N. and Kenyon, C. (2001). Regulation of the Caenorhabditis elegans 
longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat Genet 28, 139-
145. 
Liu, W., Tanasa, B., Tyurina, O. V., Zhou, T. Y., Gassmann, R., Liu, W. T., Ohgi, K. A., Benner, 
C., Garcia-Bassets, I., Aggarwal, A. K., et al. (2010). PHF8 mediates histone H4 lysine 
20 demethylation events involved in cell cycle progression. Nature 466, 508-512. 
Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. and Kroemer, G. (2013). The 
hallmarks of aging. Cell 153, 1194-1217. 
	 160	
Mathew, R., Pal Bhadra, M. and Bhadra, U. (2017). Insulin/insulin-like growth factor-1 
signalling (IIS) based regulation of lifespan across species. Biogerontology 18, 35-53. 
Mello, C. C., Kramer, J. M., Stinchcomb, D. and Ambros, V. (1991). Efficient gene transfer in 
C.elegans: extrachromosomal maintenance and integration of transforming sequences. 
Embo J 10, 3959-3970. 
Melo, J. A. and Ruvkun, G. (2012). Inactivation of conserved C. elegans genes engages 
pathogen- and xenobiotic-associated defenses. Cell 149, 452-466. 
Mentch, S. J. and Locasale, J. W. (2016). One-carbon metabolism and epigenetics: 
understanding the specificity. Ann N Y Acad Sci 1363, 91-98. 
Miller, R. A., Buehner, G., Chang, Y., Harper, J. M., Sigler, R. and Smith-Wheelock, M. (2005). 
Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters 
glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress 
resistance. Aging Cell 4, 119-125. 
Nolan, T., Hands, R. E. and Bustin, S. A. (2006). Quantification of mRNA using real-time RT-
PCR. Nat Protoc 1, 1559-1582. 
O'Rourke, E. J. and Ruvkun, G. (2013). MXL-3 and HLH-30 transcriptionally link lipolysis and 
autophagy to nutrient availability. Nat Cell Biol 15, 668-676. 
Obata, F. and Miura, M. (2015). Enhancing S-adenosyl-methionine catabolism extends 
Drosophila lifespan. Nat Commun 6, 8332. 
Oberdoerffer, P. and Sinclair, D. A. (2007). The role of nuclear architecture in genomic 
instability and ageing. Nat Rev Mol Cell Biol 8, 692-702. 
Orentreich, N., Matias, J. R., DeFelice, A. and Zimmerman, J. A. (1993). Low methionine 
ingestion by rats extends life span. J Nutr 123, 269-274. 
Paix, A., Folkmann, A., Rasoloson, D. and Seydoux, G. (2015). High Efficiency, Homology-
Directed Genome Editing in Caenorhabditis elegans Using CRISPR-Cas9 
Ribonucleoprotein Complexes. Genetics 201, 47-54. 
Panowski, S. H., Wolff, S., Aguilaniu, H., Durieux, J. and Dillin, A. (2007). PHA-4/Foxa 
mediates diet-restriction-induced longevity of C. elegans. Nature 447, 550-555. 
Pei, H., Zhang, L., Luo, K., Qin, Y., Chesi, M., Fei, F., Bergsagel, P. L., Wang, L., You, Z. and 
Lou, Z. (2011). MMSET regulates histone H4K20 methylation and 53BP1 accumulation 
at DNA damage sites. Nature 470, 124-128. 
Peters, A. H., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schofer, C., 
Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001). Loss of the 
Suv39h histone methyltransferases impairs mammalian heterochromatin and genome 
stability. Cell 107, 323-337. 
Raizen, D. M., Lee, R. Y. and Avery, L. (1995). Interacting genes required for pharyngeal 
excitation by motor neuron MC in Caenorhabditis elegans. Genetics 141, 1365-1382. 
Rothbart, S. B., Dickson, B. M., Raab, J. R., Grzybowski, A. T., Krajewski, K., Guo, A. H., 
Shanle, E. K., Josefowicz, S. Z., Fuchs, S. M., Allis, C. D., et al. (2015). An Interactive 
Database for the Assessment of Histone Antibody Specificity. Mol Cell 59, 502-511. 
Salminen, A., Kaarniranta, K. and Kauppinen, A. (2016). AMPK and HIF signaling pathways 
regulate both longevity and cancer growth: the good news and the bad news about 
survival mechanisms. Biogerontology 17, 655-680. 
Sanders, S. L., Portoso, M., Mata, J., Bahler, J., Allshire, R. C. and Kouzarides, T. (2004). 
Methylation of histone H4 lysine 20 controls recruitment of Crb2 to sites of DNA 
damage. Cell 119, 603-614. 
	 161	
Sarg, B., Helliger, W., Talasz, H., Koutzamani, E. and Lindner, H. H. (2004). Histone H4 
hyperacetylation precludes histone H4 lysine 20 trimethylation. J Biol Chem 279, 53458-
53464. 
Sarg, B., Koutzamani, E., Helliger, W., Rundquist, I. and Lindner, H. H. (2002). Postsynthetic 
trimethylation of histone H4 at lysine 20 in mammalian tissues is associated with aging. J 
Biol Chem 277, 39195-39201. 
Schotta, G., Lachner, M., Sarma, K., Ebert, A., Sengupta, R., Reuter, G., Reinberg, D. and 
Jenuwein, T. (2004). A silencing pathway to induce H3-K9 and H4-K20 trimethylation at 
constitutive heterochromatin. Genes Dev 18, 1251-1262. 
Schotta, G., Sengupta, R., Kubicek, S., Malin, S., Kauer, M., Callen, E., Celeste, A., Pagani, M., 
Opravil, S., De La Rosa-Velazquez, I. A., et al. (2008). A chromatin-wide transition to 
H4K20 monomethylation impairs genome integrity and programmed DNA 
rearrangements in the mouse. Genes Dev 22, 2048-2061. 
Serrano, L., Martinez-Redondo, P., Marazuela-Duque, A., Vazquez, B. N., Dooley, S. J., Voigt, 
P., Beck, D. B., Kane-Goldsmith, N., Tong, Q., Rabanal, R. M., et al. (2013a). The tumor 
suppressor SirT2 regulates cell cycle progression and genome stability by modulating the 
mitotic deposition of H4K20 methylation. Genes & development 27, 639-653. 
---- (2013b). The tumor suppressor SirT2 regulates cell cycle progression and genome stability 
by modulating the mitotic deposition of H4K20 methylation. Genes Dev 27, 639-653. 
Shirayama, M., Seth, M., Lee, H. C., Gu, W., Ishidate, T., Conte, D., Jr. and Mello, C. C. (2012). 
piRNAs initiate an epigenetic memory of nonself RNA in the C. elegans germline. Cell 
150, 65-77. 
Shumaker, D. K., Dechat, T., Kohlmaier, A., Adam, S. A., Bozovsky, M. R., Erdos, M. R., 
Eriksson, M., Goldman, A. E., Khuon, S., Collins, F. S., et al. (2006). Mutant nuclear 
lamin A leads to progressive alterations of epigenetic control in premature aging. Proc 
Natl Acad Sci U S A 103, 8703-8708. 
Souza, P. P., Volkel, P., Trinel, D., Vandamme, J., Rosnoblet, C., Heliot, L. and Angrand, P. O. 
(2009). The histone methyltransferase SUV420H2 and Heterochromatin Proteins HP1 
interact but show different dynamic behaviours. BMC Cell Biol 10, 41. 
Strome, S., Kelly, W. G., Ercan, S. and Lieb, J. D. (2014). Regulation of the X chromosomes in 
Caenorhabditis elegans. Cold Spring Harb Perspect Biol 6. 
Talens, R. P., Christensen, K., Putter, H., Willemsen, G., Christiansen, L., Kremer, D., 
Suchiman, H. E., Slagboom, P. E., Boomsma, D. I. and Heijmans, B. T. (2012). 
Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on 
monozygotic twin pairs. Aging Cell 11, 694-703. 
Timmons, L., Court, D. L. and Fire, A. (2001). Ingestion of bacterially expressed dsRNAs can 
produce specific and potent genetic interference in Caenorhabditis elegans. Gene 263, 
103-112. 
Tsurumi, A. and Li, W. X. (2012). Global heterochromatin loss: a unifying theory of aging? 
Epigenetics 7, 680-688. 
Vanyushin, B. F., Nemirovsky, L. E., Klimenko, V. V., Vasiliev, V. K. and Belozersky, A. N. 
(1973). The 5-methylcytosine in DNA of rats. Tissue and age specificity and the changes 
induced by hydrocortisone and other agents. Gerontologia 19, 138-152. 
Vaquero, A., Scher, M., Erdjument-Bromage, H., Tempst, P., Serrano, L. and Reinberg, D. 
(2007). SIRT1 regulates the histone methyl-transferase SUV39H1 during 
heterochromatin formation. Nature 450, 440-444. 
	 162	
Vielle, A., Lang, J., Dong, Y., Ercan, S., Kotwaliwale, C., Rechtsteiner, A., Appert, A., Chen, Q. 
B., Dose, A., Egelhofer, T., et al. (2012). H4K20me1 contributes to downregulation of X-
linked genes for C. elegans dosage compensation. PLoS genetics 8, e1002933. 
Villeponteau, B. (1997). The heterochromatin loss model of aging. Exp Gerontol 32, 383-394. 
Webster, C. M., Wu, L., Douglas, D. and Soukas, A. A. (2013). A non-canonical role for the C. 
elegans dosage compensation complex in growth and metabolic regulation downstream 
of TOR complex 2. Development 140, 3601-3612. 
Wells, M. B., Snyder, M. J., Custer, L. M. and Csankovszki, G. (2012). Caenorhabditis elegans 
dosage compensation regulates histone H4 chromatin state on X chromosomes. 
Molecular and cellular biology 32, 1710-1719. 
Willcox, B. J., Donlon, T. A., He, Q., Chen, R., Grove, J. S., Yano, K., Masaki, K. H., Willcox, 
D. C., Rodriguez, B. and Curb, J. D. (2008). FOXO3A genotype is strongly associated 
with human longevity. Proc Natl Acad Sci U S A 105, 13987-13992. 
Yamamoto, R. and Tatar, M. (2011). Insulin receptor substrate chico acts with the transcription 
factor FOXO to extend Drosophila lifespan. Aging Cell 10, 729-732. 
 
	 163	
 
 
 
 
 
Chapter 6 
Conclusions and outstanding questions 
 
Overview 
We undertook the investigations presented in this dissertation to begin building fluency in how 
epigenetic mechanisms participate in DAF-16/FoxO mediated longevity. While the signaling 
logic of the insulin-like signaling pathway is well understood, how DAF-16/FoxO cooperates 
with chromatin modifiers remains incompletely understood. Emerging evidence suggests 
epigenetic mechanisms regulate not only expression of IIS signaling genes but also facilitate 
FoxO transcription factor binding to promoters. For example, DAF-16/FoxO is known to 
physically associate with the SWI-SNF chromatin-remodeling complex to promote transcription 
of target genes (Riedel et al., 2013). FoxO also is re-activated in tumor cells treated with DNA-
hypomethylating agents (Thepot et al., 2011). Since DAF-16/FoxO can bind upstream of 
thousands of genes	(Kumar et al., 2015), the epigenetic landscape may play a critical role in 
defining the stress response programs underlying developmental diapause and extended 
longevity across taxa. We showed that in C. elegans the H4K20 methyltransferase SET-4 
promotes DAF-16/FoxO activity through repression of the DAF-2/IGFR agonist INS-9 (Delaney 
et al., 2017). Intriguingly, H4K20 methylation of the igf2 locus was different between distinct 
models of senescence in human embryonic lung fibroblasts, suggesting that H4K20 regulation of 
insulin-like peptides and FoxO activity may be conserved in mammals 	(Zhang et al., 2010). 
Throughout the preceding chapters we used dauer arrest as a readout of DAF-16/FoxO activity. 
This alternate developmental fate of C. elegans provides an obvious phenotype suitable for 
screening for new pathway regulators. Interestingly, the SEAK screen produced a 
disproportionate number of strains featuring direct or mechanistic disruption of X chromosome 
gene expression (Delaney et al., 2017; Dumas et al., 2013; Itani et al., 2015). In chapters 3 and 4, 
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we reported how disrupting set-4 led to a nonlinear increase in expression of the DAF-2/IGFR 
agonist ins-9, suggestive of a novel feedback loop contributing to the dauer decision. Such 
findings implicate the importance of maintaining chromosome-wide epigenetic programs in 
preserving developmental plasticity. In chapter 5, we began to explore how SET-4 promotes 
longevity. That we observed longevity extension in a DAF-16/FoxO independent manner 
demonstrates the complex role of epigenetic programs in diverse developmental and cellular 
contexts. 
 
SET-4 acts in a sex-dependent manner to promote dauer arrest 
Using an unbiased approach, we isolated animals that failed to arrest as dauers at 25°C despite a 
genetic background associated with enhanced DAF-16/FoxO activity. Unexpectedly, many 
strains had mutations in epigenetic modifiers. We identified three strains with mutations in the 
conserved member of the dosage compensation complex (DCC), DPY-21, as well as the 
conserved SUV4-20 methyltransferase SET-4 (Delaney et al., 2017; Dumas et al., 2013). After 
establishing that dosage compensation per se promotes dauer arrest in XX hermaphrodites, we 
found that set-4 mutant animals demonstrated the same gender-dependent phenotype as dosage 
compensation knockdown. Both dpy-21 and set-4 mutant animals were insensitive to dauer-
inducing pheromone, demonstrating the physiological relevance of these epigenetic actors in 
promoting dauer. Surprisingly, post-embryonic set-4 expression is restricted to neurons, 
including sensory neurons which have been shown to be required for dauer arrest (Bargmann and 
Horvitz, 1991). We confirmed that neuronal expression of SET-4 is functionally relevant (Fig. 
3.3C), and restoration of SET-4 solely in the ASI sensory neurons was sufficient for dauer arrest 
(Fig. 4.2). While DPY-21 acts in several pathways to promote dauer, SET-4 is specific to IIS, 
allowing us to enrich for genes regulated by dosage compensation that regulate DAF-16/FoxO 
activity in neurons. 
This work was one of the first to implicate histone H4 lysine 20 methylation in regulation of 
FoxO transcription factor activation. Nevertheless, emerging findings in mammals may indicate 
that interplay between H4K20 and FoxO is conserved. Expression of the SET-4 ortholog 
SUV420H2 is dramatically upregulated in osteoblastogenesis, and is required for H4K20me3 
(Khani et al., 2017). Knockdown of SUV420H2 in these cells down-regulated markers 
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associated with osteoblast differentiation. Deficits in osteoblast differentiation are not due to 
general loss of heterochromatin because inhibition of the H3K27 methyltransferase EZH2 
decreases H3K27me3 but accelerates osteoblast differentiation (Dudakovic et al., 2016). 
Induction of osteoblast differentiation in bone progenitor cell lines was associated with decreased 
phosphorylation of the insulin receptor β subunit, Akt, and FoxO1 (Dudakovic et al., 2013). 
FoxO activity has been shown to play a role in reducing oxidative stress in osteoblasts and 
promoting bone homeostasis (Ambrogini et al., 2010; Li et al., 2010; Rached et al., 2010). Taken 
together, these findings suggest there may be a link between H4K20 methylation and FoxO 
activity promoting skeletal bone integrity that warrants further investigation. 
 
INS-9 may represent a novel node integrating upstream and downstream signals during 
environmental stress 
Using transcriptome profiling, we identified the incompletely characterized insulin-like peptide 
ins-9 (Delaney et al., 2017). ins-9 is the only X-linked ILP gene, making it potentially subject to 
dosage compensation. We found that ins-9 is expressed primarily in ASI sensory neurons, the 
origin of many neuroendocrine signals that mediate the dauer decision. Overexpressing ins-9 was 
sufficient for dauer bypass in animals that typically arrest at 25°C, while novel null alleles of ins-
9 partially rescued the defect in set-4;daf-2 animals and completely rescued the set-4 mutant 
defect in pheromone response. We demonstrated that DPY-21, SET-4, and DAF-16/FoxO are all 
necessary for silencing ins-9, creating the potential for feedback regulation on DAF-16/FoxO 
activity. Consistent with a feed-forward model, in dpy-21 and set-4 mutant backgrounds ins-9 
expression increased far greater than the two-fold change expected from disruption of dosage 
compensation. Other ILP regulatory loops have been suggested to play a role in the dauer 
decision (Hahm et al., 2009; Matsunaga et al., 2012). The decision whether to proceed with 
reproductive development or arrest as dauers is based on complex environmental stimuli acting 
through multiple signal transduction pathways and different tissues. Yet the dauer decision is all-
or-nothing. Past a certain developmental time, animals become committed to their fate (Schaedel 
et al., 2012). Feed forward signaling loops involving ILPs like INS-9 may be part of the 
mechanism through which animals integrate their inputs to commit to alternate developmental 
strategies. 
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In addition to providing evidence of DAF-16/FoxO feedback on to ins-9 expression, we showed 
that exposure to dauer pheromone also silenced ins-9 in a DAF-16/FoxO independent manner 
(Fig. 4.3). daf-28 expression is believed to be regulated by pheromone like ins-9, but these ILPs 
act in parallel to promote dauer bypass (Fig. 4.4). Therefore, upstream and downstream inputs 
converge on the ins-9 gene to repress activation of DAF-2/IGFR. Remarkably, how pheromone 
promotes dauer arrest is still poorly understood, but it is known that pheromone represses other 
ASI neuroendocrine signals including daf-7, daf-28, and ins-6 (Cornils et al., 2011; Li et al., 
2003; Ren et al., 1996). Understanding ins-9 regulatory dynamics may lead to clarifying how 
population stress is transduced into the decision to enter diapause. 
The purpose of our genetic screen was to find novel regulators of DAF-16/FoxO (Dumas et al., 
2013). The discovery of ins-9 regulatory dynamics demonstrates the utility of our approach. 
Because ins-9 null alleles do not have a dauer phenotype, identifying this gene as potentially 
important in transducing upstream pheromone signals into DAF-16/FoxO activation would be 
unlikely in an un-sensitized background. We found that SET-4 and DPY-21/DCC are required 
epigenetic co-factors that partner with DAF-16/FoxO to fully silence ins-9. Similarly, the 
extreme redundancy within the C. elegans family of ILPs could easily mask the importance of 
any one member. The unique position of ins-9 on the X chromosome was critical for its 
discovery and subsequent characterization. Taken together, what emerges is an appreciation that 
chromosomal location and chromosome-wide epigenetic regulatory mechanisms can synergize 
with conserved signal transduction pathways to control complex developmental fates. 
 
A novel behavioral model of dietary restriction 
Having established a role for SET-4 in promoting DAF-16/FoxO activity during development, 
we asked whether SET-4 also promotes longevity. Previous data using RNAi suggested set-4 
was associated with aging (Greer et al., 2010). Epigenetic modifications are likely to have 
multiple effects on gene expression that vary in their influence throughout a lifetime. Therefore, 
it is not necessarily inconsistent that SET-4 may act differently in development and during aging. 
We sought to clarify this discrepancy using loss of function mutants and overexpression. 
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In contrast to RNAi data, we found that set-4 mutant animals live consistently shorter than their 
wild type siblings (Fig. 5.1A). Animals could be sick or it could be that SET-4 promotes 
longevity. It remains unclear how loss of set-4 shortens lifespan. Possible mechanisms include 
chronic, modest impairment of dosage compensation over time or upregulation of DAF-16 
inhibitors during development. Comparative analyses of early and late life set-4 transcriptomes 
relative to wild type animals may be informative in clarifying epigenetic influences of longevity. 
Consistent with the idea that SET-4 promotes longevity, we observed animals overexpressing 
set-4 lived longer than their wild type siblings (Fig. 5.1B). These animals presented a phenotype 
consistent with dietary restriction. Dietary restriction operates in part through DAF-16/FoxO 
independent mechanisms, and we confirmed that lifespan extension in set-4 overexpressors did 
not require DAF-16/FoxO. These animals lack obvious physiological defects that could decrease 
food consumption; rather, they manifest food avoiding behavior, choosing to eat less during 
development. Fasting behavior induces the longevity-associated hlh-30 transcription factor and 
its target genes involved in detoxification and fat metabolism. Specifically, lipase activity may 
be required for longevity in this model (Fig. 5.4D-E). 
The induction of downstream longevity programs may occur in a cell-nonautonomous fashion. 
set-4 expression is restricted to neurons in the soma and inhibits insulin-like peptide signaling 
(Delaney et al., 2017). Therefore, it is conceivable that set-4 mediated alterations of neuronal 
signals may contribute to longevity. Previous work demonstrated that SKN-1/NRF2 acting in 
ASI sensory neurons is required for increased lifespan during DR (Bishop and Guarente, 2007). 
SET-4 expression in ASI is sufficient for dauer arrest (Fig. 4.2). Further, preliminary data 
indicates that the ASI-specific skn-1b isoform was required for lipase expression (Fig. 5.4F-G). 
Whether SET-4 mediates lifespan extension from sensory neurons, and if SKN-1 is necessary for 
this extension, remains to be addressed.  
SET-4 promotes higher order methylation of H4K20 that is associated with gene silencing and 
quiescence. Greater methylation of histones leads to catabolism of SAM. Both increased 
consumption of SAM and reduction in SAM synthesis is known to promote longevity, DR-
associated phenotypes, and food avoidance behavior (Hansen et al., 2005; Melo and Ruvkun, 
2012; Obata and Miura, 2015). Using this model, we may be able to clarify how metabolite 
levels in one tissue induce conserved longevity programs in other tissues. Identifying these key 
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metabolic signals may provide new targets therapeutic interventions for chronic illnesses like 
obesity and diabetes. 
While it remains necessary to confirm whether longevity associated with set-4 overexpression is 
due to conserved SET-4 methyltransferase activity, we have isolated strains whose food avoiding 
behavior leads to phenotypes characteristic of dietary restriction. Comparison with the eat-2 
model at the transcriptional level may provide clues in to which genes modulated by DR are 
important for longevity (Heestand et al., 2013). The downstream consequences of DR are shared 
across regimens, but the means of inducing DR are variable and have identified both parallel and 
interacting signaling pathways for DR-induced longevity (Greer and Brunet, 2009). This 
disconnect between models may be due to many factors, such as at what developmental stage 
animals are subjected to DR and whether these animals are cultured in liquid or on solid media. 
set-4 overexpressors can be cultivated under identical conditions as eat-2 animals, eliminating 
experimental confounds in cross-model analyses. What may emerge is a clearer understanding of 
the pathways critical for longevity in animals experience lifelong dietary restriction. 
 
CRISPR-Cas9 offers unprecedented genomic precision in evaluating gene function 
While conducting the research presented in this dissertation, the discovery and subsequent 
optimization of CRISPR-Cas9 mediated genome editing greatly enhanced our ability to 
manipulate the C. elegans genome. We benefited from this technological advance and 
characterized different methods of genome editing. Several vector-based methods as well as a 
method employing recombinant protein and guide RNA have been described (Dickinson et al., 
2015; Farboud and Meyer, 2015; Paix et al., 2015). Although vector-based systems could 
produce results (as evidenced by the dpSi6 construct discussed below), we found this method to 
be highly inefficient. We also observed a high degree of chimerism, where Cas9 became active 
only in somatic cells, leading to animals possessing the expected phenotype of the dpy-10 co-
injected marker but unable to transmit that phenotype to progeny. As a positive, we did recover 
an insert that was greater than 5 kb, suggesting this method has similar insert potential as the 
mosSCI method (Frokjaer-Jensen et al., 2010) in addition to greater flexibility as to where in the 
genome constructs can be inserted. 
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In comparison to the vector-based genome editing, we found the Paix/Seydoux method using 
recombinant Cas9 and RNA in combination with PCR or oligo repair templates to be robust 	
(Paix et al., 2015). Further, we have shown that PCR amplicons up to 3 kb in size can be inserted 
using this method. That said, homology-directed repair using single-stranded oligo templates of 
approximately 100 bp we found most efficient. Importantly, PCR-based homology directed 
repair might allow extrachromosomal arrays to assemble in animals. If the amplicon contains 
gene-activating regulatory sequences like promoters, false positives are possible. 
Despite the relative ease of editing genomes using CRISPR, we observed unexpected confounds 
in edited strains. We found that CRISPR mutagenesis may lead to multigenerational silencing of 
the edited locus, consistent with reports using both mosSCI and CRISPR mediated transgenesis 
(Leopold et al., 2015). When propagating or crossing animals, it is important to select for 
animals expressing a marker like fluorescence if possible. If no marker or phenotype is present, 
strains may have to be propagated or outcrossed for several generations prior to an insert to 
become functional. This phenomenon is likely mediated by endogenous RNAi mechanisms 
(Leopold et al., 2015; Luteijn et al., 2012; Shirayama et al., 2012) and may be more problematic 
when inserting fragments containing gene-regulatory information (Alexander Paix, personal 
communication). Not only is stochastic silencing an issue, off-target cuts elsewhere in the 
genome remain a potential confound. Good practice, therefore, is to isolate and test several 
transgenic lines even if they contain genetically identical alleles. These strains should also be 
outcrossed several times, which in our hands seemed to alleviate locus silencing. When feasible, 
a reporter showing locus activity should be included, or injected animals should be defective in 
endogenous RNAi pathways that may participate in silencing. While CRISPR continues to be 
optimized in worm systems, a role for classical transgenesis will persist due to the limitations of 
single copy constructs including insert size, reporter detection, and RNAi-mediated silencing. 
Generating novel alleles using CRISPR was critical for our understanding of ins-9’s emerging 
role inhibiting DAF-16/FoxO during development. The flexibility and precision of this 
technology is revolutionizing how we examine specific genes’ activities. This work also 
demonstrated the continuing value of classic mutagenesis screens. The SEAK screen produced a 
functionally null set-4 allele, pinpointing an active site residue deemed essential in human 
orthologs (Southall et al., 2014; Wu et al., 2013). Despite SET-4 being required for H4K20me2 
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and me3, and that SET-4 promotes dosage compensation, set-4 null animals have no obvious 
phenotypes. Surprisingly few genes are differentially expressed between set-4 mutants and wild 
type animals (Kramer et al., 2015). Only within the context of reduced insulin-like signaling 
were we able to begin to understand the role for set-4 during development. Combining classical 
genetics, next generation sequencing, and genome editing is likely to greatly accelerate our 
understanding of genetic and epigenetic regulation of conserved programs in development. 
 
Outstanding Questions 
How does pheromone regulate INS-9 activity? 
Genetics, stressors, and neuronal ablation have all be used to dissect the dauer developmental 
paradigm (Hu, 2007). Dauer pheromone has been shown to enhance arrest in daf-c strains at 
temperatures that permit reproductive development (Thomas et al., 1993). Remarkably, no 
reports have shown the effects of combining pheromone treatment with selective ablation of 
sensory neurons. As such, the exact neuronal circuitry required to respond to population stress is 
not established. Others have shown that ILP production in ASI as well as DAF-7/TGF-β is 
sensitive to dauer pheromone (Cornils et al., 2011; Li et al., 2003; Ren et al., 1996; Schackwitz 
et al., 1996), supporting our data implicating ASI in the translation of stress signals into 
neuroendocrine responses. 
INS-9 is a type β ILP made in ASI sensory neurons that promotes reproductive development. It 
is unique among previously described ILPs to be regulated both by dauer inducing pheromone 
and DAF-16/FoxO. We established that enhanced DAF-16/FoxO activity silences ins-9 
expression in a manner dependent on dosage compensation effectors DPY-21 and SET-4 
(Delaney et al., 2017). However, pheromone silences ins-9 independently of DAF-16/FoxO. 
How pheromone acts on the ins-9 locus remains to be elucidated. 
SET-4 is required for pheromone induction of dauer arrest, while ins-9 ablation rescues the 
defect in set-4 mutant animals. Based on these findings, our hypothetical model of ins-9 
regulation shows pheromone acting through SET-4 and DPY-21 to repress ins-9 (Fig. 3.6). 
However, it is possible that pheromone and dosage compensation regulate ins-9 in parallel. We 
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will cross our endogenous ins-9 reporter into distinct daf-c and daf-d backgrounds to test whether 
parallel dauer pathways converge on ins-9 and whether SET-4 and DPY-21 are required to 
silence ins-9 in the presence of pheromone. Similarly, because we can detect the single copy ins-
9 reporter, we can screen for genes important for pheromone-mediated ins-9 repression. 
Understanding ins-9’s role in the relay of extrinsic signals into morphologically distinct 
outcomes may clarify the distinct pathways that feed in to insulin-like signaling to promote 
DAF-16/FoxO longevity. 
 
How does dosage compensation synergize with DAF-16/FoxO to repress ins-9? 
Maintenance of dosage compensation is important in promoting longevity, while skewing of 
dosage compensation is associated with diseases of aging (Bajic et al., 2015; Delaney et al., 
2017; Gentilini et al., 2012; Yurov et al., 2014). Similarly, IIS pathway repression is an 
important determinant of overall longevity (Bluher et al., 2003; Kenyon et al., 1993; Yamamoto 
and Tatar, 2011). In C. elegans these seemingly independent regulatory mechanisms intersect 
during development to promote dauer arrest by repressing X-linked ins-9 (Delaney et al., 2017; 
Dumas et al., 2013). How worm dosage compensation is achieved remains unclear, but it is 
possible that the interplay with DAF-16/FoxO may support certain proposed models. Since the 
DCC acts over far distances to regulate dosage compensation, other epigenetic partners may be 
required locally. Our data supports such a model because SET-4, which has previously been 
associated with dosage compensation, is also required for repression of ins-9. The dynamic 
regulation of DAF-16/FoxO subcellular localization may also inform how dosage compensation 
works at the level of chromatin architecture. It has been suggested that the DCC prevents 
association of the X chromosome with regions associated with active transcription near nuclear 
pores 	(Sharma and Meister, 2015). DAF-16/FoxO is excluded from the nucleus when IIS is 
active, presumably by export through nuclear pores. We observed neither dosage compensation 
nor DAF-16 is sufficient to fully silence INS-9 (Fig. 3.5A). Therefore, in the absence of DAF-
16/FoxO the DCC may continue to partially exclude the ins-9 locus from transcriptionally active 
perinuclear regions. Disrupting the DCC may permit the ins-9 locus access to permissive nuclear 
spaces; however, nuclear DAF-16 can bind the ins-9 promoter and suppress its transcription 
(Honda et al., 2011). Examining whether DAF-16/FoxO is enriched in certain subnuclear regions 
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or if there are changes in DAF-16/FoxO occupancy on the X chromosome in wild type and DCC 
mutant animals may lead to clarifying how dosage compensation in achieved in C. elegans. 
 
How does EAK-7 inhibit DAF-16/FoxO activity? 
One of the potential outcomes of the SEAK screen would be to identify one or more genes that 
act in the eak pathway. EAK proteins act in parallel with IIS to inhibit DAF-16/FoxO without 
affecting its subcellular location (Alam et al., 2010; Hu et al., 2006). However, the mechanism of 
this inhibition remains unknown. EAK-7, the most downstream gene identified in the pathway, 
localizes to the plasma membrane via a myristoylation motif on its N-terminus (Alam et al., 
2010). Myristoylation can act both as a membrane anchor as well as an activation switch via 
intramolecular interactions (Xu et al., 2015).  
Using CRISPR, we created myristoylation-dead EAK-7(G2A) mutants (Fig. 6.1A). One of these 
lines possessed a transmembrane domain on the N-terminus (TM-G2A, dpSi6), mimicking the 
effect of constitutive myristoylation, inserted in a locus on chromosome IV near the cxTi10882 
mosSCI insertion site. TM-G2A was sufficient to rescue dauer bypass in eak-7(tm3188);akt-1 
animals at 25°C (Fig. 6.1B). In contrast, the untethered G2A allele, dp684, behaved similarly to 
the null tm3188 allele when crossed in to an akt-1 background at 25°C (Fig. 6.1C). These data 
indicate membrane association is both necessary and sufficient for EAK-7 activity. Therefore, 
other proteins are likely involved in transducing the signal from EAK-7 to inhibit DAF-16 in the 
nucleus. Intriguingly, at 27°C, the dp684 allele may have a stronger dauer phenotype than the 
tm3188 allele (Fig. 6.1D). If reproducible, this finding would suggest that the myristoylation-
dead EAK-7 might retain binding to proteins important for inhibiting DAF-16/FoxO and 
sequester them away from their site of action. Future studies using the novel dp684 allele may 
provide greater insight into which proteins bind to EAK-7 and how the eak pathway inhibits the 
activity of nuclear DAF-16/FoxO. 
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Figure 6.1. EAK-7 membrane association is necessary and sufficient for inhibition of DAF-
16/FoxO. (A) Schematic of wild type EAK-7 and EAK-7(G2A) mutant protein. (B) A transmembrane 
anchored single-copy transgene encoding myristoylation-dead EAK-7(G2A), dpSi6, rescues reproductive 
development in eak-7;akt-1 animals. Results are the mean and s.e.m. of three experiments. N = 607, 657, 
503. (C) The myristoylation-dead eak-7(dp684) allele phenocopies the null eak-7(tm3188) allele in 
combination with an akt-1(ok525) null allele. Results are the mean and s.e.m. of three experiments. N = 
657, 677, 967, 737. (D) eak-7(dp684) single mutants may arrest at greater rates than the null eak-
7(tm3188) allele at 27°C on NGM plates containing typical cholesterol levels. Results are a single 
experiment performed in triplicate. N = 247, 183, 234. 
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Can we parse whether H4K20 dimethylation or trimethylation of H4K20 is required for 
dauer arrest? 
The dosage compensation complex controls the deposition of H4K20 methylation on the X 
chromosome. Relative to the autosomes, H4K20me1 is enriched while H4K20me3 is depleted. 
Loss of dosage compensation rescues the imbalance in H4K20me1 levels (Vielle et al., 2012). 
Nevertheless, our data along with others suggests that, in addition to SET-1 (monomethylase), 
SET-4 (di-/tri-methylase) may be required for dosage compensation	(Delaney et al., 2017; Lau et 
al., 2014; Webster et al., 2013; Wells et al., 2012). We confirmed previous data that 
demonstrated SET-4 is required for both H4K20 di- and tri-methylation (Delaney et al., 2017; 
Vielle et al., 2012; Wells et al., 2012); however, two possible interpretations of these data are 
that 1) SET-4 performs both functions, combining the functions of the two closely related 
mammalian homologs SUV420H1 and SUV420H2, and/or 2) a different lysine 
methyltransferase performs H4K20 trimethylation yet requires a dimethylated substrate upon 
which to act. These possibilities are not mutually exclusive, as multiple lysine methyltransferases 
may act on the same substrate (Greer et al., 2014; Towbin et al., 2012), and these histone 
methyltransferases may be expressed at different developmental times or tissues in a regulated 
fashion. 
Examining SET-4 orthologs provides conflicting data as to whether SUV4-20 enzymes can 
trimethylate H4K20. The SET domain of SUV4-20 methyltransferases is highly conserved from 
fission yeast to mammals, but these homologs display marked differences in number of methyl 
groups able to be transferred to the lysine substrate. For example, in Schizosaccharomyces 
pombe, Set9 is required for all three methylation states of H4K20 (Sanders et al., 2004; Wang et 
al., 2009). Drosophila SUV4-20, like SET-4, is believed to generate both dimethyllysine and 
trimethyllysine products with a preference for dimethylation	(Yang et al., 2008). However, both 
fission yeast and fly data are similarly confounded. Because SUV4-20 enzymes are necessary for 
lower methylation states, attributing trimethylation activity is not possible in vivo. 
Mammals have two SUV4-20 orthologs with nonredundant roles in development that recognize 
different consensus binding motifs on histone and non-histone substrates (Schotta et al., 2008; 
Weirich et al., 2016). Immunofluorescence experiments in mouse embryonic fibroblasts (MEFs) 
lacking SUV420H1 are deficient in H4K20me2 while H4K20me3 remains intact. Conversely, 
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MEFs lacking SUV420H2 lack H4K20me3 but retain H4K20me2. Importantly, antibodies to 
specific histone post-translational modifications sometimes exhibit cross-reactivity with other 
methylation states of the same residue or even modifications on other histone tails. Nevertheless, 
these data suggest that SUV420H1 is the mammalian H4K20 dimethylase while SUV420H2 can 
trimethylated H4K20, and both enzymes act on a monomethylated substrate to generate distinct 
modifications. 
In contrast to these findings, others and we have shown that SET-4 and SUV420H2, like 
SUV420H1, is limited to dimethylation in vitro using mass spectrometry and recombinant 
peptide substrates (Delaney et al., 2017; Southall et al., 2014; Wu et al., 2013). Importantly, in 
these in vitro assays, truncated human proteins possessing intact SET domains were used for 
analysis, and only peptide substrates were used. When whole nucleosome substrates were used, 
truncated versions of both SUV420H1 and SUV420H2 were reported to trimethylate H4K20 
(Schotta et al., 2004). We incubated recombinant GST::SET-4 and GST::SUV420H2 with 2.5 µg 
HeLa nucleosomes for 12 hr at 30°C as described (Delaney et al., 2017). Full length 
GST::SUV420H2 was capable of increasing trimethylated H4K20 while SET-4 depleted 
H4K20me1 without generating a detectable trimethylated product (Fig. 6.2). Together with mass 
spectrometry data, this is consistent with SET-4 being limited to dimethylation. 
 
 
Figure 6.2. SET-4 does not trimethylate H4K20 nucleosomes in vitro. (A) Histone methyltransferase 
assays were performed as described in Delaney et. al., 2017 for 12 hr at 30°C. H4K20 modifications were 
detected with western blotting. (B). Quantification of H4K20me1 depletion in (A). Results are the mean 
and s.e.m of three experiments. P < 0.05. 
	 176	
SET-4 is more similar to SUV420H1 than SUV420H2 in the amino acid residues near the 
catalytic serine. Intriguingly, the side chains of the +1 amino acid adjacent to the catalytic serine 
in SET-4/SUV420H1 and SUV420H2, valine and isoleucine, respectively, differ by a single 
methyl group; however, crystallization studies suggest these side chains stabilize protein-histone 
binding via hydrophobic interactions rather than participate in catalysis (Southall et al., 2014). 
Crystal structures also suggest that trimethylation function is energetically unfavorable due to 
hydrogen bonding between the active site serine and the lysine ε-Nitrogen, suggesting that 
SUV420 enzymes may be limited to dimethylation activity and/or they may require cofactors to 
gain trimethylase activity. These reports also demonstrated that the analogous residue to SET-4 
serine 182 is absolutely required for enzymatic activity in both SUV420H1 and SUV420H2, 
consistent with our data suggesting set-4(dp268) is a functionally null allele (Delaney et al., 
2017). 
SUV4-20 methyltransferases are most divergent in their post-SET C-terminal domains. These 
differences may be critical for proper localization and function. SET-4 is unique among its 
homologs in not possessing an extensive post-SET domain. In contrast, SUV420H2 contains a 
chromoshadow motif, which directs its localization to constitutive heterochromatin through 
interactions with HP1 (Smothers and Henikoff, 2000; Souza et al., 2009). Such an interaction 
may facilitate subsequent trimethylation. Although HP1 is implicated in regulating 
trimethylation in Drosophila, HP1 binding motifs have not been described in other H4K20 
methyltransferases (Yang et al., 2008). As such, H4K20me3 is diffuse throughout the nucleus in 
S. pombe rather than concentrated at heterochromatic foci (Sanders et al., 2004). Notably, Set9 
requires interaction with a PWWP domain-containing protein, Pdp1, in order to methylate 
H4K20 (Wang et al., 2009). The Pdp1-binding region of Set9 remains undescribed. Further 
studies are needed to understand whether SET-4 interacts with other proteins to regulate its 
function in vivo, and if so, whether H4K20 dimethylation and/or trimethylation are required for 
dauer arrest in response to stressful environmental conditions. 
Other conserved proteins have been identified as having trimethylase activity on H4K20, and all 
identified enzymes have worm homologs	(Dai et al., 2017; Foreman et al., 2011; Kidder et al., 
2017; Stender et al., 2012). Intriguingly, a recent study into Artemia developmental diapause 
implicated SETD4 in specific trimethylation of a dimethylated H4K20 substrate (Dai et al., 
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2017). SETD4 and associated H4K20me3 were required for Artemia larval arrest under adverse 
environmental conditions, analogous to C. elegans requiring SET-4. Examining strains deficient 
in these putative trimethylases may clarify the role of SUV4-20 enzymes like SET-4 in 
establishing trimethylation of H4K20. Finding ways to parse dimethylation and trimethylation 
may be critical to resolving the conflicting findings between SET-4 being required for dosage 
compensation while higher order H4K20 methylation states are depleted on X in a DCC-
dependent manner. Separating these two marks may also resolve the role of H4K20me3 
enrichment in aging organisms as either a progeric program that promotes senescence or a 
protective response against genomic stress that puts a brake on inappropriate cell proliferation. 
 
Are other epigenetic enzymes necessary for dauer arrest? 
There is evidence that certain epigenetic programs involved in heterochromatin formation 
contribute to longevity in addition to SET-4. Whether overexpression of SIR-2.1 increases 
longevity has been controversial due to genetic background (Burnett et al., 2011; Lombard et al., 
2011; Viswanathan and Guarente, 2011). Nevertheless, such a finding would be consistent with 
the established antagonistic role of H4K20 methylation and H4K16 acetylation. Further, 
knockdown of many histone methyltransferases extends mean lifespan, including the H3K4-
targeting Trithorax complex components set-2 and ash-2 (Greer et al., 2010; Greer et al., 2011). 
Unlike H4K20, H3K4 methylation is strongly associated with active gene expression. Similarly, 
loss of the heterochromatin protein 1 ortholog hpl-2, which upregulates germ line gene 
expression, modestly increases lifespan and augments dauer in animals with enhanced DAF-
16/FoxO activity (Meister et al., 2010). However, the roles of epigenetic enzymes in regulation 
of dauer arrest remains broadly unexplored. Deposition of H4K20 methylation is linked to the 
establishment of a heterochromatic landscape through the de-acetylation of H4K16 and the 
trimethylation of H3K9. Further, these marks have been associated with X chromosome 
regulation (Snyder et al., 2016; Wells et al., 2012). Our data suggests that systematically 
disrupting genes encoding epigenetic readers, writers and erasers may uncover novel influences 
on DAF-16/FoxO activity in development and longevity. Indeed, the intermediate dauer 
phenotype of set-4;daf-2 double mutants may provide a sensitized background within which to 
interrogate the contributions of candidate epigenetic modifiers to this model of developmental 
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plasticity. Findings in this context may lead to greater insight regarding how conserved 
epigenetic mechanisms regulate FoxO transcription factors in development and longevity. 
 
Summary 
We endeavored to understand how epigenetic regulators associated with dosage compensation 
promote DAF-16/FoxO activity. The work contained within this dissertation demonstrates that 
SET-4 and DPY-21 synergize with DAF-16 during development to promote dauer diapause 
through repression of X-linked insulin-like signaling genes, including insulin-like peptide ins-9. 
In answering this basic question, we have opened new avenues of investigation in to the complex 
regulation of developmental plasticity and longevity. We created new tools with which to 
explore heretofore-unaddressed gaps in our knowledge regarding the integration of transcription 
factor activity, chromatin packaging, and environmental cues to produce radically different 
developmental strategies. These and subsequent findings may contribute to understanding similar 
interplay in human tissues leading to novel interventions to address chronic diseases of aging. 
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